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Foodborne human illness caused by pathogenic bacteria is a significant health and 
economic burden worldwide. Efficient food decontamination methods that do not alter 
food quality can greatly alleviate this burden. Cold atmospheric plasma, which is ionized 
gas generated at room temperature and atmospheric pressure, is an emerging technology 
that offers a dry, non-thermal, rapid decontamination process with minimal damage to 
food products. Surface dielectric barrier discharge (SDBD) is an open-air cold plasma 
generation technology with low power requirements that is more flexible, portable, and 
scalable than current cold plasma generation methods. Although the bactericidal effects 
of cold plasma are well documented, the specific mechanism by which bacterial 
inactivation occurs is not well understood. In this research, a novel SDBD design was 
used to evaluate 1) induced airflow dynamics and bacterial foodborne pathogen 
inactivation, 2) morphological and transcriptomic responses of Salmonella to cold plasma 
treatment, and 3) the potential for bacterial resistance development to cold plasma. The 
novel SDBD actuator designs were found to induce a localized airflow that pushes 
reactive species to distant surfaces, allowing inactivation of common bacterial pathogens 
on biotic and abiotic surfaces. The transcriptomic response of surviving Salmonella cells 
to SDBD revealed a general decrease in stress responses thought to be a result of rapid 
lipid peroxidation, cytosolic leakage, and cell lysis, as revealed by transmission electron 
microscopy and RNA sequencing. In contrast, DNA and protein damage by plasma-
produced RONS were found to have a minor role in SDBD-induced inactivation of 
Salmonella. Furthermore, after treating a population of plasma-injured cells in 
succession, no significant differences in bacterial inactivation rates or differential gene 
expression were identified that could potentially lead to resistance development. These 
results confirm that the novel SDBD cold plasma actuators have potential applications in 
food surface decontamination and that the physical process of lipid peroxidation is a 
major cause of bacterial inactivation. Following further optimization and delineation of 
treatment parameters and plasma generation characteristics of the novel SDBD actuators, 
cold plasma will be a viable alternative to help alleviate the global burden of foodborne 
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 Foodborne human illness caused by pathogenic bacteria is a significant health and 
economic burden worldwide. Salmonella enterica subspecies enterica (Se), Shiga toxin-
producing Escherichia coli (STEC), and Listeria monocytogenes (Lm) are among the 
most commonly isolated bacterial foodborne pathogens and cause more hospitalizations 
and deaths than all other known bacterial pathogens (Scallan et al., 2011). Contamination 
of food products by pathogens such as these can occur at any point throughout food 
production, distribution, and preparation processes, necessitating effective and efficient 
decontamination methods prior to consumption (Aruscavage et al., 2006; Abadias et al., 
2006). However, few effective and minimally damaging decontamination methods are 
available for foods that are consumed raw or minimally processed (Goodburn and 
Wallace, 2013). Consumers are becoming increasingly conscious of the nutritional 
benefits of some minimally processed foods, especially fresh produce, and an increased 
consumption of these products has been documented in recent years (Barth et al., 2010). 
Unfortunately, concomitant with this trend, an increased incidence of foodborne illness 
associated with fresh produce has also been documented (Sivapalasingam et al., 2004; 
Painter et al., 2013; CDC, 2013).  
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 Foods consumed raw or minimally processed pose notable challenges for 
decontamination. The nutritional, structural, and aesthetic properties of such foods are 
important to consumers and need to be maintained. However, few of the major 
decontamination methods currently used for fresh produce, including chlorine washes, 
chlorine dioxide treatments, ozone fumigation, and irradiation, are ideally cost effective, 
versatile, and efficient while maintaining the physical and nutritional traits desired by 
consumers (Goodburn and Wallace, 2013; Gil et al., 2015). Therefore, new 
decontamination methodologies are continually being developed and tested (Foong-
Cunningham and Verkaar, 2012; Stopforth et al., 2008). The use of cold atmospheric 
plasma, which is ionized gas generated at ambient temperature and atmospheric pressure, 
is one such method.  
 UV light, charged particles, and reactive species are the cold plasma products 
most often cited for causing bacterial inactivation (Misra et al., 2011; Mai-Prochnow et 
al., 2014). UV light and charged particles play minor roles in bacterial inactivation, 
whereas reactive oxygen and nitrogen species (RONS) are the primary plasma products 
that damage bacterial cells when the plasma is generated in air. RONS are components or 
by-products of several essential cellular processes and bacteria have well established 
pathways for reducing these reactive species before they can cause cellular damage. 
However, in times of high oxidative stress, such as during cold plasma treatment, cells 
are not able to keep up with the accumulation of reactive species and damage to lipids, 
proteins, and DNA can occur, resulting in cell death. Ozone (O3) is a neutral reactive 
oxygen species of special note that has received increased interest in recent years for food 
decontamination applications. This relatively long-lived ROS that naturally converts back 
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to harmless molecular oxygen is a well-known and powerful antimicrobial agent that is 
produced in high amounts by cold plasma generation in air (Khadre et al., 2001; 
Sakiyama et al., 2012) and is generally recognized as safe (GRAS) by the FDA when 
used for food decontamination. It is likely that ozone itself is not a major contributor to 
bacterial inactivation but it serves as a precursor to other, more reactive species (such as 
hydrogen peroxide, superoxide, and hydroxyl radical) when it rapidly interacts with free 
water on the surface of bacterial cells (Sakiyama et al., 2012). The detrimental effects to 
bacterial cells can occur in a matter of seconds when they are exposed directly to cold 
plasma.  
 There are multiple approaches to generate cold plasma with air at atmospheric 
pressure, only a few of which are practically suitable for food decontamination 
applications in a scalable format (Misra et al., 2011; Niemira, 2012). Therefore, the main 
challenge in cold plasma treatment of complex food surfaces has to do with the means of 
reactive species delivery to the treated surface. Accordingly, the major differences in the 
various plasma-generation methods relate to the modes by which charged particles, 
photons, and reactive species are allowed to interact with target cells on contaminated 
substrates. The major plasma-generation approaches currently used include plasma pens, 
jets, torches, the use of high-energy deep-UV light, and microwave excitation (Misra et 
al., 2011). All of these approaches require complex apparatuses, high input powers, and a 
supplied flow of inert gas, resulting in high operational costs and limited practical 
applications. Dielectric barrier discharge (DBD), in contrast, is one of the simplest 
approaches for cold plasma generation (Kogelschatz et al., 1999). Using this format, 
plasma can be generated with air at room temperature and atmospheric pressure, 
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requiring no enclosures or supplied gas flow. In its most basic form, termed surface 
dielectric barrier discharge (SDBD), plasma is generated as a result of charge 
accumulation on one side of a dielectric barrier placed between two electrodes. The 
electric potential accumulates to a point until the air between the electrodes is ionized, 
forming plasma (Gibalov and Pietsch, 2000).  
 One of the results of the SDBD process is the production of an induced localized 
airflow. Accordingly, SDBD has been extensively researched and developed for 
applications in the aerospace industry, in which it is used to induce or modify airflow 
over the surfaces of aircraft wings. It is a novel low-power, active flow control technique 
used to improve the aerodynamic characteristics and propulsion efficiency of aircraft (Li 
et al., 2011). The self-induced localized airflow of SDBD is therefore hypothesized to 
carry with it the generated reactive species and charged particles for a short distance until 
they revert back to their normal, stable state. The electrodes can be arranged in such a 
way as to increase the amount of induced airflow and therefore maximize the distance 
that reactive species can travel before reverting back to their unreactive state. For food 
decontamination applications, the induced airflow allows delivery of RONS, and 
particularly ozone, to surfaces that are some distance from SDBD actuators themselves. 
As a result of these characteristics, SDBD has the potential to overcome many of the 
limitations of current plasma generation approaches for food decontamination 
applications. Surface DBD cold plasma actuators are relatively simple and flexible 
apparatuses, require less energy input than other methods, induce a localized airflow and 
thus diffusion of reactive species into hard-to-reach surface crevices without any 
additional inputs, and are easily scalable. 
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 Previous researchers investigating the effectiveness of cold plasma as a 
decontamination method have identified several aspects of treatment that are common to 
multiple types of plasma generation methods and apparatuses. These findings include that 
initial cell concentration influences bacterial inactivation rates (Fernandez and 
Thompson, 2012; Gaunt et al., 2006), bacterial inactivation is independent of growth 
phase and temperature (Fernandez et al., 2013), increased treatment time is required for 
decontamination of complex food surfaces (Fernandez et al., 2013; Ziuzina et al., 2014), 
and cold plasma treatment does not detrimentally affect fresh produce quality (Misra et 
al., 2014a; Misra et al., 2014b; Lacombe et al., 2014; Fernandez et al., 2013). What is not 
well understood, despite the commonalities for all plasma generation apparatuses, is the 
specific mechanisms by which plasma or plasma-generated species inactivate bacterial 
pathogens. The key distinctive feature of SDBD, when compared to other plasma 
generation apparatuses, is that the former induces a localized airflow that may allow 
delivery of reactive species and charged particles to distant surfaces.  
 Therefore, it was the goal of this research to evaluate the potential of SDBD to 
inactivate bacterial pathogens on biotic and abiotic surfaces and to contribute to the 
growing understanding of the mechanistic effects of cold plasma generation has on 
bacterial cells. Rather than simply repeat similar assays that have been done by other 
groups to evaluate novel cold plasma generation apparatuses, an approach was chosen for 
this research that would allow evaluation of the bacterial inactivation potential of SDBD 
in a way that has not been done before while still allowing comparison to previous 
findings in the literature. Thus, the bacterial inactivation potential and induced airflow 
dynamics of SDBD were evaluated, the transcriptomic response of Salmonella to SDBD 
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treatment was analyzed using RNA-sequencing, and the potential for resistance 
development was evaluated preliminarily for Salmonella by successively treating plasma-
injured cells and comparing any genotypic changes to before the successive treatments. 
This research report contains the first known data correlating bacterial inactivation rates 
with induced airflow by SDBD (Chapter 3), evaluating the transcriptomic response of a 
bacterial pathogen to cold plasma treatment using RNA-sequencing (Chapter 4), and 
preliminarily evaluating the potential for bacterial development of resistance by 
successive treatments of plasma injured cells (Chapter 5).  The results of this study will 
aid in design optimization of SDBD devices for increased pathogen inactivation 
efficiency and add to the growing body of literature delineating the mechanistic effects of 
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 Global awareness of the importance of food safety and food security is at an all-
time high (Yiannas, 2009). Increased globalization of the food supply, changing 
consumer habits, intentional food adulteration, the threat of agroterrorism, and growing 
concerns about the sustainability of current food production systems with a rapidly 
increasing population each brings new challenges for developing and/or maintaining a 
safe and secure food supply. As defined by the Food and Agriculture Organization (FAO) 
of the United Nations, food security is a national responsibility enjoyed by individuals 
that “exists when all people, at all times, have physical and economic access to sufficient, 
safe and nutritious food to meet their dietary needs and food preferences for an active and 
healthy life (FAO, 1996).” The 4 pillars of food security, availability, access, utilization, 
and stability, are built upon a foundation of food safety (FAO, 2006). If a food supply is 
not safe, it is probably not secure. Although great progress has been made in promoting 
food safety and reducing foodborne illnesses through good agricultural practices (GAPs), 
robust hazard analysis and critical control point (HACCP) plans during  
10 
 
food processing, and increasingly sensitive and rapid outbreak detection methods, 
foodborne illness are still major public health issues worldwide (WHO 2007). 
 Foodborne illness is defined as disease caused by an infectious or toxic agent that 
enters the body through contaminated food (WHO, 2007). It can be caused by bacteria, 
parasites, viruses, or toxins as a result of the pathogens themselves, pathogen-produced 
toxins, or toxic chemicals (Hird et al., 2009). While more than 250 distinct foodborne 
diseases have been described, the majority are caused by foodborne pathogens rather than 
by harmful chemicals (CDC, 2011). Approximately 9.4 million illnesses, 55,961 
hospitalizations and 1,351 deaths occur each year in the United States, attributed to 31 
major foodborne pathogens (Scallan et al., 2011). One in 6 Americans experience 
foodborne illness every year, but the illness incidence in other parts of the world can be 
much higher (Havelaar et al., 2013). 
 Reducing the burden of foodborne illness requires identification of commonly 
contaminated food sources and implementation of appropriate and effective control 
strategies (WHO 2007). Control strategies can be divided into 2 broad categories: 1) 
prevention of contamination and 2) decontamination (Thorns, 2000). While preventing 
contamination should be the first priority and would eliminate the need for subsequent 
decontamination, it is not feasible or practical for many food products. As a result, 
decontamination strategies are heavily relied upon in many food production, processing, 
and preparation systems prior to consumption (Goodburn and Wallace, 2013). 
Decontamination is especially important for foods that are consumed without a dedicated 
pathogen killing step before consumption (e.g. cooking), such as fresh fruits and 
vegetables. An approximately 30% increase in fresh produce consumption has been 
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observed in the United States over the past few decades (Barth et al., 2010). 
Unfortunately, fresh produce has also been increasingly associated with outbreaks of 
foodborne illness (Sivapalasingam et al., 2004; Painter et al., 2013).  
 Identification and characterization of the primary source of contamination 
associated with foodborne illness allows greater insight into the natural history, 
epidemiology, and evolution of foodborne pathogens, all of which facilitate efforts to 
improve public health (Foley et al., 2007).  However, attributing a specific illness to a 
specific source is a difficult task due to the variety of potential disease-causing agents, 
transmission through nonfood mechanisms, variable pathogen virulence and chemical 
toxicity, and extensive under diagnosis and under reporting (Painter et al., 2013; Scallan 
et al., 2011). While most foodborne illnesses are sporadic, linking an illness to a 
particular food is rarely possible except during an outbreak, in which more than one 
illness can be attributed to the same source (Painter et al., 2013). Outbreak investigations 
are the foundation of foodborne illness source attribution (Cole et al., 2014).  
 In a comprehensive review on foodborne illness outbreaks occurring in the United 
States, Painter et al. (2013) provide critical data about the foods and pathogens most 
commonly associated with foodborne illness. Using 4,589 foodborne disease outbreaks 
attributed to known sources reported to the Centers for Disease Control and Prevention 
(CDC) over an 11-year span from 1998 to 2008, illnesses were attributed to 17 different 
food categories composed of both simple and complex foods made up of plant and animal 
products. One of the key findings of the study was that produce (composed of 6 plant 
food categories) accounted for almost half (46%) of the outbreaks (Painter et al., 2013). 
Among the 6 plant food categories, vegetables contributed to more illnesses (34%) than 
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fruits and nuts (12%), with leafy vegetables accounting for the most illnesses (22%).  The 
percentage of yearly outbreaks associated with leafy vegetables has increased from 6% in 
1998-1999 to 11% in 2006-2008 (CDC, 2013). Although this increase may be an artifact 
of improved pathogen detection methods, it may also represent an emerging association 
of virulent foodborne pathogens with fresh produce (Brooks et al., 2005; Johnson et al., 
2006; Bettelheim, 2007; CDC, 2012, Brandl and Sundin, 2013). Pathogen-contaminated 
produce has been found to be a top contributor to outbreak-associated illnesses, 
hospitalizations, and deaths in the United States (CDC, 2013; Cole et al., 2014). 
 
Microbial contamination of fresh produce 
Major sources of contamination 
 Contamination of fresh produce with human pathogens can occur at any point 
along the “farm to fork” chain, consisting of field production, packaging, distribution, 
and preparation processes (Aruscavage et al., 2006). Since most foodborne pathogens are 
transmitted through the fecal-oral route, contamination of produce is often ultimately 
caused by direct and indirect contact with the feces of reservoir animals or previously 
infected humans. Survival of enteric bacterial pathogens on or within plants represents an 
important life cycle stage allowing environmental persistence (Barak and Schroeder, 
2012).  Although produce surfaces are harsh environments for enteric bacteria and enteric 
bacterial populations often decline over time on produce surfaces, they can still survive 
and persist for extended periods of time; in some instances their populations can increase 
(Barak and Schroeder, 2012). Fecal contamination of fresh produce most commonly 
occurs through soil, irrigation water, flood water, pesticide application, fertilizer 
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application, animal activity, harvesting and processing equipment, and human contact 
(Matthews, 2009; Gil et al., 2013). 
 Produce contamination events are often classified as occurring either pre-harvest 
or post-harvest (Gil et al., 2013). Pre-harvest contamination is arguably more difficult to 
control due to variations in weather, animal access, and available water sources in most 
fresh produce production environments. Good agricultural practices (GAP) are essentially 
prevention measures that are critical for reducing the likelihood of contamination and 
helping to ensure new pathogens are not introduced into a production system (Gil et al., 
2013). GAPs are not universally applicable to all commodities but are general guidelines 
that must be tailored to specific produce types and production systems (Codex 
Alimentarious, 2003; ICMSF, 2005, 2011).  
 Post-harvest production practices can also be major contributors to contamination. 
Improper food processing and storage can allow contamination, recontamination, or cross 
contamination, or allow pathogens present in low numbers to proliferate to an infectious 
titer (Gil et al., 2013). Post-harvest sources of contamination often include contaminated 
equipment or storage facilities, contaminated wash water, and human contact. In contrast 
to pre-harvest contamination, post-harvest contamination can be controlled largely by 
proper practices that can effectively eliminate introduction of pathogens into the 
production process (Gil et al., 2013; Goodburn and Wallace, 2013).  
 
Major foodborne pathogens  
 The major pathogens associated with foodborne illness in the United States 
include viruses, bacteria, and parasites. Each year, noroviruses cause the most illnesses 
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and outbreaks among adults but bacteria cause the most hospitalizations and deaths 
(Scallan et al., 2011; Painter et al., 2013). Compared to bacteria and viruses, parasites are 
relatively minor contributors to foodborne illness. Bacterial foodborne pathogens are of 
the greatest concern due to their higher virulence and environmental persistence. The 
major bacterial pathogens monitored by CDC surveillance systems include 
Campylobacter jejuni, Salmonella enterica, Shiga toxin-producing Escherichia coli 
(STEC), Listeria monocytogenes, Yersinia pestis, Shigella spp., Vibrio spp., and 
Clostridium spp. While all of these pathogens can be associated with meat and animal 
products, Salmonella, STEC, and Listeria are commonly associated with plant-based 
products (Painter et al., 2013). 
 Salmonella enterica is a rod-shaped, Gram-negative, non-spore forming, 
facultative anaerobic species of bacteria in the family Enterobacteriaceae.  This fairly 
ubiquitous and hardy species of bacteria has a complex nomenclature system composed 
of 6 subspecies and over 2500 different serological variants (or serovars) (Brenner, 1998; 
Popoff and Le Minor, 1997; 2001). The vast majority of human infections are caused by 
Salmonella enterica subspecies enterica, a group of over 1500 different serovars, each of 
which is thought to be capable of causing human illness (Popoff et al., 2004). However, 
different serovars can have different modes of pathogenesis in humans and are 
categorized as typhoidal or non-typhoidal. Salmonella Typhi and Paratyphi (Salmonella 
enterica subsp. enterica serovar Typhi) are the typhoidal serovars that, when infecting 
humans, can result in typhoid fever. Non-typhoidal infections are less severe, resulting in 
gastroenteritis, and are by far the most predominant, especially in the developed world. 
Non-typhoidal Salmonella serovars cause more hospitalizations and deaths than any other 
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bacterial pathogen in the United States (Scallan et al., 2011) and are associated with a 
broad range of both animal and plant-based food products (Painter et al., 2013; Cole et 
al., 2014). 
 Shiga toxin-producing Escherichia coli (STEC) are also rod-shaped, Gram-
negative, non-spore forming, facultative anaerobic bacteria in the family 
Enterobacteriaceae. This group of pathogenic bacteria, once dominated by a single 
serotype (E. coli O157:H7), seems to be ever expanding as more strains with the required 
virulence characteristics are being identified and isolated (Luna-Gierke et al., 2014; 
Johnson et al., 2006). It is currently debated as to whether these pathogens are truly 
emerging or if their increased isolation rates are simply an artifact of increasingly 
sensitive detection methods and a heightened awareness of their potential presence 
(Brooks et al., 2005; Johnson et al., 2006). Nevertheless, they remain an important public 
health concern and have been associated with several major national and multinational 
foodborne illness outbreaks (Sodha et al., 2014; Luna-Gierke et al., 2014). While most 
STEC infections result in mild diseases with symptoms common to gastroenteritis, a 
much more severe and life threatening complication is possible: hemolytic uremic 
syndrome (HUS), a form of kidney failure (Karmali, 1989). STEC are usually associated 
with meat products (especially beef) but have also been implicated in several major 
outbreaks involving produce, including spinach in 2006 (CDC, 2006), fenugreek sprouts 
in 2011 (CDC, 2011b), raw clover sprouts in 2012 (CDC, 2012b), and ready-to-eat salad 
in 2013 (CDC, 2013). STEC seem to be increasingly associated with leafy greens, 
possibly as a result of specific interactions that allow their survival on these products 
(Leff and Fierer, 2013). 
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 Listeria monocytogenes is a species of rod-shaped, Gram-positive, non-spore 
forming, facultative anaerobic bacteria in the family Listeriaceae. The genus Listeria 
contains 6 species but only L. monocytogenes is known to cause human illness. Only 3 of 
13 L. monocytogenes serotypes are commonly associated with foodborne illness. 
Serotypes 1/2a and 1/2b are commonly associated with sporadic cases of foodborne 
illness while serotype 4b has been associated with most known Listeria outbreaks in 
Europe and the United States (Ward et al., 2004; Painter et al., 2013). Listeria is the most 
virulent bacterial foodborne pathogen in the United States with mortality occurring in 20 
to 30 percent of cases (Ramaswamy et al., 2007). Although fewer illnesses are caused by 
Listeria than several other bacterial pathogens (Scallan et al., 2011), the high virulence 
makes this pathogen of special concern. In addition to gastroenteritis, Listeria infections 
can result in several other serious clinical manifestations including septicemia, 
meningitis, encephalitis, pneumonia, and spontaneous abortions or stillbirths 
(Ramaswamy et al., 2007). Listeria is often associated with aged cheeses and deli meats 
but can also be associated with fresh produce (Bae et al., 2013; Kovacevic et al., 2013; 
Painter et al., 2014). One of the most deadly foodborne illness outbreaks in United States 
history was caused by consumption of cantaloupes contaminated with Listeria 
monocytogenes (CDC, 2012). 
 
Decontamination of produce 
 Proper decontamination methods are critical for ensuring the safety of fresh fruits 
and vegetables (Abadias et al., 2006). Although avoiding contamination during field 
production by implementing appropriate GAPs reduces the risks of fresh produce 
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contamination, decontamination methods are heavily relied upon by the food processing 
industry (Goodburn and Wallace, 2013). Many factors can influence the efficacy of 
decontamination techniques, including initial bacterial load on produce surfaces, 
treatment type, the nature of the surface to be treated, the type of disinfectant, andwhether 
pathogens are internalized within the tissues (Erickson, 2012). The ideal decontamination 
method for fresh produce should greatly reduce or eliminate the number of pathogens 
while having little to no effect on the nutritional value or sensory characteristics of the 
product. However, these goals are not always achievable with currently used 
methodologies.  
 The major methods currently used for decontamination of fresh produce make use 
of antimicrobial chemicals in either an aqueous or gaseous solution (Foong-Cunningham 
and Verkaar, 2012). The most commonly used antimicrobial chemicals are chlorine, 
chlorine dioxide, organic peroxides, and ozone (Goodburn and Wallace, 2013). Each of 
these chemicals has been thoroughly evaluated for their effectiveness (usually measured 
in log reductions) at reducing pathogen concentrations on fresh produce surfaces 
(Stopforth et al., 2008). However, not all antimicrobial chemicals can be used in all 
processing systems. National and local regulations dictate which antimicrobials can be 
used for specific products and which cannot, depending on health and environmental 
concerns (Foong-Cunningham and Verkaar, 2012). Each decontaminant has its respective 
pros and cons and performs better with some types of produce than others (WHO, 1998; 
Goodburn and Wallace, 2013). As a result, several novel decontamination strategies are 
being developed to overcome some of the limitations of current methods (Foong-
Cunningham and Verkaar, 2012). 
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 Chlorine. Chlorine treatment, usually as a diluted sodium hypochlorite solution at 
50 to 200 ppm and pH 6.5, is perhaps the most common decontamination technique used 
currently for produce (Shen et al., 2012). It is a cost effective treatment that can be used 
for many different types of produce and usually has minimal effects on the produce itself. 
Chlorine is present in 3 different forms when added to water; elemental chlorine (Cl2), 
hypochlorous acid (HOCl), and hypochlorite ion (OCl-). HOCl is the most bactericidal 
form, inactivating bacteria by damaging the respiratory and electron transport processes 
in cell membranes (Foong-Cunningham and Verkaar, 2012). HOCl is more effective 
against planktonic bacterial cells in the wash solution than against those on produce 
surfaces (Erkmen, 2010). Chlorine is commonly added to wash water during initial post-
harvest processing with a contact time of 1 to 2 minutes to wash field debris from 
produce and to decontaminate the surface (Gil et al., 2013). However, despite variations 
in chlorine concentration, pH, and immersion times, only up to a 2 log reduction in 
bacterial populations can usually be achieved (De Giusti et al., 2010). Chlorine washes 
are effective at reducing bacterial concentrations, but not at a level high enough to ensure 
thorough decontamination (Goodburn and Wallace, 2013). Additionally, chlorine washes 
may not be possible for some types of produce due to the reduction of marketability 
through physical damage or reducing shelf-life. However, the greatest concern limiting 
the more widespread use of chlorine washes is the ability to form potentially carcinogenic 
organochlorine compounds such as chloramines, trihalomethanes (THMs), and 
semicarbizides (Foong-Cunningham and Verkaar, 2012). If a washing step is necessary, 
the addition of chlorine to the wash water may be a good way to reduce further 
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contamination but is a less than ideal method for decontamination and requires careful 
monitoring for acceptable performance (Goodburn and Wallace, 2013). 
 Chlorine dioxide. Chlorine dioxide (ClO2) can be used as a decontaminant in 
either aqueous or gaseous states, depending on the type of produce (Wu and Kim, 2007). 
Chlorine dioxide is a highly water soluble and unstable gas; therefore it is usually 
dissolved in water (Foong-Cunningham and Verkaar, 2012). Although less cost effective, 
chlorine dioxide is a more efficient decontaminant than chlorine and is also more 
versatile. ClO2 is a stronger oxidizing agent than HOCl, inactivating bacteria through 
oxidative stress and membrane damage more efficiently. Compared to chlorine washes, 
chlorine dioxide treatment is approximately 2.5 times more effective at reducing 
microorganism populations and also is less reactive to organic compounds (Beuchat et 
al., 2004). As a result, chlorine dioxide does not form potentially carcinogenic 
chlorinated organic compounds as easily as chlorine does (Nei et al., 2010). A 4 to 6 log 
reduction in common bacterial pathogen populations is often possible with chlorine 
dioxide treatment (Lee et al., 2004) and the aesthetic characteristics of produce are 
usually not adversely affected (Stopforth et al., 2008). The major drawback of chlorine 
dioxide is that it is unstable; it must be generated on site and can be explosive when 
concentrated (Goodburn and Wallace, 2013). Also, long treatment times from 10 minutes 
to 2 hours are usually necessary. 
 Organic peroxides. Organic peroxides currently used in food decontamination 
washes include peroxyacetic acid (PAA), peroxyoctanoic acid, cumene peroxide, 
hydroperoxides, diacyl peroxides, and perocyesters ((Foong-Cunningham and Verkaar, 
2012). PAA is the most commonly used and inactivates bacterial cells, similar to chlorine 
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and chlorine dioxide, by disrupting cellular respiration through oxidation reactions 
(Davidson et al., 2005). PAA is less affected by the organic load of produce washes than 
chlorine, maintaining its effectiveness for a longer period of time. Additionally, PAA is 
not known to be able to form potentially carcinogenic organic compounds (Foong-
Cunningham and Verkaar, 2012). 
 Ozone. Ozone is a powerful oxidizer that can be used in either an aqueous or 
gaseous form for decontamination of produce (Khadre et al., 2001). Ozone also 
inactivates bacterial pathogens by causing oxidative damage of cellular structures and 
results in oxidative stress, even at very low concentrations (ppb). The gaseous form is 
most commonly used for food decontamination applications and has also been used for 
decades to extend the shelf-life of food products by inactivating various food spoiling 
microorganisms (Xu, 1999; Khadre et al., 2001; Foong-Cunningham and Verkaar, 2012). 
However, the strong oxidizing effects can also damage the sensory and aesthetic 
properties of some types of produce. Ozone treatments often result in up to a 2 log 
reduction in the populations of pathogenic bacteria on fresh produce surfaces despite 
variation in temperature and treatment times (Olmez 2010). Although similar in bacterial 
inactivation rates to chlorine, the short life of ozone by-products and potential of gaseous 
treatments are advantages over chlorine (Perry and Yousef, 2011). Ozone decomposes to 
molecular oxygen (O2) in a matter of minutes in air at atmospheric pressure and room 
temperature, leaving no harmful residues (Khadre et al., 2001). These characteristics 
result few non-target effects of the decontaminant. However, the treatment times and 
temperatures associated with ozone treatments are not optimally suited for some types of 
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fresh produce, greatly limiting its industrial use. Ozone is also unstable and must be 
generated on site. 
 Novel and emerging decontamination methods. Since none of the currently 
used decontamination methods are ideally cost effective, versatile, and efficient while not 
resulting in other harmful effects, new decontamination methodologies are continually 
being developed and tested (Gil et al., 2013). A few of the promising new and emerging 
decontamination technologies having applications in the produce industry include 
irradiation, electrostatic sprays, silver and hydrogen peroxide treatment, pulsed light, 
electrolyzed water, biological controls, essential oils, and non-thermal plasma treatment 
(Goodburn and Wallace, 2013). Each of these methods show promise as effective 
decontamination methods for certain applications, but more research is necessary to more 
fully evaluate how they affect both the food product being treated and any pathogenic 
contaminants that may be present (Gil et al., 2013; Goodburn and Wallace, 2013).  
 Irradiation treatments have emerged among the most effective decontamination 
methods for fresh produce with up to 6.5 log reductions in bacterial concentrations 
possible (Foley et al., 2004). Irradiation treatments are dry, low temperature 
decontamination methods that are efficient, cost effective, and versatile. The use of 
gamma radiation to extend the shelf life of some produce products has also been 
extensively studied and represents another major benefit of this method (WHO 1998; 
FDA 2008). However, irradiation treatments have also been shown to reduce the sensory 
characteristics and shelf-life of other produce products, limiting their marketability 
(Roberts, 2014). Despite the effectiveness and broad applicability of this safe and 
efficient method, irradiation has not become a major decontamination method (Roberts, 
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2014). Production scale adoption of this method has been hampered largely as a result of 
negative consumer perception of irradiated produce (Junquiera-Goncalves et al., 2010; 
Roberts, 2014). 
 Non-thermal atmospheric plasma (or cold plasma) is one of the most promising of 
the emerging decontamination methods for fresh produce. It has been the subject of 
increased research in recent years, and has been used in a variety of configurations 
(Niemira, 2012). Cold plasma is generated at room temperature and atmospheric pressure 
from air using electricity. Therefore, it overcomes many of the limitations of chlorine, 
chlorine dioxide, ozone, and irradiation in that it is a low temperature, dry process that is 
efficient, cost effective, scalable, and potentially very versatile. Currently it has no 
negative consumer perception (Niemira, 2012). However, there is much room for 
improvement in this technology and there is very little currently known about the specific 
mechanisms by which bacteria are inactivated by this method and if there are any 
potentially negative non-target effects on produce products or consumers. 
 
Cold plasma  
 The term “plasma” generally refers to a partially or wholly ionized gas having a 
net neutral charge composed essentially of photons, ions and free electrons in addition to 
atoms in their fundamental or excited states (Misra et al., 2011). Plasma is the fourth state 
of matter, with characteristics distinctly different from those of solids, liquids, and gases. 
In contrast to particles in a gaseous state, which have random paths, plasma particles have 
a defined path that aligns with surrounding electrochemical fields. Plasma is the most 
abundant form of matter in the universe and an essential part of our everyday lives. The 
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activated “species” of which plasma is composed are classified as either light or heavy; 
photons and electrons are light species while ions and excited atoms are heavy species. 
Depending on the relative energy levels of light and heavy species, plasma can be divided 
into two broad classes: thermal plasma and non-thermal plasma (Misra et al., 2011). 
Thermal plasma, generated at high pressures with high energy inputs, is characterized by 
thermal equilibrium between light and heavy species. The Sun, for example, is primarily 
composed of thermal plasma. In contrast, non-thermal plasma, commonly referred to as 
cold plasma, is usually generated at ambient temperature at atmospheric pressure and 
requires less energy input than thermal plasma. It is generated by electric discharge in a 
gas at low pressure or by using microwaves. Since electron and photon temperatures are 
much higher than that of the surrounding gas and ions produced, non-thermal plasma is 
characterized by thermodynamic non-equilibrium between light and heavy species. 
Fluorescent light bulbs are common examples of cold plasma. 
 Although plasma is the most abundant form of matter in the universe, it is not 
commonly or directly experienced by living cells in concentrations high enough to have 
detrimental effects. Prokaryotic cells, having fewer surface protective structures and less 
efficient nucleic acid, lipid, and protein repair mechanisms compared to eukaryotic cells, 
seem to be particularly vulnerable to the reactive species and charged particles generated 
by cold plasma (Guzel-Seydim et al., 2004).  The cellular effects of cold plasma 
treatment can be selective, depending on cell type, resulting in a tunable feature such that 
pathogenic organisms can be inactivated with minimal effects on host cells or durable 
background surfaces (Dobrynin et al., 2009; Pai et al., 2015). As a result, cold plasma 
recently has been the focus of much research as a sterilization or decontamination method 
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for several different applications (Misra et al., 2011; Niemira, 2012). The interaction of 
plasma with cells has been investigated for bacteria (Lu et al., 2014; Ziuzina et al., 2014), 
bacterial spores (Klampfl et al., 2012), biofilms (Ziuzina et al., 2014a; Niemira et al., 
2014), plant cells (Puac et al., 2006; Zhang et al., 2014), and animal cells (Weiss et al., 
2015; Ma et al., 2014). The results of these investigations underscore the fact that plasma 
inactivation of cells is a complex process that depends upon the type of plasma 
generation method, the type of cells targeted, and the substrate on which cells are treated 
(Stoffels et al., 2008). Despite these complexities and mechanistic uncertainties, cold 
atmospheric plasma seems to be particularly attractive for food decontamination, 
especially fresh produce, because it is a low temperature, low energy input, dry process 
that has minimal effects on the food product itself (Critzer et al., 2007; Niemira, 2012; 
Ziuzina et al., 2014). 
 
Cold plasma generation  
 There are multiple approaches to generate cold plasma at atmospheric pressure 
(Yoon and Ryu, 2007), only a few of which are practically suitable for food product 
decontamination in a scalable format (Misra et al., 2011; Niemira, 2012). The cell-
inactivating properties of plasma can be a result of either direct or indirect contact with 
plasma. Direct contact with plasma results in optimal inactivation efficiency since even 
the most short-lived reactive species can contact cell surfaces (Stoffels et al., 2004; Kieft 
et al., 2005). However, the effects of direct plasma treatment can be quite drastic on both 
the treated cells and the substrate. When used for decontaminating delicate surfaces, such 
as fresh produce, direct plasma treatment may not be ideal, damaging the sensory and 
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aesthetic properties of the product (Stoffels et al., 2008). Indirect plasma treatments result 
in cellular inactivation due to the charged particles, photons, and reactive species that are 
by-products of plasma generation rather than contact with the plasma per se. Although 
this is a more gentle approach, the most reactive and most short-lived species generated 
by cold plasma are unlikely to interact with the surface being treated (Stoffels et al., 
2008). Therefore, the main challenge in cold plasma treatment of delicate or complex 
surfaces (requiring indirect treatment) has to do with the means of reactive species 
delivery to the treated surface, which may be at some distance from the plasma itself. 
Accordingly, the major differences in the various plasma generation methods relate to the 
modes by which charged particles, photons, and reactive species are allowed to interact 
with target cells. The major plasma generation approaches currently used include plasma 
pens, jets, or torches, the use of high-energy deep-UV light, microwave excitation, and 
dielectric barrier discharge (Misra et al., 2011).  
 Plasma pens, jets, and torches use a stream of gas that is excited with an electric 
charge as it passes through a nozzle directed at the object being treated (Misra et al., 
2011). This indirect plasma-cell interaction method represents a very successful approach 
for localized plasma generation in medical settings for wound and medical instrument 
sterilization (Hoffmann et al., 2013; Klampfl et al., 2012; von Woedtke et al., 2014). 
However, plasma torches are not well suited for food decontamination due to the small 
effective treatment areas, high energy inputs, and complicated apparatus requirements 
(Niemira, 2012). Using high-energy deep-UV light and microwaves to generate cold 
plasma have potential applications in the food industry and can be scaled up for 
production purposes. However, the high amount of required energy input is a major 
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detractor. Also, production of microwaves and/or UV light tends to have negative effects 
on food quality or appearance, and therefore on marketability. Dielectric barrier 
discharge approaches are much more practical for the food industry, allowing more 
configuration options, lower energy inputs, less complicated configurations, and more 
scalability (Misra et al., 2011; Niemira, 2012). 
 
Dielectric barrier discharge 
 Cold plasma generation by dielectric barrier discharge (DBD) occurs as a result of 
charge accumulation on one side of a dielectric barrier placed between two electrodes. 
The dielectric barrier does not allow the electrical current to pass between the electrodes 
until the accumulation of charge on one side of the barrier results in the production of 
plasma, which is conductive, allowing the electric field to balance (Kogelschatz et al., 
1999). In this process, the migration of charge and generation of light and heavy species 
continues until the charge stops growing and the discharge extinguishes. Plasma 
generation by this method is an ephemeral process consisting of a large number of 
randomly distributed short-lived microdischarges (Kogelschatz et al., 1999; Gibalov and 
Pietsch, 2000; Enloe et al., 2004). DBD has traditionally been used for commercial 
production of ozone for water treatments since the 1930s; only relatively recently has it 
been investigated for surface sterilization applications (Kogelschatz et al., 1999).  
 DBD applications for food decontamination must allow for an approximately 
even distribution of reactive species over the entire surface, since contamination could 
occur anywhere on the surface of a food product. The complex and irregular surfaces of 
many food products can make this goal difficult to achieve. DBD plasma generation 
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apparatuses can be arranged so that the treated surface either directly or indirectly 
contacts the plasma itself (Sysolyatina et al., 2014). Direct plasma contact with food 
surfaces requires the food itself to be grounded, allowing the applied current to pass 
through the food product. This required feature would pose major challenges in 
production and processing facilities. As a result, DBD designs currently being 
investigated for food decontamination applications generate diffuse reactive species via 
an introduced or induced airflow within a given volume or area surrounding the food 
product (Niemira, 2012). The two DBD approaches used to achieve this are volumetric 
DBD and surface DBD. 
 Volumetric dielectric barrier discharge. In volumetric DBD (VDBD), a low 
pressure gas is passed through an enclosure between the dielectric covered electrode and 
the exposed electrode (Kogelschatz et al., 1999). The gas is the medium used for plasma 
generation, forming a region of plasma between the dielectric barrier and the exposed 
electrode. Effective decontamination is possible with both pure and mixed gasses, even 
air (Pankaj et al., 2014). VDBD has recently been the primary and almost exclusive cold 
plasma generation approach investigated for applications in food decontamination, 
including produce (Misra et al., 2011; Niemira, 2012; Ziuzina et al., 2014; Fernandez et 
al., 2013). It has been used for decontamination of such diverse products as strawberries 
(Misra et al., 2014), red pepper powder (Kim et al., 2014), cherry tomatoes (Misra et al., 
2014b), fresh corn salad leaves (Baier et al., 2013), and almonds (Niemira, 2012). In 
most of these studies, the food product being treated was placed inside a closed chamber 
or a low pressure gas flow was supplied across the food surface. These characteristics 
impose distinct limitations on the size of potential food products for decontamination and 
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complicate the apparatus configuration. In-package cold plasma treatment, in which the 
food packaging itself serves as a dielectric barrier and the atmospheric gas inside the 
package serves as the plasma medium, is a practical application of this technology and 
has been the focus of recent research (Pankaj et al., 2014). However, the complexity of 
the required cold plasma generation apparatus and the high energy input requirements 
will likely limit its commercial use. 
 Surface dielectric barrier discharge. Surface DBD (SDBD), in contrast, is one 
of the simplest approaches for cold plasma generation (Kogelschatz et al., 1999). Two 
electrodes are placed on both sides of a dielectric barrier, usually in an asymmetrical 
arrangement. Using this format, plasma can be generated with air at room temperature 
and atmospheric pressure, requiring no enclosures or supplied gas flow. One of the 
electrodes (anode) is covered to prevent contact with the ambient gas while the other 
(cathode) is left uncovered. Plasma, formed adjacent to the uncovered cathode, consists 
of forms that vary from distinct streamers to diffuse discharges with low glow, based on 
the amplitude of supplied AC voltage and the applied frequency (Gibalov and Pietsch, 
2000). This plasma actuator design has been extensively researched and developed for 
applications in the aerospace industry, in which it is used to induce or modify airflow 
over the surfaces of aircraft wings. It is a novel active flow control technique used to 
improve the aerodynamic characteristics and propulsion efficiency of aircraft (Li et al., 
2011). Additionally, less input energy per plasma generation area is required since the 
electrodes are much closer to each other and less charge buildup occurs before plasma 
generation takes place. Therefore, SDBD overcomes many of the current limitations of 
plasma generation approaches for applications in food decontamination in that it is a 
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relatively simple and flexible apparatus, it requires less energy input, it induces airflow 
and thus diffusion of reactive species without any additional inputs, and it is easily 
scalable. There are currently no published reports of food decontamination using cold 
plasma generated by SDBD. Using a recently developed, novel SDBD design, 
preliminary results indicate the possibility of a 6 log reduction of pathogenic bacteria on 
sterile, non-food surfaces in 2 minutes or less. Further research is necessary to delineate 
the optimal treatment parameters using this design and also to evaluate its inactivation 
efficiency and possible undesirable effects on food products. 
 
Potential mechanisms of bacterial inactivation by cold plasma 
 The biocidal properties of cold plasma were recognized early (Nelson and Berger, 
1989) and considerable research has been performed to elucidate the mechanisms of 
biological inactivation (Montie et al., 2002; Misra et al., 2011). Logically, the photons, 
electrons, ions, and other reactive molecular species that compose and are by products of 
cold plasma could cause mechanical and metabolic damage to cells. However, the exact 
cellular processes involved and the mechanisms of cellular inactivation by cold plasma 
treatment remain largely unknown (Mai-Prochnow et al., 2014). There have been 
conflicting reports on the roles of some mechanisms in inactivation of different cell types, 
and it is likely that different types of cells respond differently to cold plasma treatments 
(Feng et al., 2010; Niemira, 2012). Most research on plasma-induced cellular inactivation 
of bacterial cells shows that the process is quite complex, although not as complex as in 
eukaryotes (Stoffels et al., 2008). Bacteria respond in a dose-dependent manner that 
ranges from lethal to sublethal (cell cycle arrest or induction of a viable but non-
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culturable state), to nonlethal metabolic changes (Stoffels et al., 2008). UV light, charged 
particles, and reactive species are the reasons most often cited for bacterial inactivation 
(Misra et al., 2011; Mai-Prochnow et al., 2014). 
 UV light. UV light, emitted when cold plasma is ignited in air, has well-
characterized bactericidal properties (Gaunt et al., 2006). UV photons are absorbed by 
bacterial chromophores and nucleic acids at discrete wavelengths ranging from 220-280 
nm. The maximum bactericidal effect occurs at a wavelength of 254 nm, which is the 
optimal wavelength absorbed by nucleic acids, causing formation of nucleotide base 
(mostly pyrimidine) dimers (Beggs, 2002). Although other photoproducts and multiple 
combinations of nucleotide base dimers can be created by UV photons, thymine dimers 
are the most common (Beggs, 2002; Vleugels et al., 2005; Boudam et al., 2006; Roth et 
al., 2010). However, UV photons emitted from plasma generated at atmospheric pressure 
are mostly reabsorbed by ozone during the plasma generation process and do not have 
sufficient propagation length or penetration depths to cause cellular inactivation (Gaunt et 
al., 2006; Boudam et al., 2006; Roth et al., 2012; Mols et al., 2013). In contrast, plasma 
generated under low-pressure (vacuum) conditions produces more diffuse UV radiation 
in the proper wavelength range to interact with treated cells and less ozone to absorb the 
UV photons (Gaunt et al., 2006). Even if UV photons are not absorbed during plasma 
generation, UV radiation exposure (via UV lights) has been found to be less effective 
than plasma treatments of the same duration (Laroussi, 1996). Additionally, quartz filters 
have been used with atmospheric pressure DBD apparatuses to filter out all reactive 
species and charged particles, but not UV photons, from interacting with target cells and 
have confirmed that UV radiation is a negligible contributor to cellular inactivation 
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(Fridman et al., 2007). Therefore, UV radiation is not considered to be an important 
aspect of cellular inactivation with SDBD cold plasma actuators. 
 Charged particles. The charged particles produced by cold plasma include ions 
and electrons resulting from electrical excitation of neutral atoms. Charged species are 
the essence of plasma and must be considered in plasma-induced cellular inactivation 
models (Stoffels et al., 2008). Cell wall ruptures due to the accumulation of electrostatic 
charges at the cell surface is thought to be the major way in which charged particles 
contribute to cell inactivation (Mendis et al., 2002; Laroussi et al., 2003). Bacterial outer 
surfaces have a net negative charge since they are made up of mostly electronegative 
components such as teichoic acids linked to peptidoglycan in Gram positive bacteria and 
the carbohydrate ends of lipopolysaccharides in Gram negative bacteria (Stoffels et al., 
2008). The accumulation of charges (either positive or negative) on the surface of 
bacterial cells and the production of electrochemical gradients across bacterial cell walls 
and membranes has been demonstrated to cause mechanical damage to a point that may 
result in cell death if cellular repair processes are not able to maintain structural integrity 
(Stoffels et al., 2008; Sysolyatina et al., 2014). Disturbing the surface charge equilibrium 
of bacterial cells may also induce cell death without actually causing mechanical damage 
(Wasserman and Felmy, 1998; Campanha et al., 1999). Gram negative bacteria, having 
thinner cell walls, are often reported to be more susceptible to cell wall rupture than are 
Gram positive bacteria (Stoffels et al., 2008); however, the double membrane of Gram 
negative bacteria may also allow increased resistance to surface charge accumulations 
(Sysolyatina et al., 2014). Since the charged particles produced by cold plasma are so 
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short-lived and many other factors need to be considered, the precise mechanisms of 
cellular inactivation due to charged particles has been particularly difficult to elucidate. 
 Despite the potential effectiveness of surface charge accumulation for bacterial 
inactivation, it is important to consider that electrons, ions, and other charged particles 
that are produced during plasma ignition are almost exclusively limited to the confines of 
the plasma itself. Therefore, direct plasma interaction with cells is the primary means by 
which charged particles can accumulate to a level high enough to cause mechanical 
damage (Montie et al., 2002; Stoffels et al., 2008). Indirect plasma exposure results in 
minimal to no accumulation of charged particles on the surface of treated cells 
(Sysolyatina et al., 2014). As a result, the effects of charged particles are not thought to 
be a major contributor to bacterial inactivation with SDBD cold plasma actuators.  
 Reactive species. Reactive species are formed by collisions among electrons, ions 
and neutral atoms as a result of the excitation and dissociation caused by cold plasma 
generation. Reactive species, although often charged, differ from charged particles in that 
they are more chemically reactive and readily participate in oxidation and reduction 
(redox) reactions with other molecules (Buettner et al., 2013). The most reactive of the 
reactive species, free radicals, are atoms, ions, or molecules with unpaired valence 
electrons; they rapidly gain or lose an electron with other molecules with which they 
come into contact. Many reactive species can damage or alter all three of the major 
cellular constituents: lipids, nucleic acids, and amino acids (Imlay 2003). In addition to 
charged species and free radicals, reactive species can also include neutral species, which 
are less reactive but more stable, having a longer half-life. Neutral reactive species can 
accumulate to high local concentrations and can travel some distance from the site of 
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generation. As a result, neutral reactive species are thought to be the major contributors to 
bacterial inactivation by cold plasma generated by SDBD (Sakiyama et al., 2012). 
Reactive neutral species themselves can have detrimental effects on bacterial cells and 
can also serve as precursors to other reactive species in chemical reactions that occur at 
the cell surface or in the cell interior (Sakiyama et al., 2012). Oxygen gas plasma has 
been found to allow for the most efficient cellular inactivation, followed closely by air, 
and then by nitrogen. When plasma is ignited in air (approximately 80% nitrogen and 
20% oxygen), the relatively long-lived neutral reactive species include hydrogen (H2), 
hydrogen peroxide (H2O2), nitrous oxide (N2O), nitrogen dioxide (NO2), nitrous acid 
(HNO2), ozone (O3), nitrate (NO3), nitric acid (HNO3), and dinitrogen pentoxide (N2O5) 
(Sakiyama et al., 2012). 
 Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are essential 
for the normal function of all types of cells, both prokaryotic and eukaryotic, serving as 
cell signaling molecules, helping with cellular defense against pathogens, and being key 
byproducts of energy metabolism. Accordingly, cells have well-developed systems in 
place to alleviate the potentially negative effects of ROS and RNS by rapid enzymatic 
conversion of these reactive molecules to their neutral forms (Imlay 2003). However, if 
reactive species concentrations become too high, oxidative stress occurs through damage 
to cellular macromolecules. If cellular repair systems are not able to keep up with the 
damage, cell death may occur (Farr and Kogoma 1991; Imlay 2003). Such irreversible 
damage can often initiate a chain reaction of supplementary damage unrelated to the 
initial damage caused by exposure to reactive species (Gaunt et al., 2006). Eukaryotes, 
having more efficient reactive species neutralization and damage repair systems, are 
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generally more resistant to oxidative stress than prokaryotes (Farr and Kogoma 1991; 
Imlay 2003). In fact, ROS are commonly used by plant and animal cells, such as during 
phagocytosis in mammalian cells, as a form of defense against bacterial pathogens due to 
the higher sensitivity of bacteria to oxidative stress (Fang 2004). In response, several 
bacterial species have adapted to these environments and developed multigene 
antioxidant defense systems to neutralize their effects (Farr and Kogoma 1991; Fang 
2004; Imlay 2013). ROS and RNS produced by cold plasma mimics the oxidative stresses 
experienced by bacteria in these interactions (Gaunt et al., 2006). Depending upon the 
amount of oxidative stress imposed on bacteria, the following responses can be observed: 
1) alleviation of oxidative stress through increased expression of associated enzymes, 2) 
cell injury to macromolecules that are then repaired, and 3) cell death arising from 
damaged macromolecules and/or triggering of programmed cell death. 
 ROS and RNS generated by plasma ignited in oxygen, nitrogen, and air have been 
shown to effectively inactivate a wide range of microorganisms (Kelly-Wintenberg et al., 
1999; Feichtinger et al., 2003), spores (Lee et al., 2006), and viruses (Terrier et al., 2009) 
via degradation of lipids, proteins, and nucleic acids (Mogul et al., 2003; Critzer et al., 
2007). The major ROS include superoxide (O2
-), peroxide (O2
-2), hydrogen peroxide 
(H2O2), hydroxyl radical (.OH), and hydroxyl ion (OH
-). Superoxide and peroxide are 
each formed by the sequential reduction of oxygen (O2) by the addition of electrons, 
whereas the formation of hydrogen peroxide, hydroxyl radical, and hydroxyl ion require 
the addition of hydrogen, with water (H20) as the usual precursor (Ryan et al., 2015). 
Several other ROS with increasing complexity can be formed depending upon the 
presence of other gas molecules but often have minor chemical and biological roles 
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(Ryan et al., 2015). The major RNS are nitric oxide (.NO), peroxynitrate  (ONOO-), and 
nitrogen dixode (.NO2). The interaction of nitric oxide with superoxide forms 
peroxynitrate, which is a precursor for many other RNS formed by the interaction with 
water, hydrogen ions, and carbon dioxide (CO2). When plasma is ignited in air, 
superoxide and nitric oxide are the first reactive species to form as a result of the 
reduction/addition of electrons/oxidation of oxygen and nitrogen (Sakiyama et al., 2012). 
Many other ROS and RNS are then able to form as these reactive species continue to 
interact with other molecules. If water vapor is present when plasma is ignited in humid 
air, over 50 different species can be formed from over 600 elementary reactions 
(Sakiyama et al., 2012). 
 Superoxide, hydrogen peroxide, and hydroxyl radical are the primary precursors 
of other reactive species, are the most reactive species, and are continually produced 
during normal cell function (Fang 2004). Therefore, careful cellular management of these 
potentially damaging molecules is essential. No enzymes generate superoxide 
specifically, rather, it is formed “by accident” when oxygen adventitiously oxidizes redox 
enzymes that transfer electrons to other substrates or enzymes, most notably in the 
electron transport chain involved in cellular respiration (Imlay 2013). If superoxide 
produced by this process does not immediately diffuse away, a second electron transfer 
occurs and hydrogen peroxide is formed. Since superoxide and hydrogen peroxide can be 
produced relatively rapidly and can also rapidly interact with other cellular 
macromolecules, a large number of scavenging enzymes usually are present. These 
superoxide and hydrogen peroxide scavenging enzymes or proteins in bacteria include 
several superoxide dismutases (SODs), catalases, peroxidases, and flavoproteins. SOD 
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converts superoxide and hydrogen ions into hydrogen peroxide and molecular oxygen, 
catalases convert hydrogen peroxide into molecular oxygen and water, and peroxidases 
convert hydrogen peroxide, hydrogen ions, and NAD(P)H to water and NAD+ (Imlay, 
2013). Formation of hydroxyl radicals, the most reactive of the ROS (reacting with 
virtually all organic molecules) occurs through the Fenton reaction, in which hydrogen 
peroxide oxidizes Fe2+ as part of a small set of Fe-S dehydratases, forming a ferryl radical 
([FeO]2+) that rapidly interacts with a hydrogen ion to form Fe3+ and hydroxyl radical 
(Fang 2004). In contrast to superoxide, nitric oxide requires an enzyme for formation. In 
bacteria, nitric oxide synthase (iNOS) oxidizes L-arginine to nitric oxide, which can then 
be oxidized further to form other RNS (Crane et al., 2010). If cells are not able to keep up 
with endogenous production of these reactive species or exogenous challenge to the cell 
is too much, damage to lipids, proteins, and DNA can occur.  
 Lipid peroxidation is one of the most well-known and substantial results of 
oxidative stress in eukaryotic systems (Imlay 2013). ROS, in particular, are well-known 
to act on fatty acids composing the lipid bilayer of cell membranes, resulting in 
mechanical damage and cytosolic leakage (Montie et al., 2002; Critzer et al., 2007). 
However, lipid peroxidation requires that lipids be polyunsaturated while most bacterial 
lipids are saturated or monounsaturated. According to the standard model of lipid 
peroxidation, it is unlikely that lipid damage is an initial contributor to bacterial 
inactivation. Yet, cell membrane leakage and structural damage to plasma-treated cells is 
observed commonly (Mai-Prochnow et al., 2014; Guzel-Seydim et al., 2004). While loss 
of membrane integrity of plasma treated cells is common, this characteristic may be a 
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feature of downstream cell death responses and not a contributor to cell death per se 
(Gaunt et al., 2006). 
 Protein damage due to oxidative stress occurs mainly via oxidative modifications 
to proteins with metal ion cofactors; especially iron (Fang 2004). Dehydratases with Fe-S 
clusters and mononuclear iron proteins are particularly vulnerable to oxidative damage 
(Imlay 2013). Oxidative modifications can also occur at cysteine (the most sensitive 
residue), methionine, tyrosine, phenylalanine, and tryptophan residues (Fang 2004). 
However, the affinity of cysteine to oxidation by reactive species is orders of magnitude 
less than that of iron. Protein carbonyls can also be formed by oxidation of arginine, 
proline, and lysine, but are even less likely to form than disulfide bonds at cysteine 
residues (Cabiscol et al., 2000). Additionally, the sulfhydryl groups of thiols, present in 
many cofactors, such as Coenzyme A, are also sensitive to oxidative modification, but 
also may not be important contributors to cell inactivation (Cabiscol et al., 2000; Fang 
2004; Imlay 2013). The main result of protein damage is loss of function, which can have 
an additive detrimental effect on normal cell function as more and more proteins are 
oxidized during oxidative stress events. Damaged proteins must be removed to prevent 
their accumulation inside the cell, and are normally degraded by proteases. Interestingly, 
heavily oxidized proteins can inhibit the action of proteases, preventing the degradation 
of these proteins (Grune et al., 1997). 
 DNA damage is the most important and consequential form of cellular damage 
that can occur by the actions of ROS and RNS (Imlay, 2013; Fang, 2004). Hydroxyl 
radicals, rather than superoxide or hydrogen peroxide, are the main ROS that cause DNA 
lesions (Imlay 2013). Hydroxyl radicals are very short lived and must be produced in 
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close proximity to nucleic acids to cause damage. Therefore, it is suspected that 
hydrogen, reacting via the Fenton reaction with unincorporated iron ions that 
adventitiously associate with DNA, serves as a precursor to hydroxyl radicals that can 
rapidly interact with nucleotide bases and sugar moieties, blocking polymerase 
progression and causing single or double strand breaks, respectively (Imlay 2013). 
Peroxynitrite (ONOO-) and nitrite ions (NO2-) can also cause DNA damage but are less 
reactive than hydroxyl radicals (Fang 2004). Rapid repair of DNA damaged in this way is 
essential to maintain proper cellular function. DNA glycosylases, exonucleases, 
endonucleases, and polymerases are normally expressed to facilitate DNA damage repair 
but may be upregulated during times of increased oxidative stress (Fang 2004). If DNA 
excision-repair systems are not able to keep up with the amount of damage, post-
replication and recombination repair mechanisms are induced (Villani and Tanguy Le 
Gac, 2014). In post-replication repair, enzymes excise a stretch of damaged or newly 
synthesized DNA and a new strand is synthesized complementary to the old, undamaged 
strand. In recombination repair, double strand breaks or areas where both strands are 
damaged are excised by recombination enzymes (most notably RecA) that cut both 
strands of the damaged DNA and replace it with the same sequence from a sister 
molecule (Villani and Tanguy Le Gac, 2014). Expression of RecA also controls 
expression of the SOS system, which suspends cell separation until normal DNA 
replication can resume (Imlay 2013). These DNA repair systems involve a plethora of 
genes that are upregulated as needed and then downregulated as the cell recovers and can 
resume normal function. Depending upon the type of repair systems utilized and the 
extent of the DNA damage, it may be possible to gain a better understanding of the 
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specific mechanisms by which ROS and RNS from plasma generated by SDBD 
inactivate bacterial cells. 
 Genetic responses to oxidative stress can be varied depending upon the specific 
reactive species involved and the type and extent of macromolecule damage. However, 
activation of two transcription factors as a result of oxidative stress is of particular 
importance in Escherichia coli and Salmonella enterica (and several other gram-negative 
bacteria): OxyR and SoxRS (Imlay 2013; Farr and Kogoma, 1991). OxyR and SoxRS are 
expressed at a basal level under normal cell function but are activated when endogenous 
ROS or RNS concentrations rise above the normal level. Hydrogen peroxide rapidly 
reacts with an active site cysteine residue of OxyR, activating this transcription regulator 
that actively promotes a 10-fold or higher increase in transcription of a dozen or more 
operons and over 30 genes around the chromosome (Imlay, 2013). Many of the genes that 
are thus upregulated are catalases and peroxidases that can alleviate the burden of high 
hydrogen peroxide concentrations. Gram-positive bacteria have recently been found to 
have a similar peroxide-responsive regulator (PerR) that is activated by hydrogen 
peroxide and induces expression of many homologues of the enzymes that OxyR controls 
(Lee and Helmann, 2006; Imlay 2013). SoxRS, in contrast, is a homodimeric 
transcription regulator that has one Fe-S sensory cluster for each subunit that is oxidized 
by redox-cycling compounds such as phenazines and quinones, activating the regulon 
(Imlay 2013). Once activated, SoxRS also promotes increased expression of many genes 
from all over the chromosome. The SoxRS system is thought to have arisen due to the 
ability of some plants and other bacteria to induce increased intracellular superoxide 
production by excretion of phenaxines and quinones that are transported directly or 
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passively into target cells as a means of causing oxidative stress and potentially cell death 
(Imlay 2013). Therefore, in Gram-negative bacterial cells treated with SDBD cold 
plasma, the OxyR system is expected to be activated while the SoxRS system is not. 
Additionally, OxyR does not regulate any DNA repair related enzymes, its main function 
being to increase expression of proteins that alleviate the burden of hydrogen peroxide in 
the cell, possibly because the DNA repair mechanisms and SOS system need to continue 
even after the oxidative stress is no longer present. Therefore, it is expected that in 
bacterial cells challenged with reactive species from plasma treatment, the OxyR system 
will be induced first, followed by the SOS response if the damage is able to be repaired 
(Imlay 2013).  
 Ozone (O3) is a neutral reactive oxygen species that is relatively long-lived, is a 
well-known and powerful antimicrobial agent produced in high amounts by dielectric 
barrier discharge in air (Khadre et al., 2001; Sakiyama et al., 2012). In fact, ozone 
generated by dielectric barrier discharge has been used for several decades for efficient 
industrial decontamination of water (Mizuno, 2007). Although much is known about the 
stability, chemical properties, and reactivity of ozone, the specific mechanisms that cause 
bacterial inactivation are not well characterized. Conflicting reports have been published 
about the importance of the role of ozone in bacterial inactivation by dielectric barrier 
discharge, ranging from having no effect (Gallagher et al., 2007; Gustol et al., 2007) to 
being the major contributor to bacterial inactivation (Sakiyama et al., 2012). It is likely 
that ozone itself is not a major contributor to bacterial inactivation but serves as a 
precursor to other, more reactive species (such as hydrogen peroxide, superoxide, and 
hydroxyl radical) when it rapidly interacts with free water on the surface of bacterial cells 
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(Sakiyama et al., 2012). Especially in indirect SDBD plasma treatments, the neutral and 
long-lived nature of ozone may allow it to travel further distances from SDBD actuators 
and facilitates the generation of more reactive species at the cell surface that can diffuse 
through the cell membrane and cause damage to vital macromolecules. 
  
Elucidation of molecular mechanisms of bacterial inactivation by SDBD cold plasma 
 Almost all reports of cold plasma inactivation of cells have focused on 
mechanical characteristics and surface structure damage (Mai-Prochnow et al., 2014). 
However, observing dead cells may not necessarily reveal the means of death. For 
example, cell lysis may be observed after cell death but membrane damage might not 
have played any role in inactivation (Gaunt et al., 2006). A critical look at the genetic 
response of cells treated with cold plasma could shed light on the specific cellular 
pathways and mechanisms involved in bacterial inactivation. Evaluation of genetic 
responses of bacterial cells to cold plasma treatment could help identify whether cell 
structure damage, protein damage, DNA damage, or activation of cell death related 
pathways are the dominant means of bacterial inactivation. Knowledge gained from such 
a study would help guide future development of cold plasma generation devices and help 
delineate the optimal cold plasma generation parameters that ensure maximal bacterial 
inactivation with minimal effects on background substrates. Evaluating gene expression 
through transcriptional changes in cells treated with cold plasma would be the ideal 
method of identifying the molecular mechanisms involved in bacterial inactivation. DNA 
microarrays and RNA-Seq are the main transcriptome analysis methods that provide the 
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most complete evaluation of gene expression changes resulting from a given stimulus or 
treatment. 
 DNA microarray. A DNA microarray is collection of unique oligonucleotide 
probe clusters spotted onto a glass slide. Tens of thousands of oligonucleotide clusters, 
each composed of a single, unique DNA sequence, can be covalently bound in spots to a 
single slide in a known arrangement. Each oligonucleotide probe sequence is designed to 
be complementary to a single gene. Hybridization of fluorescently labeled cDNA from 
one or both of two samples to a specific probe reveals that expression of that gene occurs 
at the time of sample mRNA isolation. Therefore, gene expression changes of a given 
sample can be evaluated across tens of thousands of genes at a single point in time. 
Microarray analysis is a powerful methodological approach that has had a major impact 
on advancement of molecular biology in recent years (Hoheisel, 2006). However, DNA 
microarrays can be limited by a lack of knowledge of specific gene expression since 
identification of gene expression requires a specific probe for that gene. Additionally, 
background noise can complicate data analysis and careful normalization is necessary to 
obtain quality data. While DNA microarrays can still provide extensive data for global 
evaluation of bacterial gene expression, they are continually becoming less common due 
to the advantages of next-generation sequencing based techniques. 
 RNA-Seq. RNA-Seq (RNA sequencing) is a powerful next-generation 
sequencing based technique being used with increasing frequency for both mapping and 
quantifying of transcriptomes (Wang et al., 2009). Briefly, total mRNA from an organism 
is converted to cDNA and sequenced, and then resulting sequence reads are aligned to a 
reference genome, allowing the construction of a genome-scale transcription map that 
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contains the transcriptional structure as well as the level of expression for each gene. 
Compared to microarray analysis and a few other transcriptomic techniques, RNA-Seq 
usually allows higher throughput, has single base resolution, has low background noise 
requiring little or no normalization, can simultaneously map transcribed regions and gene 
expression, and has a higher dynamic range for quantifying gene expression levels. 
Additionally, RNA-Seq requires less starting RNA and the cost is relatively low (Wang et 
al., 2009). RNA-Seq has also been shown to be highly accurate for expression level 
quantification compared to quantitative real-time PCR (qPCR) (Nagalakshmi et al., 2008) 
and is highly reproducible (Cloonan et al., 2008).     
 
Evaluation of bacterial transcriptional changes induced by cold plasma  
 Evaluation of bacterial inactivation by cold plasma at the transcriptome level is in 
its infancy. Currently, a single study looking at transcriptional changes in a prokaryotic 
species (Bacillus cereus) resulting from nitrogen gas plasma inactivation has been 
published (Mols et al., 2013). Transcriptional changes observed in this study were 
minimal, possibly a result of using the microarray approach and using only nitrogen gas. 
Conversely, a targeted gene expression study evaluating the effects of human cells to cold 
plasma treatment found noticeable transcriptional changes (Arndt et al., 2013). A more 
complete evaluation of the transcriptome profile of pathogenic foodborne bacteria using 
RNA-Seq would allow a clearer understanding of the means of plasma-induced cell 
inactivation. Because of the reactive species and charged particles produced by cold 
plasma treatments, the cellular processes involving protein degradation, DNA repair, and 
lipid modification are of special interest. The knowledge gained from such a study would 
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help direct future development of cold plasma actuator designs and treatment conditions 
to optimize pathogen inactivation while maintaining the structural, aesthetic, and 
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INACTIVATION OF SALMONELLA ENTERICA, SHIGA TOXIN-PRODUCING 




Ionized gas generated at room temperature and atmospheric pressure, or cold atmospheric 
plasma, is an emerging technology that offers a dry, non-thermal, rapid process with 
minimal damage to food products, overcoming many of the limitations of current food 
decontamination methods. Each of the multiple means of generating cold plasma have 
direct impacts on the microbial inactivation efficiency. Surface dielectric barrier 
discharge (SDBD), an open-air, room temperature cold plasma generation technology 
having low power requirements, is more flexible, portable, and scalable than other cold 
plasma generation methods. In this study, a novel SDBD design that induces a localized 
airflow was evaluated for bacterial foodborne pathogen inactivation. Particle image 
velocimetry (PIV) was used to evaluate induced airflow dynamics. Bacterial inactivation 
was evaluated on sterile glass coverslips and on the surfaces of in-shell pecans and cherry 
tomatoes that were spot inoculated with multiple-strain suspensions of Salmonella 
enterica (Se), Shiga toxin-producing Escherichia coli (STEC), or Listeria monocytogenes 
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(Lm) (107 CFU/sample), air dried, and treated by cold plasma for 2 and 4 min at1, 3, 5, 
and 7 cm. PIV data revealed that the SDBD electrode arrangement influences the induced 
localized airflow due to the coupling of the electric field into the neighboring fluid (air). 
Inactivation of bacterial cells was observed at all distances and at all treatment times but 
with decreasing efficiency at increasing distance and shorter treatment times. Average log 
CFU/mL reductions for 4 min treatments at 1cm were 3.0 for Se, 3.6 for STEC, and 4.0 
for Lm. Decimal reducition times in minutes (D-values) at 1 cm were 1.3 for Se, 0.9 for 
STEC, and 1.0 for Lm. An approximately 1 and 2 log CFU/mL reduction was observed 
on pecans and cherry tomatoes at 4 and 10 min, respectively. These results confirm that 
the novel SDBD actuator design induces a localized airflow that propels reactive species 
to distant surfaces. SDBD cold plasma actuators have potential applications in food 
decontamination, wound healing, and medical instrument sterilization. 
 
INTRODUCTION 
 Foodborne human illness caused by pathogenic microorganisms is a significant 
health and economic burden worldwide. Salmonella enterica subspecies enterica (Se), 
Shiga toxin-producing Escherichia coli (STEC), and Listeria monocytogenes (Lm) are 
among the most commonly isolated bacterial foodborne pathogens and cause more 
hospitalizations and deaths than all other known bacterial pathogens (Scallan et al., 
2011). Contamination of food can occur at multiple points throughout the food 
production, distribution, and preparation processes, necessitating effective and efficient 
decontamination methods prior to consumption (Aruscavage et al., 2006; Abadias et al., 
2006). However, few effective and minimally damaging decontamination methods are 
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available for foods that are consumed raw or minimally processed (Goodburn and 
Wallace, 2013). Consumers are becoming increasingly conscious of the nutritional 
benefits of some minimally processed foods, especially fresh produce, and an increased 
consumption of these products has been documented in recent years (Barth et al., 2010). 
Unfortunately, concomitant with increased consumption of these higher risk foods, an 
increased incidence of foodborne illness associated with fresh produce has also been 
documented (Sivapalasingam et al., 2004; Painter et al., 2013; CDC, 2013).  
 Foods that are consumed raw or minimally processed pose notable challenges for 
decontamination. The nutritional, structural, and aesthetic properties of such foods are 
important to consumers and need to be maintained. However, few of the major 
decontamination methods currently used for fresh produce, such as chlorine washes, 
chlorine dioxide treatments, ozone fumigation, and irradiation, are ideally cost effective, 
versatile, and efficient while maintaining the physical and nutritional traits desired by 
consumers (Goodburn and Wallace, 2013; Gil et al., 2015). Therefore, new 
decontamination methodologies are continually being developed and tested (Foong-
Cunningham and Verkaar, 2012; Stopforth et al., 2008). Non-thermal atmospheric 
ionized gas, or cold plasma, has been the focus of increased research in recent years since 
it is a dry process that occurs at room temperature and atmospheric pressure (Niemira, 
2012). Bacterial inactivation from cold plasma treatments is a result of the reactive 
species, charged particles, and photons that are constituents of cold plasma (Stoffels et 
al., 2008). Much of the recent research evaluating cold plasma as a decontamination 
method has been in regard to different plasma generation methods and the ways in which 
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reactive species produced by these methods interact with microbial pathogens on 
contaminated surfaces (Stoffels et al., 2008; Misra et al., 2011; Niemira, 2012). 
 Surface dielectric barrier discharge (SDBD) is an open-air, low power input 
plasma generation method that has the potential to overcome many of the limitations of 
current cold plasma apparatuses. The basic SDBD apparatus is relatively simple, 
consisting of a power supply and two electrodes placed on either side of a dielectric 
barrier. One of the electrodes is covered to prevent contact with atmospheric gas while 
the other electrode is left uncovered. Plasma, which is formed adjacent to the uncovered 
electrode, consists of forms that vary from distinct streamers to diffuse discharges with 
low glow based on the amplitude of supplied AC voltage and the applied frequency 
(Gibalov and Pietsch, 2000). SDBD was developed initially for applications in the 
aerospace industry, in which it is used to induce or modify airflow over the surfaces of 
aircraft wings, improving the aerodynamic characteristics and propulsion efficiency of 
aircraft (Li et al., 2011). The self-induced localized airflow of SDBD is therefore 
hypothesized to carry with it the generated reactive species and charged particles for a 
short distance until they revert back to their normal, stable state. The electrodes can be 
arranged so as to increase the amount of induced airflow and therefore maximize the 
distance that reactive species can travel before reverting back to their unreactive state. 
Accordingly, SDBD has the potential to be versatile and particularly attractive for 
decontamination applications. This form of cold plasma generation requires no 
enclosures or supplied gas flow and has a broad treatment area, making it more flexible 
and scalable than other cold plasma-based decontamination apparatuses. Additionally, a 
minimal amount of supplied power is necessary: just enough to ignite the plasma over the 
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entire surface of the desired electrode arrangement (6.75 W for the actuators used in this 
study). 
 SDBD actuator design and treatment parameters have direct effects on the 
pathogen inactivation effectiveness of cold plasma generated by SDBD. Based on 
previous studies with other cold plasma generation apparatuses, treatment duration, 
treatment distance, initial cell concentration, and treated surface structure are the 
variables that are likely to alter the effectiveness of SDBD devices and these factors must 
be thoroughly investigated and defined (Misra et al., 2011; Niemira, 2012). The purpose 
of this study was to evaluate the effects of treatment time and treatment distance on 
inactivation efficiency of SDBD plasma actuators on Se, STEC, and Lm and to evaluate 
the induced airflow dynamics of the SDBD design for decontamination applications. Two 
designs for electrode arrangement in relation to the dielectric barrier used for SDBD 
actuators, a key consideration for optimal airflow induction, were compared. 
Additionally, the effects of different contaminated surfaces were evaluated by comparing 
bacterial inactivation on artificially contaminated sterile glass, cherry tomatoes, and in-
shell pecans. The results of this study will aid in design optimization of SDBD devices 
for increased pathogen inactivation efficiency.  
 
MATERIALS AND METHODS 
 Plasma actuator construction. Surface dielectric barrier discharge (SDBD) 
actuators were constructed using 3.6 cm x 0.5 cm x 0.5 mm (l x w x h) copper electrodes 
(McMaster-Carr Supply Company, GA, USA) placed on both sides of  5 cm2 x 0.127 mm 
Teflon dielectric barrier sheets (McMaster-Carr Supply Company, GA). Two different 
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electrode arrangements, referred to as symmetric and asymmetric, were used to evaluate 
their differential effects on airflow induction through particle image velocimetry (PIV) 
and bacterial inactivation. In the symmetric design, electrodes were placed in line with 
each other on each side of the dielectric material, whereas the asymmetric design had the 
electrodes staggered in relation to the dielectric material (Figure 1). The grounded 
electrodes were insulated to prevent plasma ignition. SDBD actuators were operated with 
an input power of 6.75 W and 13.5 V with a 50% duty cycle using a high voltage 
transformer (Information Unlimited, NH).  Pulse width modulation (PWM), using an 
Arduino Uno microcontroller setup (Arduino LLC, Italy), was used to allow actuators to 
be on for 800 ms and off for 300 ms. Pulsing the power was found to reduce heat buildup, 
extending actuator lifespans (data not shown).  
 Particle image velocimetry. Particle image velocimetry (PIV) was used to 
determine the flow rate of air induced by the SDBD actuators as previously described 
(Pai and Jacob, 2013).  In this setup, a 100 mW, 532 nm EVO laser (Wicked Lasers, 
Hong Kong, China) was used to generate a sheet of light with which individual particle 
paths could be visualized. A MotionPro X3 high speed CCD camera (IDT, FL, USA) was 
used to capture images at 100 frames per second using the software MotionStudio (IDT, 
FL, USA). The images were analyzed using ISSIPIV software (Innovative Scientific 
Solutions Inc., OH, USA). Smoke particles of approximately 1 µm were used as seed 
particles for tracking of induced fluid motion. Image analysis was carried out by 
comparing the procured images and generating composite images to show the motion of 
bulk fluid in 240 ms. 
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 Bacterial strains and culture conditions. Multiple-strain mixtures of Salmonella 
enterica subspecies enterica (serovars Enteritidis, Typhimurium, Javiana, Seftenburg, 
and Poona), Shiga toxin-producing Escherichia coli (serotypes O157:H7, O111:H2, 
O26:H11, O103:H2, O121:H19, O145:H28, and O45:NM), and Listeria monocytogenes 
(strains F6854, 12433, G3982, J0161, and Scott A) were used for inoculation of sterile 
glass coverslips, cherry tomatoes, and pecans. Multiple-strain mixtures were used to more 
accurately represent environmental contamination of inoculated surfaces. Each bacterial 
strain was separately grown aerobically overnight with shaking (250 rpm) at 37°C in 5 
mL tryptic soy broth (TSB, Difco, Sparks, MD). The bacterial concentration of each 
overnight liquid culture was determined by serially diluting the culture in 0.1% (w/v) 
sterile peptone (Difco, Sparks, MD) and plating in duplicate on tryptic soy agar (TSA, 
Difco, Sparks, MD), incubated overnight at 37°C.  
 Preparation of inoculum. To prepare the inocula, 1 mL of each liquid culture 
was centrifuged at 12,000 rpm for 3 minutes and re-suspended in 1 mL of 0.1% (w/v) 
sterile peptone before being combined with all other strains of the same species. The 
multiple-strain bacterial mixtures were then diluted to approximately 108 CFU/mL and 
100 µL of the bacterial suspensions were used as inocula (approximately 107 
CFU/inoculated surface), spotted in 20-25 spots (between 105 and 106 CFU/spot) onto 
single sterile 22 x 22 mm glass coverslips, whole unshelled pecans, or cherry tomatoes. 
Pecans and cherry tomatoes were obtained from a local native pecan orchard and local 
grocery store, respectively, and stored at 4°C until inoculated. Glass coverslips were 
inoculated with Se, STEC, and Lm whereas pecans and cherry tomatoes were inoculated 
only with Se. Inocula spots were spaced evenly over the entire surface of the coverslips or 
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within a 2 cm2 region on the upper surface of pecans and cherry tomatoes. Inoculation 
spots were dried in a biosafety cabinet for 60 minutes prior to cold plasma treatment.  
 Cold plasma treatment by SDBD. The bacterial inactivation difference 
between symmetric and asymmetric electrode arrangements with SDBD actuators was 
evaluated only with 4 min treatments with Lm. Coverslips inoculated with STEC, Se, and 
Lm were placed in sterile 35 mm plastic petri dishes and treated with asymmetric SDBD 
actuators for 2 and 4 min from a distance of 1, 3, 5, and 7 cm (Figure 2). Three replicates 
of each culture were treated in duplicate (2 coverslips) at each distance and time at room 
temperature (~25°C) and atmospheric pressure. Inoculated pecans and cherry tomatoes 
were also placed in sterile 35 mm petri dishes but were treated for 4 and 10 min at 1cm. 
 Assessment of bacterial inactivation. Immediately after cold plasma treatment, 
treated and untreated control inoculated coverslips, pecans, and cherry tomatoes were 
washed by vortexing for 30 s in 10 mL 0.1% (w/v) sterile peptone in 50 mL conical 
tubes. The wash fluid was 10-fold serially diluted in 0.1% peptone and 100 µL of 
appropriate dilutions were plated in duplicate on TSA and incubated overnight at 37 °C. 
Pecans and cherry tomatoes, which were inoculated with Se, were plated on xylose lysine 
deoxycholate (XLD, Difco, Sparks, MD) agar overlaid with TSA. XLD, selective for 
Salmonella, was used to differentiate inoculated bacteria from background bacteria 
already present on the produce surfaces. Bacterial inactivation was assessed by 
comparing plate counts of each treatment with untreated controls. 
 Statistical analysis. Three biological repeats containing two replicates of each 
treatment were conducted. The plate counts of cells recovered from wash fluids for each 
replicate were transformed to log CFU/mL. Log reductions due to plasma treatment were 
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calculated by comparing the numbers of recovered cells from treated and untreated 
controls. Analysis of variance (ANOVA) was used to calculate statistical differences 
between samples from plate counts using SAS (Statistical Analysis System. Inst. Inc., 
Cary, NC, USA). Significant difference was defined at P ≤ 0.05. Decimal reduction time 
(D-value) in minutes was calculated for the inoculated coverslips at each treatment 
distance according to the equation D = t/(logN0-logNu), where t is treatment time, N0 is 
the bacterial concentration recovered from untreated controls, and Nu is the bacterial 
concentration recovered from plasma treated samples. Since bacterial survival curves 
with increasing treatment times were not calculated in this study and bacterial 
inactivation at single treatment times (2 and 4 min) were used for D-value calculations, 
the reported D-values are only estimates that may differ from actual values depending 
upon specific inactivation kinetics for different pathogens, initial cell concentrations, and 
treatment conditions. These calculations are beyond the scope of this study and will be 
thoroughly evaluated in future studies. 
 
RESULTS 
 SDBD-induced airflow dynamics. PIV was used to evaluate the induced airflow 
characteristics of symmetric and asymmetric electrode arrangements with SDBD 
actuators. Smoke particles, following the airflow, were pulled in from the sides of the 
actuators and pushed towards the sample in a direction perpendicular to the actuators 
(Figure 3). The flow was pulled through the plasma generating region and then pushed 
towards the sample, allowing the air to act as a carrier for the generated reactive species. 
The asymmetric arrangement resulted in higher particle velocities and increased flow 
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turbulence than did the symmetric arrangement (Figure 3). Analysis of the direction and 
magnitude of the particle movement revealed that particle velocities were 3 to 4 orders of 
magnitude higher with the asymmetric electrode arrangement than with the symmetric 
arrangement (Figure 3). The symmetric arrangement produced a fluid motion that was 
slower and more streamlined. The more turbulent flow of the asymmetric design is 
thought to result in better mixing of generated plasma species.  
 SDBD electrode arrangement effects on bacterial inactivation. Comparing the 
use of the symmetric and asymmetric electrode arrangements of SDBD actuators, both 
designs reduced L. moncytogenes populations on the inoculated coverslips (Table 1, 
Figure 4). Following 4 minute treatments at 1 cm, the asymmetric arrangement reduced 
the number of recovered viable cells on the coverslips from an average of 5.33 log 
CFU/mL to 1.34 log CFU/mL (a 3.99 log CFU reduction), whereas the symmetric 
arrangement reduced the number of viable cells to an average of 2.99 log CFU/mL (a 
2.34 log CFU reduction) (Table 1). A decrease in bacterial inactivation efficiency, 
measured by averge log reduction, for both of the arrangements was observed as the 
sample distance from the actuators was increased (Table 1, Figure 4). At 1 and 3 cm 
treatment distances, the asymmetric arrangement allowed for significantly higher 
bacterial inactivation (P ≤ 0.05) compared to symmetric arrangements. At 5 and 7 cm 
treatment distances, the differences between symmetric and asymmetric arrangements 
were not significantly different (Table 1, Figure 4). These data confirm that SDBD 
actuators with asymmetric electrode arrangements allow significantly increased bacterial 
inactivation efficiency compared to symmetric arrangements at distances up to 3 cm, 
suggesting that increased airflow induction allows reactive species to be pushed further 
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distances. However, there is a limit to the distance at which the reactive species are 
detrimental to living cells, probably a result of their relatively short half-lives.  
 Bacterial pathogen inactivation on sterile glass and fresh produce surfaces. 
Using SDBD actuators having asymmetrically-arranged electrodes, inactivation of STEC, 
Se, and Lm inoculated onto glass coverslips was observed at treatment times of both 2 
and 4 min and at all distances, 1, 3, 5, and 7 cm (Table 2). Inactivation efficiency 
decreased with increasing distance and with shorter treatment times. When treated for 4 
min, bacterial inactivation, measured by log reduction, was not statistically different 
among all 3 pathogens at each of the 4 distances (P ≤ 0.05). Additionally, bacterial log 
reductions were significantly different from each other at 1, 3, and 7 cm. Results from 
treatment at 5 cm were significantly different from those of 1 cm treatments but not from 
3 and 7 cm treatments (Table 2, Figure 5). The differences between individual pathogens 
and treatment distances were less pronounced when 2 min treatments were used (Table 
2). Average log CFU/mL reductions for 4 min treatments at 1cm were 3.0 for Se, 3.6 for 
STEC, and 2.6 for Lm. D-value (min) estimates using 4 min treatments at 1 cm were 1.3 
for Se, 0.9 for STEC, and 1.0 for Lm (Figure 5, Table 2). The highest log reduction, 4.90 
CFU/mL, was observed with STEC at 1 cm after 4 min of cold plasma treatment. D-value 
(min) estimates using 2 and 4 min treatments at 1 cm ranged between 0.96 and 1.43 for 
all three pathogens (Table 2). 
 On both pecans and cherry tomatoes, an approximately 1 and 2 log CFU/mL 
reduction of Se was observed at 4 and 10 min, respectively. For each type of produce, the 
inoculated populations of Se were significantly decreased, compared to controls, by cold 
plasma treatment after both 4 and 10 min treatments (P ≤ 0.05). However, the observed 
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log reductions on pecans and cherry tomatoes were substantially less than those observed 
in similar treatments of inoculated coverslips. Four min treatments at 1 cm reduced Se 
populations on pecans and cherry tomatoes by 1.16 and 0.7 log CFU/mL (Table 3), 
whereas the same treatment of Se populations on coverslips allowed a 3.02 log CFU/mL 
reduction (Table 2). 
 
DISCUSSION 
 Cold atmospheric plasma, which is simply ionized air generated at ambient 
temperature and atmospheric pressure, is rapidly becoming one of the most talked about 
technologies of our day. Potential applications of cold plasma include medical instrument 
sterilization (Popelka et al., 2012), more rapid wound healing (Isbary et al., 2013), 
potential cancer therapies (Weiss et al., 2015), pesticide degradation (Misra et al., 2014), 
and food decontamination (Niemira, 2012). The interaction of plasma with cells has been 
investigated for bacteria (Lu et al., 2014; Ziuzina et al., 2014), bacterial spores (Klampfl 
et al., 2012), biofilms (Ziuzina et al., 2014b; Niemira et al., 2014), plant cells (Puac et 
al., 2006; Zhang et al., 2014), and animal cells (Weiss et al., 2015; Ma et al., 2014). The 
results of these investigations underscore the fact that plasma inactivation of cells is a 
complex process that depends upon the type of plasma generation method, the type of 
cells used, and the substrate on which cells are treated (Stoffels et al., 2004). UV light, 
charged particles, and reactive species, the cold plasma products most often cited for 
causing bacterial inactivation, are generated in a range of relative concentrations 
depending upon the specific type of plasma generation process used (Misra et al., 2011;  
Gaunt et al., 2006).  
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 Although multiple approaches have been reported for generating cold plasma with 
air at atmospheric pressure for food decontamination applications, few are economically 
practical in a scalable format (Niemira, 2012). Therefore, the main challenge in cold 
plasma treatment of sensitive or complex surfaces (such as food surfaces) relates to the 
means of reactive species delivery to the treated surface. Accordingly, the major 
differences in the various plasma-generation methods are the modes by which charged 
particles, photons, and reactive species are allowed to interact with target cells on 
contaminated substrates. The major plasma-generation approaches currently used include 
plasma pens, jets, torches, high-energy deep-UV light, and microwave excitation (Misra 
et al., 2011). All of these approaches require complex apparatuses, high input powers, 
and a supplied flow of inert gas, resulting in high operational costs and limited practical 
applications. 
 Surface dielectric barrier discharge (SDBD), in contrast, is one of the simplest 
approaches for cold plasma generation (Kogelschatz et al., 1999). Using this format, 
plasma can be generated in air at room temperature and atmospheric pressure, requiring 
no enclosures or supplied gas flow. In its most basic form, plasma is generated by SDBD 
as a result of charge accumulation on one side of a dielectric barrier placed between two 
electrodes. The electric potential accumulates to a point at which the air between the 
electrodes is ionized, forming plasma (Gibalov and Pietsch, 2000). As a low-power, 
active flow control technique, SDBD has been used to improve the aerodynamic 
characteristics and propulsion efficiency of aircraft (Li et al., 2011). For food 
decontamination applications, the induced airflow may allow delivery of reactive species, 
particularly ozone, to surfaces that are some distance from DBD actuators themselves. 
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Ozone (O3) is a neutral reactive oxygen species of special note that has received 
increased interest in recent years for medical instrument sterilization. This relatively 
long-lived reactive oxygen species (ROS) that naturally converts back to harmless 
molecular oxygen is a well-known and powerful antimicrobial agent that is produced in 
high amounts by cold plasma generation in air (Khadre et al., 2001; Sakiyama et al., 
2012) and is generally recognized as safe (GRAS) by the FDA when used for food 
decontamination (Khadre et al., 2001). It is likely that ozone itself is not a major 
contributor to bacterial inactivation but it serves as a precursor to other, more reactive 
species (such as hydrogen peroxide, superoxide, and hydroxyl radical) when it rapidly 
interacts with free water on the surface of bacterial cells (Khadre et al., 2001). 
 Previous studies investigating the effectiveness of cold plasma as a 
decontamination method have identified several features of such treatment in common, 
despite differences in plasma generation methods. These finding include that initial cell 
concentration influences bacterial inactivation rates (Fernandez and Thompson, 2012; 
Deng et al., 2005; Gaunt et al., 2006), bacterial inactivation is independent of growth 
phase and temperature (Fernandez et al., 2013), increased treatment time is required for 
decontamination of complex food surfaces (Vannini et al., 2009; Fernandez et al., 2013; 
Ziuzina et al., 2014), and that cold plasma treatment does not drastically affect fresh 
produce quality (Misra et al., 2014a; Misra et al., 2014b; Lacombe et al., 2014; 
Fernandez et al., 2013). The key distinctive feature of SDBD when compared to other 
plasma generation apparatuses is that SDBD induces a localized airflow that may allow 
delivery of reactive species and charged particles to distant surfaces. Therefore, it was the 
goal of this research to evaluate the induced airflow characteristics of SDBD actuators 
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and to evaluate bacterial pathogen inactivation at various distances on abiotic (glass) and 
biotic (fresh produce) surfaces. Based on the size of the SDBD actuators, glass 
coverslips, pecans, and cherry tomatoes were inoculated with Shiga toxin-producing 
Escherichia coli, Salmonella enterica, and Listeria monocytogenes to evaluate these 
effects. Differences in initial cell concentration, rates of inactivation, and effects of 
produce quality as a result of SDBD cold plasma treatment will be evaluated in future 
studies. Confirmation of the airflow-inducing properties of this design and an 
understanding of the design parameters that influence bacterial inactivation so as to allow 
design optimization is required prior to such studies using specific pathogens and specific 
substrates. 
 Particle image velocimetry (PIV) was used in this study to evaluate airflow 
induction of SDBD actuators with two different electrode arrangements, visualized by 
tracking smoke particles over time. Although both the asymmetric and symmetric 
electrode arrangements (Figure 1) induced a localized airflow (Figure 3), the asymmetric 
arrangement resulted in a significantly increased airflow velocity and turbulence. This 
characteristic was hypothesized to influence bacterial inactivation at increased distances 
due to the potential ability of the fluid motion to carry reactive species further, which was 
confirmed in this study (Figure 4). However, there is a limit to the distance at which the 
asymmetric arrangement out-performed the symmetric arrangement (5 cm), likely a result 
of the short lifespan of the reactive species generated from air. Accordingly, it may be 
possible to further increase the effective treatment distance by SDBD actuator design 
modifications that increase the velocity of induced airflow. The effects of actuator design 
on bacterial inactivation, although for a different basic design, has also been noted in 
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other studies (Schwabedissen et al., 2007; Leipold et al., 2011). Input power, electrode 
arrangement, electrode density, electrode material, and dielectric material have direct 
effects on induced airflow characteristics and may be tailored to develop SDBD actuators 
for specific food decontamination applications. 
 In this study, Shiga toxin-producing Escherichia coli (STEC), Salmonella 
enterica (Se), and Listeria monocytogenes (Lm), three of the most common bacterial 
foodborne pathogens, were shown to be inactivated by SDBD cold plasma actuators at 
distances up to 7 cm. After 4 minutes of cold plasma treatment, pathogen populations on 
glass coverslips were decreased by 3.6, 3.0, and 4.0 log CFU/mL for STEC, Se, and Lm, 
respectively. In corroboration with other cold plasma studies using different apparatuses, 
bacterial inactivation efficiency was reduced when complex biotic surfaces such as fresh 
produce were treated (Vannini et al., 2009; Fernandez et al., 2013; Ziuzina et al., 2014). 
Similar to the higher chlorine concentration requirment observed in chlorine washes used 
for fresh produce, this observation may be a result of a decreased concentration of ROS 
present due to the ROS-scavenging ability of the organic surfaces being treated. Since 
complete bacterial inactivation curves were not evaluated in this study, D-values (min), 
estimated using 2 and 4 min treatments at 1 cm, ranged between 0.96 and 1.43 for all 
three pathogens. These levels of bacterial reduction and rates of bacterial inactivation are 
similar to or slightly less than previous findings using different cold plasma apparatuses 
(Niemira, 2012). Although volumetric dielectric barrier discharge and atmospheric 
pressure plasma jet apparatuses may show faster bacterial inactivation rates, they incur 
the disadvantages of significantly increased power requirements, more moving parts, 
small effective treatment areas, and increased setup and scaling costs (Niemira, 2012). 
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Because of these limitations, such apparatuses may be too expensive, bulky, and 
inconvenient for food production applications. Using a SDBD-based design similar to 
that described herein, Yong et al. (2015) observed a 4.75 log CFU/mL reduction of Lm. 
As in this study, decreased distance from actuators and increased treatment time resulted 
in increased bacterial inactivation (Yong et al., 2015). Although a lower level of Lm 
inactivation was observed in this study (3.99 compared to 4.75 CFU/mL for Yong et al.), 
only 6.75 W were required to power the SDBD actuators compared to 250 W for similar 
treatment areas (Yong et al., 2015).  
 Based on the results of this study, SDBD has the potential to overcome many of 
the limitations of other investigated cold plasma generation apparatuses for food 
decontamination applications. This plasma generation method is likely to be flexible, 
scalable, and cost-effective for large scale food production applications after the 
treatment and design parameters of this technology are more fully defined. Ample 
research has been conducted on how various SDBD scaling parameters, such as input 
power and frequency, influence the physical plasma characteristics and induction of 
airflow, as well as documentation of the biocidal effects of cold plasma. However, the 
relationships between induced airflow and bacterial inactivation have not been previously 
correlated. Additionally, the aspects of food quality, shelf life, nutritional characteristics, 
and by-product generation as a result of SDBD-treated foods must be thoroughly 
investigated. This study confirmed the ability to inactivate bacterial pathogens with cold 
plasma by SDBD and that induced airflow is the means of reactive species delivery to 
contaminated surfaces. In addition to food decontamination, SDBD has potential 
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Table 1. Average log reduction of Listeria monocytogenes (Lm) populations on inoculated glass coverslips after 4 min treatments with 
SDBD actuators having either asymmetric or symmetric electrode arrangements. 
Treatment 
distance (cm) 
  Log reduction of Lm (CFU/mL) ± SD 
  Asymmetric  Symmetric 
1 
 
3.99 ± 0.86 a 2.34 ± 0.46 b 
3 
 
2.00 ± 0.59 b 1.16 ± 0.18 c 
5 
 
0.83 ± 0.28 cd 1.12 ± 0.25 c 
7   0.35 ± 0.34 
d 0.42 ± 0.2 d 
 
 
Table 2. Average log reductions and D-values for Salmonella, STEC, and Listeria monocytogenes populations on inoculated glass 





Log reduction (CFU/mL) ± SD   D-value (min) ± SD 
Salmonella STEC Listeria   Salmonella STEC Listeria 
2 min 
1 1.56 ± 0.37 a 2.10 ± 0.23 a 2.01 ± 0.50 a 
 
1.32 ± 0.28 0.96 ± 0.1 1.04 ± 0.24 
3 1.16 ± 0.44 ab 1.41 ± 0.25 ab 1.31 ± 0.45 b 
 
1.88 ± 0.62 1.45 ± 0.24 1.65 ± 0.54 
5 0.62 ± 0.41 ab 0.80 ± 0.24 ab 0.63 ± 0.31 bc 
 
5.38 ± 5.14 2.64 ± 0.7 4.06 ± 2.74 
7 0.42 ± 0.33 b 0.42 ± 0.1 b 0.14 ± 0.07 c 
 
8.54± 7.96 4.97 ± 1.34 16.59 ± 6.71 
         
4 min 
1 3.02 ± 0.91 a 3.61 ± 1.15 a 3.99 ± 0.86 a 
 
1.43 ± 0.52 1.18 ± 0.35 1.13 ± 0.35 
3 1.65 ± 0.46 b 2.13 ± 0.73 b 2.00 ± 0.59 b 
 
2.55 ± 0.62 2.01 ± 0.58 2.11 ± 0.56 
5 1.15 ± 0.50 c 1.11 ± 0.09 bc 0.83 ± 0.28 bc 
 
3.86 ± 1.37 3.61 ± 0.3 5.17 ± 1.61 
7 0.64 ± 0.27 c 0.49 ± 0.16 c 0.35 ± 0.34 c   7.15 ± 3.1 8.68 ± 2.54 108.75 ± 173.38 
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Table 3. Average log reduction of Salmonella populations after inoculation onto pecans and cherry tomatoes, treated with asymmetric 
SDBD actuators for 4 and 10 min at 1 cm. 
Treatment 
time (min) 
  Log reduction of Se (CFU/mL) ± SD 
  Pecans Cherry tomatoes 
4 
 
1.16 ± 0.51 a 0.70 ± 0.03 ab 
10   2.33 ± 0.01 










Figure 1. Asymmetric and symmetric electrode arrangements for novel surface dielectric 
barrier discharge (SDBD) actuators. 
 
 
Figure 2. Schematic representation of the asymmetric SDBD set up for treating 
pathogen-inoculated coverslips, cherry tomatoes, and pecans at variable distances ranging 




Figure 3. PIV images comparing the bulk fluid flow induction at time T=0 (blue) and 
T=0.24s (green) with vectors representing particle movement for asymmetric (A) and 
symmetric (B) electrode arrangements. Asymmetric electrode arrangements also caused a 
more turbulent airflow (C) compared to symmetric electrode arrangements (D) when 





Figure 4. Average log reductions in CFU/mL of Listeria monocytogenes inoculated onto 
sterile glass coverslips treated for 4 min at 1, 3, 5, and 7 cm with SDBD actuators having 
asymmetric and symmetric electrode arrangements. 
 
 




Figure 5. Average log reductions in CFU/mL of STEC, Se, and Lm inoculated onto 









Figure 6. Average log reduction in CFU/mL of Salmonella enterica inoculated onto 













MORPHOLOGICAL AND TRANSCRIPTOMIC RESPONSE OF SALMONELLA 




 As an emerging technology, cold atmospheric plasma offers a dry, non-thermal, 
and rapid bacterial inactivation process that has multiple potential applications in surface 
and food decontamination. Although the bactericidal effects of cold plasma are well 
documented, the specific mechanisms and modes of interaction that result in bacterial 
inactivation are not well understood. The purpose of this study was to evaluate the 
morphological and transcriptomic response of Salmonella Enteritidis to surface dielectric 
barrier discharge (SDBD) cold plasma treatment and to identify the mechanisms of 
inactivation through transmission electron microscopy (TEM) and RNA sequencing 
(RNA-Seq). Among 764 differentially expressed genes with fold changes greater than 
1.50 (P ≤ 0.01, FDR ≤ 0.05), 255 were up-regulated (1.50 to 3.23-fold) and 509 were 
downregulated (-1.50 top -120.67-fold) after plasma treatment. Genes associated with 




proteins, and DNA damage repair were significantly downregulated after plasma 
treatment. Differentially expressed metabolic pathways included upregulation of 
ethanolamine utilization and downregulation of colonic acid and enterobactin 
biosynthesis. The observed general decrease in stress responses by SDBD plasma-treated 
Salmonella cells is thought to be a result of rapid lipid peroxidation, cytosolic leakage, 
and cell lysis, as revealed by TEM, of cells adjacent to those from which RNA was 
isolated, resulting in a nutrient rich and osmotically balanced microenvironment for 
surviving cells. Accordingly, DNA and protein damage by plasma-produced reactive 
oxygen and nitrogen species were found to have a minor role when dried Gram-negative 
bacteria were treated with SDBD. These results emphasize the importance of lipid 
peroxidation as a major mechanism by which bacterial cells are inactivated by treatment 
with cold plasma. SDBD plasma actuators are more flexible, scalable, versatile, and less 
expensive than many other cold plasma generation apparatuses and have multiple 
potential applications for surface sterilization or decontamination. 
 
INTRODUCTION 
 Cold atmospheric plasma, ionized gas generated at ambient temperature and 
atmospheric pressure, has gained intense interest in recent years for a variety of surface 
sterilization and decontamination applications (Laroussi, 2005; Kong et al., 2009; 
Niemira 2012). UV radiation, charged particles, and reactive oxygen and nitrogen species 
(RONS) are the cold plasma components or by-products most often cited for causing 
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cellular inactivation when generated in air, with RONS playing a dominant role (Misra et 
al., 2011; Mai-Prochnow et al., 2014; Han et al., 2016). The interaction of cold plasma 
with cells has been investigated for bacteria (Lu et al., 2014; Ziuzina et al., 2014), 
bacterial spores (Klampfl et al., 2012), biofilms (Ziuzina et al., 2014b; Niemira et al., 
2014), viruses (Ahlfeld et al., 2015), plant cells (Puac et al., 2006; Zhang et al., 2014), 
and animal cells (Weiss et al., 2015; Ma et al., 2014). These studies have shown that 
inactivation of cells by cold plasma is a complex process influenced by the type of 
plasma generation method, the type of treated cells, and the substrate on which cells are 
treated (Stoffels et al., 2004; Han et al., 2016; Lunov et al., 2016). Recent literature 
suggests that prokaryotes are more sensitive than eukaryotes to plasma treatment and 
inactivation of bacterial pathogens on contaminated surfaces is one of the primary 
potential applications of this technology (Mai-Prochnow et al., 2015; Pai et al., 2015; 
Chapter 3). However, despite the rapidly growing body of literature on cold atmospheric 
plasma and its effects on living bacterial cells, the specific mechanisms that cause cellular 
inactivation are still not well understood. 
 Lipid peroxidation and oxidative DNA damage by plasma-produced RONS are 
emerging as the major contributors to bacterial inactivation (Joshi et al., 2011; Mai-
Prochnow et al., 2014; Lunov et al., 2016). High local concentrations of RONS result in 
membrane or cell wall damage and intracellular ROS accumulation, potentially inducing 
programmed cell death (Lunov et al., 2016). Gram-negative bacteria are usually more 
sensitive to plasma treatment, have more rapid inactivation rates, and are inactivated by 
cell leakage and low-level DNA damage (Joshi et al., 2011; Mai-Prochnow et al., 2014; 
Han et al., 2016), than the more robust, thicker cell walled Gram-positive bacteria. 
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Plasma treatment of Gram-positive bacteria, on the other hand, often results in minimal 
cell envelope damage but significantly higher intracellular DNA damage (Kvam et al., 
2012; Han et al., 2016). Cell concentration and growth phase also affect bacterial 
inactivation rates, likely a result of a shadowing effect, in which some cells are shielded 
from the plasma produced species by other cells, and differing metabolic rates, 
respectively (Mai-Prochnow et al., 2014). Although these findings are similar for 
multiple types of plasma generation methods, bacterial inactivation rates can vary from 
seconds to minutes when different plasma generation apparatuses are used (Mai-
Prochnow et al., 2014).  
 More complete elucidation of the specific mechanisms of bacterial inactivation 
caused by cold plasma is thought to be limited by the methodological difficulty 
associated with separating the effects of plasma-generated reactive species on bacterial 
cells themselves from the indirect effects of the reactive species on the medium or 
solution in which bacteria are growing or suspended (Kvam et al., 2012). Additionally, 
the relatively short half-lives and high reactivity of RONS makes identifying their 
individual effects on cells a challenge (Lunov et al., 2016). Although most practical 
applications of cold plasma treatment are for surface decontamination applications, 
almost all studies investigating the mechanistic effects of cold plasma treatment on 
bacteria have been evaluated using bacterial suspensions and bacteria growing on agar or 
growth-supporting membrane filters rather than dried cells on a given substrate. Thus, 
evaluation of the genotypic and phenotypic responses of dried bacterial cells exposed to 
plasma-produced reactive species is needed to ascertain the real-world applicability of 
cold plasma treatments for surface sterilization or decontamination applications. 
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 Therefore, the goal of this study was to evaluate the genotypic and phenotypic 
responses of dried Salmonella cells to surface dielectric barrier discharge (SDBD), a 
novel semidirect cold plasma treatment method, using RNA sequencing (RNA-seq) and 
transmission electron microscopy (TEM), respectively. Salmonella was chosen for this 
study because it is a robust and common bacterial foodborne pathogen that has a high 
tolerance to desiccation stress (Li et al., 2012). Compared to other plasma generation 
methods, SDBD is a relatively inexpensive, simple, scalable, and flexible apparatus that 
has multiple potential applications for surface sterilization (Pai et al., 2015; Chapter 3). 
RNA-seq is ideally suited for evaluating genotypic responses to cold plasma treatment 
due to its high resolution with limited background noise and high dynamic range, 
allowing identification of even relatively subtle differential gene expression changes 
resulting from the treatment (Wang et al., 2009). This study allowed comparison of the 
genotypic and phenotypic cellular effects of SDBD cold plasma on bacterial cells to other 
studies using different plasma generation apparatuses and helped identify the major 
mechanisms of bacterial inactivation on dried surfaces.  
 
MATERIALS AND METHODS 
 Bacterial strain and culture conditions. Salmonella enterica subspecies 
enterica serovar Enteritidis strain H4639 was used to evaluate SDBD-induced 
inactivation and for RNA-seq analysis. An attenuated strain of Salmonella enterica 
subspecies enterica serovar Typhimurium, in which the major virulence genes had been 
knocked out, was used for transmission electron microscopy. For all experiments the 
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strains were grown aerobically for 18-20 hours with shaking (250 rpm) at 37°C in 5 mL 
tryptic soy broth (TSB, Difco, Sparks, MD). The bacterial concentration of each liquid 
culture was determined by serially diluting the culture in 0.1% (w/v) sterile peptone 
(Difco, Sparks, MD) and plating in duplicate on tryptic soy agar (TSA, Difco, Sparks, 
MD), incubated overnight at 37°C.  
 Plasma actuator construction. Surface dielectric barrier discharge (SDBD) 
actuators were constructed using 3.6 cm x 0.5 cm x 0.5 mm (l x w x h) copper electrodes 
(McMaster-Carr Supply Company, GA, USA) placed on both sides of  5 cm2 x 0.127 mm 
Teflon dielectric barrier sheets (McMaster-Carr Supply Company, GA). Electrodes were 
staggered in relation to the dielectric material and grounded electrodes were insulated to 
prevent plasma ignition (Figure 1). SDBD actuators were operated with an input power of 
13.5 V with a 50% duty cycle using a high voltage transformer (Information Unlimited, 
NH) and pulse width modulation (PWM) with an Arduino Uno microcontroller setup 
(Arduino LLC, Italy) was used to allow actuators to be on for 800 ms and off for 300 ms. 
 Plasma treatment conditions for RNA-seq analysis. To prepare the bacterial 
inoculum, 1 mL of liquid culture was centrifuged at 9,000 x g for 3 minutes and the cell 
pellet was re-suspended in 1 mL of 0.1% (w/v) sterile peptone. One hundred µL of the 
bacterial suspensions were spotted in 20-25 evenly spaced spots onto sterile 22 x 22 mm 
glass coverslips (approximately 108 CFU/coverslip, between 106 and 107 CFU/spot). 
Three replicates, each consisting of 10 inoculated coverslips placed in sterile 35 mm 
plastic petri dishes, were treated with SDBD cold plasma for 2 minutes at a distance of 1 
cm from the actuators at room temperature (~25°C) and atmospheric pressure (Figure 1).  
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 Plasma-treated and untreated control inoculated coverslips were washed by 
vortexing for 30 s in 10 mL 0.1% (w/v) sterile peptone in 50 mL conical tubes. The 10 
coverslips of each replicate were washed individually in the same wash fluid in 
immediate succession following treatment of all coverslips for each replicate. The 10 
untreated control coverslips for each of 3 replicates were washed in the same way after 
drying for 60 minutes. For enumeration, wash fluids were serially diluted 10-fold in 0.1% 
peptone and 100 µL of each dilution was plated in duplicate on TSA and incubated 
overnight at 37 °C. Bacterial inactivation due to cold plasma treatment was assessed by 
comparing the bacterial recovery rates from plasma-treated samples to those from 
untreated controls. 
 Isolation of bacterial RNA. Bacterial RNA was isolated from each10 mL 
volume of 0.1% peptone used to wash the 10 coverslips of each of 3 replicates of plasma-
treated and untreated control samples. Wash fluids for each replicate were centrifuged at 
9,000 x g for 3 minutes and the pellet was re-suspended in 400 µL of 0.1% peptone and 
then added to 800 µL of Qiagen RNA Protect Bacteria Reagent according to the 
manufacturer’s protocol. RNA was then isolated using the Qiagen RNeasy minikit with 
an on-column RNase-free DNase treatment according to the manufacturer’s protocol. The 
quantity and quality of isolated RNA was assessed using a NanoDrop ND-2000 
spectrophotometer (Thermo Fisher Scientific) and an Agilent 2100 Bioanalyzer (Agilent 
Technologies). Since fragmented 23S rRNA is characteristically high in 
Enterobacteriaceae (Bhagwat et al., 2013) and since the plasma treatment itself was 
suspected to contribute further to RNA degradation (Joshi et al., 2011), DV200 values 
were used as a measure of RNA quality rather than the traditional RNA integrity number 
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(RIN). The DV200 value, a metric developed by Illumina that correlates to the percentage 
of RNA transcripts of at least 200 nucleotides in length, has been found to be more 
reliable than RIN for high quality RNA-sequencing (Illumina, 2014). Only samples with 
a DV200 value of 40 or higher were used for cDNA library preparation and sequencing.  
 Library preparation and sequencing. Enrichment of mRNA by rRNA 
depletion, fragmentation of mRNA, cDNA synthesis, and cDNA library preparation were 
done using the ScriptSeq Complete Kit (Bacteria) (Illumina), a kit designed specifically 
for low input concentrations and partially degraded RNA samples. Some RNA 
degradation was expected as a result of the plasma treatment and was confirmed by 
relatively low RIN numbers. Library quality was assessed using an Agilent 2100 
Bioanalyzer and subsequently normalized and diluted according to Illumina protocols. 
All sample libraries were sequenced in a multiplexed manner on an Illumina HiSeq flow 
cell. Library preparation and sequencing was performed by Cofactor Genomics (St. 
Louis, MO). 
 Read mapping and differential gene expression analysis. Mapping and 
analysis of FastQ-files were performed using the CLC Genomics Workbench version 9 
(Qiagen) using default mapping parameters. Although Salmonella Enteritidis strain 
H4639 was used in this study, sequence reads were mapped against Salmonella enterica 
subspecies enterica serovar Typhimurium strain LT2 (accession number NC_003197) 
rather than Salmonella enterica subspecies enterica serovar Enteritidis strain P125109 
(accession number NC_011294) since strain LT2 is more fully annotated than strain 
P125109. When comparing read mapping against LT2 and P125109, mapping was almost 
identical for the annotations in common (data not shown). The average percentage of 
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reads mapped to the reference sequence was 84.44% (Table 1). Reproducibility of the 
read mapping was confirmed by comparing 3 replicates of each treatment and 3 replicates 
of each untreated control. Average gene fold changes were calculated from the combined 
replicates of each condition and genes were considered to be differentially expressed if 
the average fold change was greater than 1.5 or less than -1.5 with a false discovery rate 
(FDR) ≤ 0.05 and P value ≤ 0.01. 
 qRT-PCR analysis. Six genes (pstA, phoR, phnU, fimA, eutD, invA) differentially 
expressed (P  <  0.01) by RNA-seq were selected for analysis by quantitative real-time 
reverse transcriptase-PCR (qRT-PCR). Primer3 software (Untergasser et al., 2012) was 
used to design PCR primers, producing amplicon sizes between 100 and 200 bp (Table 
2). The gene encoding GyrB was used as a reference for relative expression 
normalization using PCR primers previously described (Goudeau et al., 2013). Total 
RNA was isolated as described above using a DNase I treatment (Qiagen) to eliminate 
genomic DNA contamination. cDNA was synthesized from total RNA with GoScript 
Reverse Transcriptase (Promega, Madison, WI) using gene-specific primers. SYBR 
Green qPCR was performed using 20 μL reaction mixtures containing 10 μL (1X) of 
Platinum SYBR Green real-time PCR SuperMix-UDG (Life Technologies, Foster City, 
CA), 1 μL (5 μM) of each primer, 1 μL of template cDNA, and 7μL of nuclease free 
water. A negative control (nuclease free water) and an RNA sample without reverse 
transcriptase were included to detect potential genomic DNA contamination for each 
reaction. qRT-PCR was performed in a Rotor-Gene 6000 thermocycler (Corbett 
Research, Sydney, Australia) with an initial hold for 10 min at 95°C, followed by 40 
cycles at 95°C for 15 sec, 60°C for 15 sec, and 72°C for 60 sec. The relative expression 
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fold change for each gene was calculated using a method described previously (Pfaffl, 
2001) using the equation R = Etarget
ΔCp target/Eref
ΔCp ref, where R is the relative expression 
ratio, E is the qPCR efficiency for each gene, “ref” refers the gyrB reference, “target” 
refers to target genes, and ΔCp equals control threshold crossing point (Cp) minus 
treatment Cp.   
 Transmission electron microscopy. Transmission electron microscopy (TEM) 
was used to visualize untreated control and plasma-treated Salmonella cells to evaluate 
the morphological effects of the plasma treatment. A suspension of approximately 107 
CFU/mL of attenuated Salmonella Typhimurium cells prepared as described above were 
spotted onto carbon-backed gold TEM grids placed onto sterile glass coverslips, air-dried 
for 60 minutes, and treated with SDBD plasma actuators for 2, 4, and 6 minutes at a 
distance of 1 cm as described above. The cells were then negative stained with 
phosphotungstic acid and visualized with a JEOL JEM-2100 Scanning Transmission 
Electron Microscope System. 
 
RESULTS 
Global transcriptional changes resulting from SDBD treatment.  
 An average of 1.12 log CFU/mL reduction was observed after a 2 min treatment 
for 3 replicates. The SDBD plasma treatment of dried Salmonella Enteritidis cells on 
sterile glass coverslips resulted in significant transcriptional changes within surviving 
cells. Among 4,631 annotated genes of Salmonella Typhimurium LT2, 764 (16.5%) were 
differentially expressed by at least 1.5-fold. Interestingly, twice as many genes were 
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downregulated ≤ -1.5-fold (509) than upregulated ≥ 1.5-fold (255) (Tables 3 and 4). The 
fold changes of downregulated genes were also noticeably higher, down to -120-fold with 
65 genes expressed ≤ -5.0-fold, whereas all upregulated genes were expressed less than 
5.0-fold and only 43 were expressed ≥ 2.0-fold. Compared to similar transcriptomic 
studies using microarrays and bacterial cells in suspension or on growth media, the 
relatively moderate differential gene expression observed may be a result of the potential 
shadowing effect of the dried cells on the coverslips in which some cells are shielded 
from the reactive plasma-generated species by other cells and may have had less contact 
with the reactive species. For this reason, genes having statistically significant expression 
changes (P-value ≤ 0.01 and FDR P-value ≤ 0.05) as minor as 1.5-fold were further 
investigated in this study. Functional annotation clustering based on known or predicted 
gene ontology was performed using PANTHER 10.0 (Mi et al., 2016). Co-regulated 
genes and gene pathways were identified by the KEGG Pathway database and STRING 
10.0 (Szklarczyk et al., 2015). Three major KEGG pathways were differentially 
expressed and helped reveal the primary responses of Salmonella to SDBD plasma and 
the potential mechanisms by which inactivation of Gram-negative bacteria may occur. As 
identified by STRING 10.0, “bacterial secretion system” was the single upregulated 
KEGG pathway, while “ribosome” and “biosynthesis of siderophore group nonribosomal 
proteins” were the two significantly downregulated KEGG pathways.  The major 
functional groups to which differentially expressed genes were clustered were transport 
and localization, metabolism, regulatory functions, and pathogenesis (Table 5).  
 Transport and localization. At least 8 ATP-binding cassette (ABC) transporters 
were differentially expressed after SDBD plasma treatment when compared to untreated 
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control samples. More transport associated genes were downregulated than upregulated, 
with upregulated genes primarily associated with histidine (hisMPQ), arginine (artQ), 
sulfate (cysCUW) or dipeptide (dppDF, sapDF) transport. Genes involved in phosphate 
transport were among the most highly downregulated (Tables 4 and 5). The Pst operon 
(pstSCAB-phoU), encoding a high-affinity phosphate-specific ABC transport complex 
that rapidly imports inorganic phosphate into the cell (Van Veen, 1997; Aguena et al., 
2002), was downregulated by -11.5- to -50-fold. PstS is a periplasmic protein that binds 
inorganic phosphate, PstA and PstC form a membrane channel, and PstB is an ATPase 
that interacts with PstC and provides the energy for phosphate translocation (Hsieh and 
Wanner, 2010). The Pst system is regulated by the PhoB/PhoR two component system 
(both downregulated) in which the histidine-kinase PhoR phosphorylates PhoB in 
phosphate limited conditions and inactivates the regulator of the Pst operon, PhoU (Dong 
and Schellhorn, 2009; Hsieh and Wanner, 2010). Phosphorylated PhoB also regulates the 
ugp operon (ugpABCE), which encodes an ABC transport system for glycerol-3-
phosphate and glycerophosphoryl diesters (Kasahara et al., 1991), and the phnR to phnX 
operon (phnSTUV),  importing 2-aminoethylphosphonate (Kim et al., 2002). These 
operons are also activated under phosphate-limited conditions but were both 
downregulated after plasma treatment. Since all of these phosphate transport systems are 
directly regulated by the intracellular availability of phosphate (Hsieh and Wanner, 2010; 
Kasahara et al., 1991; Kim et al., 2002), a significant downregulation of these genes after 
plasma treatment indicates an evident increase in phosphate availability. Further evidence 
of increased phosphate concentrations is upregulation of ppk, encoding a polyphosphate 
kinase that generates long polyphosphate chains in the presence of abundant phosphate 
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availability (Crooke et al., 1994). Since phosphate is a major constituent of the 
phospholipids that make up bacterial cell membranes, the increased phosphate 
availability after plasma treatment may be a result of lipid peroxidation and subsequent 
phospholipid oxidative degradation by plasma-generated RONS. Such downregulation of 
phosphate import systems may be experienced either by cells with damaged outer 
membranes due to lipid peroxidation or by undamaged cells adjacent to damaged or 
possibly lysed cells. 
 In addition to decreased phosphate transport, multiple cation trans-membrane 
transport genes for magnesium (mgtAB, corA), zinc (zntAB), and potassium (kdpBC) were 
significantly downregulated after plasma treatment (Table 5). Such downregulation may 
indicate a reduction in osmotic stress experienced by the dried Salmonella cells following 
treatment with SDBD plasma. Expression of the kdp operon is one of the primary 
responses to osmotic stress and well-studied in E. coli, allowing rapid intracellular 
accumulation of potassium ions (Roe et al., 2000). Another well-known gene induced by 
osmotic stress, osmB, encoding an osmotically induced lipoprotein precursor (Boulanger 
et al., 2005), was also highly downregulated by more than 20-fold (Table 5). Since no 
additional nutrients were added to plasma treated samples, an increased availability of 
necessary cations and alleviated osmotic stress was not expected and might be explained 
by lysis of surrounding cells by the plasma treatment and extensive cytosol leakage. This 
would alleviate the osmotic stress and nutrient limitation of cells that might not have been 
exposed to a damaging dose of plasma-generated reactive species. In addition to lipid 
peroxidation by RONS, SDBD actuators have been found to produce high amounts of 
negative ions that can travel a short distance from the actuator surface when the plasma is 
98 
 
generated in air (Pai et al., 2015) and may be responsible for a trans-membrane ionic 
potential that may contribute to cell lysis (Lunov et al., 2016).  
 Metabolism. The metabolic pathways for which genes were differentially 
expressed as a result of plasma treatment included ethanolamine utilization, colanic acid 
synthesis, and enterobactin synthesis. Phosphoethanolamine is one of the most abundant 
phospholipids in prokaryotes and is readily broken down by phosphodiesterases into 
ethanolamine and glycerol (Garsin, 2010). Ethanolamine can then be utilized as a carbon 
and nitrogen source, particularly as a precursor of acetyl-CoA (Jones and Turner, 1984). 
The ethanolamine utilization process, well-undersood for Salmonella Typhimurium, is 
encoded by 17 genes on a single eut operon, and often takes place within a cellular 
microcompartment termed the carboxysome (Kofoid et al., 1999). Six of the 17 eut genes 
were significantly upregulated after plasma treatment (1.85 - 2.5-fold). EutS and EutN 
are carboxysome structural proteins, EutT is a cobalamin adenosyltransferase, EutD is a 
phosphotransacetylase, and EutP and EutQ are ethanolamine utilization proteins of 
unknown function (Garsin, 2010; Kofoid et al., 1999). Increased expression of these 
genes in response to plasma treatment may indicate an increased availability of 
ethanolamine, as would be expected by significant lipid peroxidation. Interestingly, the 
propanediol utilization pathway, encoded by the similarly extensive pdu operon, which 
also requires cobalamin (vitamin B12) and is often expressed in conjunction with the eut 
operon under anaerobic conditions, was not differentially expressed. In fact, the negative 
regulator of the pdu operon, PrpR, was moderately upregulated (1.93-fold). Increased 
utilization of ethanolamine but not propanediol further indicates a potential increase in 
ethanolamine concentration via lipid peroxidation following plasma treatment. 
99 
 
 While ethanolamine utilization was upregulated, colanic acid biosynthesis was 
significantly downregulated. Colanic acid is a major capsular polysaccharide produced by 
several enteric bacteria in response to desiccation, temperature, acid, osmotic, or 
oxidative stress (Lee and Chen, 2004; Chen et al., 2004; Navasa et al., 2013). Colanic 
acid is synthesized in the cell interior and then exported to the cell surface. Expression of 
the colonic acid biosynthesis (cps) operon is positively activated by the Rcs phosphorelay 
system (Clarke, 2010), primarily through the action of RcsA and RcsB (Ebel and 
Trempy, 1999), the genes for both of which were downregulated by -7.99 and -1.78-fold, 
respectively. Accordingly, at least 14 of the 21 genes in the cps cluster were 
downregulated by as much as -32-fold (ranging from -1.68 – 31.78-fold). This significant 
downregulation also indicates a reduced stress response by the plasma-treated Salmonella 
cells. Again, this response may be a result of lipid peroxidation and lysis of the cells 
surrounding those from which RNA was isolated. Lysis of some cells may have the effect 
of creating a nutrient-rich microenvironment for the surviving cells with prevalent 
cellular and extracellular components, alleviating desiccation, osmotic, or oxidative 
stress. 
 Biosynthesis of enterobactin, a high-affinity siderophore that acquires 
extracellular iron for intracellular transport and subsequent utilization, was also 
significantly downregulated. The iron uptake system via enterobactin is composed of at 
least 11 proteins (Fleming et al., 1983). The 7 proteins encoded by entA-entG synthesize 
enterobactin from chorismate and serine while the proteins encoded by fepA, fepB, tonB, 
and fes allow reception, internalization, and release of the iron molecule bound to 
enterobactin (Fleming et al., 1983). Nine of these 11 genes were significantly 
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downregulated following SDBD plasma treatment, ranging from -1.54 to -8.61-fold. 
However, the enterobactin transport protein FepE was moderately upregulated 1.56-fold. 
It is expected that the presence of free iron within cells exposed to cold plasma would be 
a significant liability due to rapid production of the highly reactive hydroxyl radical by 
the Fenton reaction (Fang, 2004). Thus, it is expected that cells exposed to plasma-
generated reactive species would downregulate iron sequestration mechanisms. However, 
based on the widespread downregulation of nutrient uptake pathways discussed above, 
the observed downregulation of the enterobactin iron uptake system may be a result of 
indirect alleviation of nutrient limitation or desiccation stress rather than direct oxidative 
stress caused by the plasma treatment. 
 Regulatory functions. Two component systems are well-conserved sensory 
systems consisting of a sensor and a transcriptional regulator that allow Salmonella to 
respond to environmental signals (Capra and Laub, 2012). Several two component 
systems were differentially expressed following plasma treatment, indicating a 
coordinated response to the treatment. The TtrR/TtrS two component system, allowing 
Salmonella to use tetrathionate as a terminal respiratory electron acceptor under 
anaerobic conditions (Hensel et al., 1999), was downregulated due to increased 
expression of the response sensor gene ttrR (1.52-fold) and the response regulator gene 
ttrS (1.76-fold). Downregulation of tetrathionate utilization may indicate a reduction of 
anaerobic conditions or an increase in nutrient availability. The FlhD/FlhC two 
component system, positively regulating flagella biosynthesis (Stafford and Hughes, 
2007), was upregulated after plasma treatment (2.04-fold for flhD and 2.05-fold for flhC) 
but none of the flagella biosynthesis genes for which it regulates were differentially 
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expressed. Similarly, the gene encoding the CsgD protein, a master regulator of curli 
biosynthesis, was upregulated 2.59-fold but only csgE and csgF were upregulated (2.85 
and 1.97-fold, respectively) from the csgDEFG and csgBA operons (Barnhart and 
Chapman, 2006). Thus, it is unclear whether changes in flagella or curli biosynthesis, and 
therefore chemotaxis, were altered by plasma treatment. 
 Three other systems with regulatory roles in the maintenance of transmembrane 
proton motive force were differentially expressed. These included the nuo locus, the hyb 
operon, and the Psp system, encoding a proton-translocating NADH dehydrogenase, 
hydrogenase 2, and phage-shock-proteins, respectively. Such systems are of interest since 
SDBD plasma produces a high local concentration of negative ions and potentially 
produces hydrogen ions through the interaction of reactive species with water molecules 
on cell surfaces (Pai et al., 2015). The nuo locus is composed of 14 genes that encode 
structural proteins associated with a type I NADH dehydrogenase, the first enzyme 
complex in the prokaryotic electron transport chain, that couples the oxidation of NADH 
to the generation of a proton motive force. NuoE, part of the peripheral fragment of the 
complex and exhibiting NADH dehydrogenase activity that oxidizes NADH to NAD+, 
and NuoK, part of the membrane fragment that catalyzes ubiquinone (Q) to its reduced 
form (QH2) (Falk-Krzesinski et al., 1998), were upregulated by 1.5 and 1.6-fold, 
respectively. While the nuo locus proteins aid proton translocation into the cytosol, 
hydrogenases then reduce the amount of reactive protons by converting them to hydrogen 
(H2). The hyb operon has 7 open reading frames associated with production of 
hydrogenase 2, which catalyzes H2 production under glycerol fermentation (Trchounian 
and Trchounian, 2009). Six of the 7 genes in the hyb operon (hybB, D, E, F, and G) were 
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upregulated by 1.63 to 2.12-fold after plasma treatment, along with hypA (by 2.05-fold), 
which may be essential for proper hydrogenase function (Menon et al., 1994). Also 
associated with maintenance of proton motive force in addition to other functions 
(Darwin, 2005), several phage-shock-proteins were also differentially expressed, albeit 
downregulated in contrast to the nuo locus and the hyb operon. Phage-shock-protein 
genes pspA-D and pspG were downregulated by -1.94 to -3.43-fold following plasma 
treatment. Downregulation of these genes may indicate a reduction in proton motive 
force as well as alleviation of osmotic or oxidative stress by the cells from which RNA 
was isolated after plasma treatment (Darwin, 2005). 
 Regulation of gene expression on a more global level was observed after plasma 
treatment by significant downregulation of multiple genes associated with ribosome 
structure and function. Identified as one of the major KEGG pathways differentially 
expressed in this study by STRING 10.0, this observation may explain the imbalanced 
downregulation of genes compared to upregulation after plasma treatment. Ribosome 
synthesis has been found to be downregulated in conditions where energy yield is 
restricted and in cases of essential nutrient starvation (Liu et al., 2005; Hayes et al., 
2006). A majority of genes encoding ribosomal subunit proteins (rps, rpm, and rpl) were 
significantly downregulated following plasma treatment. 
 One of the most unexpected findings of this study was downregulation of multiple 
DNA repair related genes. It was suspected that SDBD plasma treatment would induce 
nucleic acid strand breaks due to the generation of reactive oxygen species and that DNA 
repair mechanisms would be upregulated, as previously observed in other studies 
(references). However, 9 genes of the SOS response pathway were downregulated 
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following plasma treatment (Table 5), along with the SOS response activator RecA (-
5.21-fold) and regulator LexA (-1.78-fold) (Kreuzer, 2013). Other downregulated 
constituents of the SOS response were RuvA (-2.12-fold) and RuvB (-1.5-fold), Holliday 
junction ATPases, UvrA (-1.9-fold) and UvrB (-2.0-fold), parts of an excision repair 
endonuclease complex, and SulA (-6.5-fold), which is associated with cell cycle arrest 
(Kreuzer, 2013). Additionally, the oxidative stress related OxyR and SoxRS regulons, 
which are activated by increased intracellular hydrogen peroxide and superoxide 
concentrations, were not differentially expressed after plasma treatment. These data 
indicate that DNA damage and oxidative stress via increased RONS production by SDBD 
actuators may not have been major contributors to bacterial inactivation in this study. 
 Pathogenesis. Another unexpected finding of this study was increased expression 
of multiple pathogenicity genes, especially those located on Salmonella pathogenicity 
island 2 (SPI2) which encodes a type 3 secretion system (T3SS) and associated effector 
proteins. Salmonella Typhimurium has as many as 5 SPIs, each with slightly different 
functions in pathogenesis (Marcus et al., 2000). SPI1 and SPI2 are among the most well-
known and encode proteins that allow entry into and survival within eukaryotic host cells 
(Ochman et al., 1996). SPI1 is primarily associated with invasion into epithelial cells 
whereas SPI2 is primarily associated with macrophage infection and survival within a 
Salmonella-containing vacuole (SCV) within macrophages (Marcus et al., 2000; 
Chakraborty et al., 2015). At least 39 genes associated with SPI1 and SPI2 were 
upregulated after plasma treatment, with as many as 26 contained within SPI2 (Figure 6). 
Accordingly, the major regulators of SPI2 expression, SsrA and SsrB (Xu and Hensel, 
2010), were upregulated 1.78 and 1.61-fold, respectively. However, upon closer analysis 
104 
 
of the upregulation of these genes among the 3 treated replicates, increased expression of 
SPI1 and SPI2 was inconsistent. SPI1 was more upregulated in replicate 1 whereas SPI2 
was more upregulated in replicates 2 and 3 (Figure 6). Despite this inconsistency, twice 
as many genes from SPI2 were upregulated as from SPI1, indicating a potentially more 
dominant role of SPI2 in response to SDBD treatment (Figure 6). Although the precise 
signals that trigger SPI2 expression when Salmonella cells interact with macrophages is 
not known, acidification of the bacterial cytoplasm by macrophages is thought to be a 
major contributor (Chakraborty et al., 2015). Phosphate and magnesium ion limitation 
and hydrogen peroxide stress have also been found to play a key role in inducing 
expression of the SPI2-encoded T3SS and the secreted effector proteins, respectively 
(Kroger et al., 2013). Since hydrogen peroxide stress was minimal in treated cells, 
acidification of the bacterial cytoplasm may be the major contributor to increased SPI2 
expression resulting from plasma treatment by SDBD. 
 
qRT-PCR validation of RNA-seq gene expression. 
 qRT-PCR analysis of 4 downregulated genes (pstA, phoR, phnU, fimA) and 2 
upregulated genes (eutD, invA) was used to validate differential gene expression 
identified by RNA-seq. The fold change differences for each gene were similar for the 
two methods despite their inherent differences in sensitivity (Figure 6). However, the 2 





Cell surface effects of SDBD treatment.  
 TEM of SDBD plasma-treated and untreated Salmonella cells revealed noticeable 
morphological differences in the former, their significance increasing with increasing 
treatment times ranging from 2 to 6 min (Figure 5). Untreated cells had distinct 
boundaries when clustered in groups, with multiple cells undergoing mitosis and fimbriae 
clearly visible using high magnification (20,000-40,000 X). After 2 min treatments cell 
surfaces were visually darker and cell boundaries appeared more ragged, less uniform, 
and less distinct between individual cells. Substantially more debris was also visible in 
treated samples and may be a result of membrane damage and cytosol leakage. 
Membrane and cell surface damage became increasingly more evident after 4 and 6 min 
treatments, evidenced by darker staining, less distinct cellular margins, and increasing 
extracellular debris (Figure 5).  
 
DISCUSSION 
 Despite the recent increased interest in cold plasma-induced bacterial inactivation 
for surface decontamination applications, there are no known studies evaluating the 
transcriptomic response of bacterial cells exposed to cold plasma outside of a suspension 
or growth promoting medium. Since bacterial cells on contaminated surfaces are usually 
in a low moisture environment with limited nutritional resources, it is necessary to 
evaluate how bacteria in such environments respond to cold plasma if this technology is 
to be used for surface decontamination applications. Thus, it was the goal of this study to 
evaluate the morphological and transcriptional changes that are induced in air-dried 
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bacterial cells by exposure to cold atmospheric plasma generated by SDBD. Salmonella 
was selected for this purpose since the transcriptomic response of Salmonella to 
desiccation stress has been well studied (Deng and Zhang, 2012; Gruzdev et al., 2012; 
Finn et al., 2014), allowing potential differentiation between desiccation-related stress 
and plasma-induced stress. Typical desiccation stress responses, such as increased 
nutrient import, osmoregulation, and fatty acid metabolism (Li et al., 2012), were 
expected to be upregulated in untreated control samples and plasma treated samples. In 
contrast, genes associated with oxidative stress were expected to be overexpressed only 
in plasma treated samples as a result of the high concentration of RONS produced by 
SDBD plasma actuators. However, a very different response to SDBD plasma treatment 
was supported by the data.  
 Genes associated with phosphate uptake, cation uptake, osmoregulation, 
tetrathionate utilization, phage-shock proteins, and DNA damage repair were 
significantly downregulated by surviving cells after plasma treatment, indicating a 
reduction of cellular stress. In contrast, as many as 21 ribosomal subunit proteins were 
downregulated and as many as 39 pathogenicity associated proteins were upregulated 
after plasma treatment, indicating an increase in cellular stress. Differentially expressed 
metabolic pathways included upregulation of ethanolamine utilization and 
downregulation of colonic acid and enterobactin biosynthesis, associated with nutrient 
limitation, desiccation stress, and oxidative stress, respectively. It is important to note that 
the RNA isolation protocol used in this study only allowed isolation of RNA from intact 
cells and a suboptimal SDBD plasma treatment of only 2 minutes was used to ensure 
enough intact bacterial cells could be recovered after treatment. This method was chosen 
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so that the response of potentially injured but surviving cells could be investigated. 
However, due to a shadowing effect of multiple layers of dried cells on coverslip 
surfaces, many cells might not have been exposed to a damaging dose of cold plasma. 
Therefore, taking these apparently conflicting results and methodological considerations 
into account, it became evident that the identified differential gene expression was from 
minimally injured cells responding to membrane damage and lysis of adjacent cells rather 
than injured cells responding to the cold plasma treatment per se. Widespread  and rapid 
lipid peroxidation of some cells resulting in degradation of membrane phospholipids, 
membrane damage, and cytosol leakage helps explain the results of this study. 
Phospholipid and lipopolysaccharide degradation would result in increased availability of 
phosphate, colonic acid, and ethanolamine, resulting in downregulation of phosphate 
uptake and colonic acid biosynthesis along with upregulation of ethanolamine utilization 
pathways. Cytosolic leakage would alleviate any osmotic stress experienced by adjacent 
cells and would also provide ample nutrient availability, allowing downregulation of 
important cation translocation pathways. TEM further confirmed rapid lipid peroxidation 
and membrane damage. However, stress responses were not completely eliminated as 
evidenced by downregulation of ribosomal subunit genes and upregulation of 
pathogenicity islands, resulting from mild oxidative stress or cytosolic acidification. 
Indeed, on a global transcriptomic scale, the observed response of Salmonella to SDBD 
plasma was similar to its observed response to acidic environments (Ryan et al., 2015).  
 Thus, lipid peroxidation rather than DNA or protein damage is supported by the 
results of this study as the primary means of inactivation for dried Gram-negative 
bacteria on an inorganic surface. Plasma generated by DBD devices has long been used 
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in material science applications for surface modification of carbon-based polymers 
through an etching mechanism caused by random ion bombardment and physical 
deposition of RONS (Solis-Fernandez et al., 2010). The same mechanism can cause 
physical damage to living cellular surface structures, leading to partial or complete cell 
lysis and bacterial inactivation (Joshi et al., 2011; Kvam et al., 2012; Han et al., 2016). 
TEM was an ideal method to visualize the superficial effects of SDBD in this study since 
TEM grids can be directly inoculated with a suspension of bacteria, air-dried, treated with 
SDBD plasma, stained, and immediately viewed with no fixation or surface modification 
steps that may alter physical cellular structures. TEM revealed rapid membrane damage 
and apparent cytosolic leakage following plasma treatment in accordance with results 
from other groups using membrane adsorption techniques (Kvam et al., 2012), scanning 
electron microscopy (Lunov et al., 2016; Han et al., 2016), and TEM (Ma et al., 2008; 
Venezia et al., 2008) but with different plasma generation devices. 
 The type of device used to generate cold plasma and the means of delivery of 
plasma-produced reactive species has critical effects on the rates of bacterial inactivation 
and potentially on the mechanisms of inactivation (Mai-Prochnow et al., 2014; Kvam et 
al., 2012; Han et al., 2016). Direct plasma treatments, in which plasma directly contacts 
treated bacterial cells, result in more rapid inactivation rates than indirect treatments, in 
which only the longer-lived plasma-produced reactive species interact with treated cells 
(Misra et al., 2011; Kong et al., 2009). SDBD has been described as a semi-direct plasma 
treatment method since cells do not interact directly with the plasma itself, as in 
volumetric DBD apparatuses, but reactive species produced by SDBD are actively 
pushed towards cells by the locally induced airflow. The active pushing of reactive 
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species by SDBD is in contrast to simple diffusion alone as in indirect methods (Pai et 
al., 2015; Chapter 3). The results of this study further substantiate SDBD as a semi-direct 
plasma treatment method. The bacterial inactivation rate of SDBD is comparable to 
indirect methods (Misra et al., 2011; Niemira, 2012; Mai-Prochnow et al., 2014), while 
the inactivation mechanisms of rapid lipid peroxidation and ion bombardment are 
comparable to direct methods (Lunov et al., 2016; Han et al., 2016). Inactivation rates by 
SDBD may be less than direct methods due to a lower concentration of short-lived 
reactive species and ions reaching cell surfaces. An increased role of lipid peroxidation 
by SDBD compared to indirect methods may be a result of cellular interaction with 
shorter-lived RONS (such as superoxide) and ions rather than only longer-lived RONS 
(such as ozone and nitric oxide). 
 Whether or not treated bacterial cells are in a liquid suspension during plasma 
treatment may also affect the rate and mechanism of inactivation (Kvam et al., 2010). 
Most of the available methods for evaluating bacterial responses to antibacterial 
treatments require treatment of liquid suspensions. Accordingly, a majority of studies 
evaluating bacterial responses to cold plasma have been done using bacterial suspensions 
(Kong et al., 2009; Mai-Prochnow et al., 2014). However, RONS produced by plasma 
rapidly interact with water molecules and are potentially altered in abundance and 
characteristics before contacting bacterial cells in a suspension. Moreover, alteration of 
the properties of the liquid, such as pH reduction (Pai et al., 2015), may also indirectly 
affect bacterial inactivation mechanisms. All other known studies evaluating the 
transcriptomic response of bacterial cells to cold plasma treatment have used cells in 
suspension and have found differing emphases of oxidative stress responses. Sharma et 
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al. (2009) found DNA damage repair mechanisms and general oxidative stress responses 
to be upregulated after plasma treatment in Escherichia coli, whereas Winter et al. (2010) 
and Mols et al., (2013) found upregulation of general oxidative stress responses only 
after plasma treatment in Bacillus subtillus and Bacillus cereus, respectively. In contrast, 
the results of this study indicate a general reduction of both oxidative stress responses and 
DNA damage repair. However, these results were observed among surviving cells that 
might not have been directly exposed to reactive plasma-produced species. Significant 
downregulation of ribosomal subunit proteins, an indication of a reduction in metabolic 
activity, and upregulation of pathogenicity associated genes may have been more a result 
of mild cytosolic acidification rather than widespread oxidative stress (Kroger et al., 
2013; Ryan et al., 2015; Chakraborty et al., 2015). Cytosolic acidification may instead 
have resulted from an indirect combination of oxidative stress from plasma-produced 
RONS and rapid cytosolic leakage and increased nutrient availability from adjacent cells. 
It is suspected that the importance of the role of lipid peroxidation in bacterial 
inactivation may not have been identified in previous transcriptomic studies as a result of 
treating cells in suspensions rather than dried cells directly exposed to the treatment. 
 In summary, the results of this study underscore lipid peroxidation as the primary 
means of Gram-negative bacterial inactivation on dried surfaces. This was observed by 
TEM and by the transcriptomic response by RNA-seq of surviving cells adjacent to 
inactivated cells that were lysed or had significant cell membrane damage as a result of 
the plasma treatment. This is the first known report evaluating the transcriptomic 
response of dried bacterial cells by RNA-seq exposed to SDBD plasma treatments. The 
results confirm that SDBD, as a semi-direct plasma treatment device, can rapidly 
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inactivate bacterial pathogens via production of RONS and has potential for a variety of 
surface decontamination applications. DNA damage repair processes and oxidative stress 
responses were alleviated rather than induced after plasma treatments of Salmonella cells 
experiencing desiccation stress on dried coverslips, indicating a minimal negative 
response of cells not exposed to plasma generated species and rapid inactivation and lysis 
of those that are. Accordingly, these results further support the claims that cold plasma 
treatments, especially by SDBD, inactivate bacterial cells by a multimodal physical 
means to which the potential for developing resistance may be minimal. Based on these 
results, SDBD is confirmed to be an efficient cold plasma generation and RONS delivery 
apparatus that overcomes many of the practical limitations of more complex and 
resource-intensive plasma apparatuses and has immediate potential for multiple surface 
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Table 1. Total number of cDNA sequence reads, number of mapped reads, and 
percentage of mapped reads for each treated and untreated control replicate. 
Sample 






Control (1) 22,819,401 19,088,383 83.65 
Control (2) 22,679,322 19,214,731 84.72 
Control (3) 23,616,195 19,999,609 84.69 
    
Treated (1) 21,718,998 17,986,809 82.82 
Treated (2) 23,288,150 20,022,770 85.98 




Table 2. Target genes, gene function, and primer pair sequences used for qRT-PCR 
validation of differential gene expression observed by RNA-seq.  
Gene 
name 
Function Primer pair (5'-3') 
pstA phosphate ABC transporter permease subunit F: GAATCCCGTCGCAAGATG 
  
R: GGCGTCATTTCGGTAAACAG 
   phoR sensory kinase F: TCATTTGGTGCTCAATACCG 
  
R: CAATACCGTCAAGGGCGTA 
   phnU 2-aminoethylphosphonate ABC transporter permease F: CTGCCGATGATGGTTTACAG 
  
R: CAGGCGATAGAGGGAGAACA 
   fimA type-1 fimbrial protein subunit A F: GCTGGCTGTCTCCTCTGC 
  
R: AGCGTATTGGTGCCTTCAAC 
   
eutD phosphotransacetylase F: CGACCCACACAGCAACCT 
  
R: CCTGCGATACACACATCAGC 
   invA invasion protein F: TCCAACAATCCATCAGCAAG 
  
R: ACCGCCAGACAGTGGTAAAG 








Table 3. Functional description, fold change, and statistical significance of genes 
upregulated by 1.5-fold or greater after SDBD plasma treatment. 







FDR           
p-value 
agp glucose-1-phosphatase/inositol phosphatase 1.5 0.59 0.01 0.05 
aidB DNA alkylation damage repair protein 1.58 0.66 2.38E-03 0.02 
argR arginine repressor 1.65 0.72 1.39E-03 0.01 
aroD 3-dehydroquinase 1.5 0.58 1.78E-03 0.01 
aroG 3-deoxy-7-phosphoheptulonate synthase 1.77 0.82 1.73E-03 0.01 
artQ arginine ABC transporter permease ArtQ 1.5 0.58 3.37E-03 0.02 
bssR biofilm formation regulatory protein BssR 1.6 0.68 3.54E-04 3.55E-03 
cafA RNase G 1.59 0.67 1.80E-03 0.01 
cbiJ cobalt-precorrin-6x reductase 1.59 0.67 2.10E-03 0.02 
cbiO 
cobalt ABC transporter ATP-binding 
protein CbiO 
1.6 0.67 2.18E-03 0.02 
cbiQ cobalt ABC transporter permease CbiQ 1.78 0.83 1.52E-06 2.88E-05 
ccmA_1 
 
1.96 0.97 4.72E-03 0.03 
celA N'-diacetylchitobiose-specific transporter 
subunit IIB 
1.57 0.65 4.23E-04 4.18E-03 
celB N'-diacetylchitobiose-specific transporter 
subunit IIC 
1.56 0.64 4.32E-04 4.24E-03 
celD cel operon transcriptional repressor 1.92 0.94 1.05E-06 2.07E-05 
celF 6-phospho-beta-glucosidase 1.57 0.65 1.42E-03 0.01 










1.52 0.6 7.25E-04 6.59E-03 
csgD 
DNA-binding transcriptional regulator 
CsgD 
2.59 1.37 6.64E-11 2.29E-09 
csgE 
curli production assembly/transport protein 
CsgE 
2.85 1.51 1.75E-12 7.58E-11 
csgF 
curli production assembly/transport protein 
CsgF 
1.97 0.98 7.86E-07 1.60E-05 
cspB cold-shock protein 2.11 1.08 3.87E-05 5.17E-04 
cspD stress response protein 1.67 0.74 1.44E-04 1.64E-03 




1.58 0.66 7.43E-03 0.04 
cysW sulfate/thiosulfate ABC transporter 
permease CysW 
1.62 0.69 5.28E-03 0.03 
dcuR transcriptional regulator 1.59 0.66 4.92E-03 0.03 
120 
 
dppC dipeptide ABC transporter permease DppC 1.66 0.73 3.23E-04 3.27E-03 
dppD dipeptide ABC transporter ATP-binding 
subunit DppD 
1.8 0.85 7.28E-04 6.60E-03 
dppF dipeptide ABC transporter ATP-binding 
subunit DppF 
1.68 0.75 8.38E-03 0.05 
eutD phosphotransacetylase EutD 1.89 0.92 3.32E-03 0.02 
eutN microcompartment shell protein EutN 1.82 0.86 3.18E-03 0.02 
eutP ethanolamine utilization protein EutP 2.34 1.23 1.43E-07 3.29E-06 
eutQ ethanolamine utilization protein EutQ 2.03 1.02 4.91E-04 4.74E-03 
eutS carboxysome structural protein EutS 2.5 1.32 1.20E-08 3.26E-07 
eutT cobalamin adenosyltransferase EutT 2.11 1.08 1.20E-03 9.82E-03 
fepE ferric enterobactin transport protein 1.56 0.64 1.32E-04 1.53E-03 
flhC transcriptional regulator FlhC 2.05 1.04 2.35E-05 3.39E-04 
flhD transcriptional regulator FlhD 2.04 1.03 5.44E-06 8.66E-05 
fliE 
flagellar hook-basal body complex protein 
FliE 
1.65 0.72 8.15E-04 7.22E-03 
fliF flagellar MS-ring protein FliF 1.73 0.79 9.80E-06 1.50E-04 
fliG flagellar motor switch protein FliG 1.56 0.64 2.12E-03 0.02 
fre NAD(P)H-flavin reductase 1.56 0.64 3.24E-04 3.27E-03 
ftsW lipid II flippase FtsW 1.5 0.59 1.24E-03 0.01 
galS HTH-type transcriptional regulator GalS 1.57 0.65 1.65E-03 0.01 
gpsA glycerol-3-phosphate dehydrogenase 1.59 0.67 9.76E-03 0.05 
hilD transcriptional regulator HilD 1.5 0.59 3.16E-03 0.02 
hisM histidine ABC transporter permease HisM 2 1 2.26E-06 4.08E-05 
hisP 
histidine ABC transporter ATP-binding 
protein HisP 
1.81 0.86 1.80E-04 2.01E-03 
hisQ histidine ABC transporter permease HisQ 1.84 0.88 1.73E-03 0.01 
hutC histidine utilization repressor 1.53 0.61 8.07E-04 7.16E-03 
hutG formimidoylglutamase 1.63 0.71 7.97E-05 9.82E-04 
hutI imidazolonepropionase 1.58 0.66 3.27E-03 0.02 
hybB hydrogenase 2 b cytochrome subunit 1.63 0.71 1.08E-03 8.97E-03 
hybD hydrogenase 2 maturation endopeptidase 1.89 0.92 5.09E-05 6.60E-04 
hybE hydrogenase 2-specific chaperone 2.01 1.01 2.82E-08 7.26E-07 
hybF 
hydrogenase nickel incorporation protein 
HybF 
2.04 1.03 9.53E-08 2.27E-06 
hybG hydrogenase 2 accessory protein HypG 2.12 1.08 5.17E-10 1.63E-08 
hypA hydrogenase nickel incorporation protein 2.05 1.03 1.13E-03 9.27E-03 
iacP acyl carrier protein 1.75 0.8 4.27E-05 5.64E-04 
idnT GntP family L-idonate transport protein 1.52 0.6 4.98E-04 4.79E-03 
ilvL ilvG operon leader peptide 1.72 0.78 6.31E-04 5.85E-03 
invA invasion protein InvA 1.66 0.74 1.08E-04 1.29E-03 
invB 
surface presentation of antigens protein 
SpaK 
1.86 0.9 4.80E-05 6.24E-04 
invE invasion protein InvE 1.7 0.77 3.99E-05 5.31E-04 




ksgA rRNA small subunit methyltransferase A 1.51 0.59 4.56E-03 0.03 
manX PTS system mannose-specific transporter 
subunit IIAB 
1.65 0.72 1.49E-03 0.01 
mig-14 transcriptional activator 1.95 0.96 1.98E-03 0.01 
napF ferredoxin-type protein 1.5 0.59 4.51E-03 0.03 
nuoE NADH-quinone oxidoreductase subunit E 1.6 0.68 7.72E-03 0.04 
nuoK NADH-quinone oxidoreductase subunit K 1.5 0.59 1.71E-03 0.01 
orfX pathogenicity island-encoded protein 1.7 0.76 1.93E-04 2.14E-03 
pgtB phosphoglycerate transport system sensor 
protein PgtB 
1.53 0.61 0.01 0.05 
pheV 
 
1.85 0.89 6.43E-03 0.04 
pipD dipeptidase 1.62 0.7 9.62E-03 0.05 
pmrD signal transduction protein PmrD 1.57 0.65 2.45E-04 2.59E-03 
pocR transcriptional regulator PocR 1.53 0.61 3.12E-03 0.02 
ppk polyphosphate kinase 1.6 0.68 5.55E-04 5.24E-03 
ppx exopolyphosphatase 1.55 0.63 2.92E-04 3.01E-03 
pqaA PhoPQ-regulated protein 1.64 0.71 3.63E-05 4.86E-04 
prgH secretion system protein PrgH 1.59 0.67 1.15E-03 9.39E-03 
prgJ secretion system protein PrgJ 1.61 0.69 1.03E-03 8.65E-03 
prgK secretion system lipoprotein PrgK 1.79 0.84 2.99E-04 3.06E-03 
prpR 
propionate catabolism operon regulatory 
protein 
1.93 0.95 5.90E-05 7.57E-04 
res type III restriction-modification system 
DNA helicase 
1.57 0.65 4.22E-03 0.03 
rfaL O-antigen ligase 1.75 0.8 1.07E-03 8.93E-03 
rfbN 
O antigen biosynthesis 
rhamnosyltransferase RfbN 
1.5 0.59 8.98E-03 0.05 
rfbU O-antigen biosynthesis protein RfbU 1.52 0.6 6.47E-04 5.97E-03 
rfbX O-antigen transferase 2.22 1.15 3.10E-04 3.14E-03 




1.8 0.85 3.28E-06 5.56E-05 
sapD 
peptide ABC transporter ATP-binding 
protein SapD 
1.51 0.59 2.03E-04 2.22E-03 
sapF 
peptide ABC transporter ATP-binding 
protein SapF 
1.55 0.63 2.74E-03 0.02 
sicP chaperone protein SicP 1.95 0.96 1.14E-06 2.23E-05 
sigE chaperone protein SigE 1.5 0.58 1.81E-03 0.01 
sirB2 regulatory protein SirB2 1.53 0.62 1.35E-03 0.01 
sopD secreted effector protein SopD 1.59 0.67 4.59E-03 0.03 
spaP 
surface presentation of antigens protein 
SpaP 
2.12 1.08 6.98E-10 2.13E-08 
spaQ 
surface presentation of antigens protein 
SpaQ 
1.64 0.72 4.55E-04 4.45E-03 





surface presentation of antigens protein 
SpaS 
2.28 1.19 7.91E-07 1.60E-05 
ssaB secretion system apparatus protein SsaB 2.58 1.37 5.79E-07 1.21E-05 
ssaC secretion system apparatus outer membrane 
protein SsaC 
1.82 0.86 2.91E-05 4.03E-04 
ssaD secretion system apparatus protein SsaD 2.24 1.16 1.62E-08 4.29E-07 
ssaE secretion system effector SsaE 2.32 1.21 5.41E-07 1.14E-05 
ssaG secretion system apparatus protein SsaG 2.69 1.43 1.95E-11 7.35E-10 
ssaH secretion system apparatus protein SsaH 2.43 1.28 2.24E-12 9.35E-11 
ssaI secretion system apparatus protein SsaI 1.77 0.82 2.35E-04 2.51E-03 
ssaJ secretion system apparatus lipoprotein SsaJ 1.93 0.95 2.27E-04 2.43E-03 
ssaK secretion system apparatus protein SsaK 2.36 1.24 1.54E-10 5.09E-09 
ssaL secretion system apparatus protein SsaL 1.93 0.95 1.94E-04 2.14E-03 
ssaM secretion system apparatus protein SsaM 2.09 1.07 2.27E-04 2.43E-03 
ssaN 
secretion system apparatus ATP synthase 
SsaN 
1.9 0.93 1.29E-03 0.01 
ssaO secretion system apparatus protein SsaO 3.23 1.69 0 0 
ssaP secretion system apparatus protein SsaP 3.16 1.66 1.62E-13 8.08E-12 
ssaQ secretion system apparatus protein SsaQ 2.24 1.16 5.53E-06 8.77E-05 
ssaR secretion system apparatus protein SsaR 1.93 0.95 1.08E-05 1.65E-04 
ssaS secretion system apparatus protein SsaS 3.08 1.62 6.87E-14 3.54E-12 
ssaT secretion system apparatus protein SsaT 2.01 1.01 2.80E-03 0.02 
ssaV secretion system apparatus protein SsaV 2.08 1.06 7.87E-04 7.01E-03 
sscB secretion system chaperone SscB 1.73 0.79 1.98E-03 0.01 
sseD translocation machinery protein SseD 1.5 0.58 8.16E-03 0.04 
sseE secretion system effector SseE 1.54 0.63 3.20E-03 0.02 
sseF secretion system effector SseF 2.51 1.33 1.36E-09 3.99E-08 
sseG secretion system effector SseG 2.44 1.29 1.29E-08 3.48E-07 
sseI required for maintaining a long-term 
systemic infection 
1.87 0.9 2.65E-05 3.73E-04 
sseL deubiquitinase SseL 1.76 0.81 4.64E-05 6.08E-04 
ssrA secretion system sensor kinase SsrA 1.78 0.83 8.20E-07 1.65E-05 
ssrB 
secretion system transcriptonal activator 
SsrB 
1.61 0.69 5.98E-05 7.65E-04 
STM0028.1n hypothetical protein 1.51 0.59 6.29E-03 0.04 
STM0211 hypothetical protein 1.59 0.67 2.29E-03 0.02 
STM0258 hypothetical protein 1.52 0.61 4.91E-04 4.74E-03 
STM0327 cytoplasmic protein 1.75 0.8 3.04E-03 0.02 
STM0354 transcriptional regulator 1.66 0.73 2.60E-04 2.74E-03 
STM0355 copper chaperone 1.73 0.79 2.84E-03 0.02 
STM0412 
 
1.57 0.65 6.14E-03 0.04 
STM0438 hypothetical protein 1.67 0.74 8.87E-04 7.75E-03 
STM04630 hypothetical protein 1.53 0.61 5.12E-03 0.03 
123 
 
STM05020 hypothetical protein 1.59 0.67 9.06E-04 7.87E-03 
STM05025 hypothetical protein 1.55 0.63 3.75E-03 0.02 
STM0557 inner membrane protein 1.68 0.75 1.79E-03 0.01 
STM05625 hypothetical protein 1.78 0.83 1.02E-03 8.59E-03 
STM0699 cytoplasmic protein 1.78 0.83 1.76E-03 0.01 
STM0763.s LysR family transcriptional regulator 1.78 0.83 3.58E-07 7.81E-06 
STM0859 LysR family transcriptional regulator 1.83 0.87 6.42E-07 1.32E-05 
STM0907 prophage chitinase 2.35 1.24 1.16E-03 9.52E-03 
STM0972 secreted effector protein SopD2 1.77 0.83 7.95E-03 0.04 
STM1048 host specificity protein J 1.5 0.59 1.08E-03 8.97E-03 
STM1052 
 
1.83 0.87 1.03E-03 8.67E-03 
STM1055 hypothetical protein 1.61 0.68 4.75E-04 4.61E-03 
STM1089 pathogenicity island-encoded protein 1.86 0.89 1.52E-04 1.72E-03 
STM1123 periplasmic protein 1.57 0.66 4.35E-03 0.03 
STM1146 hypothetical protein 1.52 0.6 5.12E-03 0.03 
STM1188 inner membrane lipoprotein 1.88 0.91 2.47E-07 5.51E-06 
STM1248 
 
1.58 0.66 1.51E-03 0.01 
STM1262 
 
1.67 0.74 1.62E-03 0.01 
STM1265 response regulator 1.57 0.65 1.60E-03 0.01 
STM1266 transcriptional regulator 2.03 1.02 4.56E-06 7.49E-05 
STM1269 chorismate mutase 1.66 0.73 3.48E-03 0.02 
STM1317 hypothetical protein 1.57 0.66 2.75E-03 0.02 
STM1388 hypothetical protein 1.63 0.71 7.20E-05 9.04E-04 
STM1410 cytoplasmic protein 2.5 1.32 4.25E-11 1.50E-09 
STM1484 protease 1.71 0.77 3.36E-03 0.02 
STM1530 outer membrane protein 2.05 1.04 3.19E-07 7.07E-06 
STM1531 
hydrogenase nickel incorporation protein 
HypA 
2.05 1.03 2.21E-07 5.00E-06 
STM1532 dehydrogenase protein 1.82 0.87 9.09E-07 1.82E-05 
STM1533 hydrogenase 1.68 0.75 4.16E-04 4.12E-03 
STM1541 GntR family regulatory protein 1.54 0.62 3.05E-04 3.11E-03 
STM1542 zinc-binding dehydrogenase 1.82 0.87 1.45E-06 2.75E-05 
STM1543 transporter 1.59 0.67 7.34E-03 0.04 
STM1549 translation initiation inhibitor 1.59 0.67 1.26E-03 0.01 
STM1613 PTS system transporter subunit IIB 1.56 0.64 0.01 0.05 
STM1618 
sgc operon DeoR familytranscriptional 
repressor 
1.53 0.62 7.24E-04 6.59E-03 
STM1672 cytoplasmic protein 1.58 0.66 8.85E-03 0.05 
STM1697 diguanylate cyclase/phosphodiesterase 
domain-containing protein 
1.66 0.73 1.66E-03 0.01 
STM1829 cytoplasmic protein 2.05 1.04 2.96E-05 4.09E-04 
STM1864 inner membrane protein 1.59 0.67 1.19E-04 1.41E-03 
STM1866 
 
1.74 0.8 2.54E-05 3.61E-04 
STM1872 cytoplasmic protein 1.86 0.9 1.42E-04 1.63E-03 
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STM2137 cytoplasmic protein 2.13 1.09 1.82E-06 3.38E-05 
STM2240 cytoplasmic protein 2.2 1.14 1.90E-06 3.51E-05 
STM2288 cytoplasmic protein 2.32 1.21 8.57E-08 2.07E-06 
STM2302 
4-amino-4-deoxy-L-arabinose-
phosphoundecaprenol flippase subunit 
ArnE 
1.86 0.89 3.93E-06 6.52E-05 
STM2303 4-amino-4-deoxy-L-arabinose-phospho-
UDP flippase 
1.66 0.73 5.35E-05 6.92E-04 
STM2452 hypothetical protein 1.71 0.78 1.77E-03 0.01 
STM2585A PagK-like protein 1.79 0.84 1.63E-06 3.06E-05 
STM2651 protein lysine acetyltransferase 1.51 0.59 8.17E-03 0.04 
STM2690 outer membrane efflux protein 1.57 0.65 2.95E-04 3.03E-03 
STM2704 tail fiber assembly-like protein 2.72 1.44 6.54E-09 1.80E-07 
STM2705 hypothetical protein 1.57 0.66 3.02E-03 0.02 
STM2938 CRISPR-associated endonuclease Cas1 1.62 0.7 1.31E-03 0.01 
STM2942 transposase 1.61 0.68 3.29E-03 0.02 
STM2943 cytoplasmic protein 1.55 0.63 2.23E-03 0.02 
STM3096 hypothetical protein 1.5 0.59 1.77E-03 0.01 
STM3124 response regulator 1.58 0.66 7.54E-04 6.77E-03 
STM3369 hypothetical protein 1.56 0.64 4.15E-04 4.12E-03 
STM3460 
 
1.62 0.7 1.33E-04 1.55E-03 
STM3599 anaerobic C4-dicarboxylate transporter 1.52 0.6 6.56E-03 0.04 
STM3600 sugar kinase 1.73 0.79 3.08E-03 0.02 
STM4155 inner membrane protein 1.54 0.63 1.08E-03 8.96E-03 
STM4156 cytoplasmic protein 1.61 0.68 2.41E-03 0.02 
STM4157 cytoplasmic protein 1.97 0.98 4.25E-08 1.07E-06 
STM4186 cytoplasmic protein 1.53 0.61 2.64E-03 0.02 
STM4262 bacteriocin/lantibiotic ABC transporter 1.81 0.85 2.65E-06 4.67E-05 
STM4272 inner membrane protein 1.61 0.69 7.06E-03 0.04 
STM4302 cytoplasmic protein 1.76 0.82 1.58E-04 1.79E-03 
STM4504 cytoplasmic protein 1.88 0.91 6.76E-06 1.05E-04 
tctD transcriptional regulator TctD 1.98 0.99 6.55E-06 1.03E-04 
tctE tricarboxylic transport regulatory protein 1.76 0.82 2.15E-05 3.13E-04 
ttrR tetrathionate response regulator TtrR 1.52 0.6 7.69E-04 6.89E-03 
ttrS tetrathionate sensor histidine kinase TtrS 1.76 0.81 2.95E-04 3.03E-03 
tus 
DNA replication terminus site-binding 
protein 
1.7 0.76 6.28E-03 0.04 
tyrB aromatic amino acid aminotransferase 1.56 0.64 7.78E-04 6.95E-03 
uvrC excinuclease ABC subunit C 1.92 0.94 6.75E-05 8.56E-04 
uvrY LuxR/UhpA family response regulator 1.69 0.76 2.93E-03 0.02 
valV 
 
1.9 0.93 2.69E-03 0.02 
yaaY cytoplasmic protein 1.87 0.91 4.60E-05 6.04E-04 
yafK periplasmic protein 1.52 0.6 2.91E-04 3.01E-03 
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ybdN 3'-phosphoadenosine 5'-phosphosulfate 
sulfotransferase 
1.5 0.58 5.20E-04 4.95E-03 
ybfM required for uptake of chitin-derived 
oligosaccharides 
1.54 0.62 2.18E-03 0.02 
ybgE inner membrane protein 1.71 0.78 2.33E-05 3.38E-04 
ybgT outer membrane lipoprotein 1.54 0.62 1.35E-03 0.01 
ybhQ inner membrane protein 1.93 0.95 7.80E-04 6.96E-03 
ybhR ABC transporter permease 1.51 0.59 1.01E-03 8.50E-03 
ydcI LysR family transcriptional regulator 1.73 0.79 2.28E-03 0.02 
yeaS leucine efflux protein 1.75 0.81 9.08E-06 1.40E-04 
yfbB 4-cyclohexadiene-1-carboxylate synthase 1.5 0.58 5.89E-04 5.49E-03 
yfdH glycosyltransferase 1.54 0.63 7.51E-03 0.04 
yfeC negative regulator 1.69 0.76 3.35E-06 5.62E-05 
yfeD negative regulator 1.61 0.69 2.41E-05 3.47E-04 
yfiM outer membrane lipoprotein 1.5 0.59 1.56E-03 0.01 
ygbE inner membrane protein 1.55 0.64 4.75E-03 0.03 
ygbJ 3-hydroxyisobutyrate dehydrogenase 1.73 0.79 3.29E-03 0.02 
ygcB helicase 2.04 1.03 3.86E-08 9.89E-07 
ygcH cytoplasmic protein 1.55 0.63 0.01 0.05 
ygjR dehydrogenase 1.58 0.66 1.82E-03 0.01 
yheL 
tRNA 2-thiouridine synthesizing protein 
TusB 
1.6 0.68 5.68E-04 5.34E-03 
yheM 
tRNA 2-thiouridine synthesizing protein 
TusC 
1.58 0.66 9.57E-04 8.19E-03 
yheN 
tRNA 2-thiouridine synthesizing protein 
TusD 
1.58 0.66 1.38E-04 1.59E-03 
yheO regulatory protein 1.68 0.75 1.97E-03 0.01 
yhfA inner membrane protein 1.77 0.82 2.04E-04 2.22E-03 
yhfK inner membrane protein 1.51 0.6 5.17E-04 4.94E-03 
yhjV HAAAP family transport protein 1.85 0.89 2.20E-04 2.37E-03 
yjfN inner membrane protein 1.77 0.82 7.26E-05 9.09E-04 
yjfO biofilm peroxide resistance protein 2 1 4.86E-06 7.89E-05 
yncJ periplasmic protein 1.86 0.9 1.16E-06 2.26E-05 
ynfA membrane protein 1.54 0.62 5.44E-03 0.03 
yoaE inner membrane protein 1.53 0.61 6.54E-04 6.02E-03 
yobF cytoplasmic protein 2.38 1.25 1.90E-05 2.79E-04 
yqgF Holliday junction resolvase 1.67 0.74 4.24E-04 4.18E-03 
yrfA inner membrane protein 1.71 0.77 9.18E-03 0.05 
yrfC inner membrane protein 1.65 0.73 9.40E-04 8.08E-03 
ytfP cytoplasmic protein 1.54 0.62 4.25E-04 4.18E-03 
a Functional annotations are from NCBI for Salmonella Typhimurium strain LT2 (accession number 






Table 4. Functional description, fold change, and statistical significance of genes 
downregulated by -1.5-fold or greater after SDBD plasma treatment. 






FDR             
p-value 
aaeX membrane protein AaeX -1.54 -0.63 3.05E-03 0.02 
adk adenylate kinase -1.59 -0.67 8.44E-03 0.05 
ahpF alkyl hydroperoxide reductase subunit F -1.82 -0.87 1.72E-03 0.01 
alaT 
 
-1.59 -0.67 6.81E-03 0.04 
alaV 
 
-1.74 -0.8 4.98E-04 4.79E-03 
alaW 
 
-2.1 -1.07 6.77E-03 0.04 
amiC N-acetylmuramoyl-L-alanine amidase -2.24 -1.16 1.44E-07 3.29E-06 
apbE thiamine biosynthesis lipoprotein ApbE -1.91 -0.94 4.75E-04 4.61E-03 
apeE 
outer membrane N-acetyl phenylalanine 
beta-naphthyl ester-cleaving esterase 
-1.87 -0.9 2.70E-05 3.79E-04 
argO arginine exporter protein ArgO -2.75 -1.46 9.99E-16 5.78E-14 
bioA 
adenosylmethionine--8-amino-7-
oxononanoate aminotransferase BioA 
-1.77 -0.83 4.67E-04 4.55E-03 
bioB biotin synthetase -2.37 -1.24 1.65E-05 2.47E-04 
bioF 8-amino-7-oxononanoate synthase -1.95 -0.96 2.23E-04 2.40E-03 
carA 
carbamoyl phosphate synthase small 
subunit 
-1.53 -0.61 9.33E-04 8.04E-03 
chaA calcium/sodium:proton antiporter -2.3 -1.2 6.32E-10 1.94E-08 
cigR inner membrane protein -3.39 -1.76 1.23E-06 2.36E-05 
cirA catecholate siderophore receptor CirA -3.73 -1.9 0 0 
cmk cytidylate kinase -2.03 -1.03 7.16E-08 1.75E-06 
cobA 
cob(I)yrinic acid a; c-diamide 
adenosyltransferase 
-2.48 -1.31 3.35E-06 5.62E-05 
corA magnesium transport protein CorA -2.46 -1.3 5.60E-10 1.74E-08 
cpsG phosphomannomutase -6.76 -2.76 0 0 
cpxA sensory kinase CpxS -1.56 -0.64 4.14E-04 4.12E-03 
cpxP cpx regulon periplasmic repressor -2.62 -1.39 1.69E-05 2.52E-04 
cpxR response reguator CpxR -1.63 -0.7 2.05E-04 2.23E-03 
csgB minor curlin subunit -2.1 -1.07 1.31E-03 0.01 
cueO blue copper oxidase CueO -1.79 -0.84 5.36E-06 8.59E-05 
cutF 
 
-1.95 -0.96 5.61E-07 1.18E-05 
cvpA colicin V production protein -1.7 -0.76 1.22E-03 9.90E-03 
cysZ sulfate transport protein CysZ -3.44 -1.78 0 0 
dacB D-alanyl-D-alanine carboxypeptidase -1.54 -0.62 1.08E-03 8.97E-03 
dcoB oxaloacetate decarboxylase subunit beta -1.59 -0.67 1.64E-03 0.01 
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deoA thymidine phosphorylase -1.54 -0.62 6.86E-03 0.04 
deoC 2-deoxyribose-5-phosphate aldolase -1.74 -0.8 1.37E-03 0.01 
dinF DNA-damage-inducible protein F -2.7 -1.43 2.17E-11 8.10E-10 
dinI DNA damage-inducible protein I -7.16 -2.84 0 0 
dinP DNA polymerase IV -2.61 -1.39 1.01E-13 5.10E-12 
dkgB 5-diketo-D-gluconic acid reductase B -1.62 -0.7 1.38E-04 1.59E-03 
dps 
DNA starvation/stationary phase 
protection protein 
-1.73 -0.79 2.27E-03 0.02 




-1.86 -0.9 5.41E-06 8.65E-05 
eco ecotin -3.6 -1.85 3.65E-09 1.03E-07 
emrD MFS family multidrug tranport protein -1.99 -0.99 1.33E-07 3.11E-06 








-6.35 -2.67 0 0 
entC isochorismate synthase -9.79 -3.29 0 0 
entD 4'-phosphopantetheinyl transferase -3.87 -1.95 0 0 
entE 3-dihydroxybenzoate-AMP ligase -8.61 -3.11 0 0 
entF enterobactin synthase subunit F -2.31 -1.21 8.57E-07 1.72E-05 
envE lipoprotein EnvE -2.68 -1.42 4.44E-11 1.56E-09 
envF lipoprotein EnvF -4.52 -2.18 0 0 
fbaB fructose-bisphosphate aldolase -2.48 -1.31 3.77E-07 8.16E-06 
fepA outer membrane porin -5.33 -2.41 0 0 
fes enterochelin esterase -2.84 -1.5 1.73E-09 5.03E-08 
fhuE 
ferric-rhodotorulic acid outer membrane 
transporter 
-5.43 -2.44 0 0 
fieF cation-efflux pump FieF -2.09 -1.06 2.74E-09 7.83E-08 
fimA type-1 fimbrial protein subunit A -2.32 -1.21 9.56E-07 1.90E-05 
fimC chaperone protein FimC -1.66 -0.73 2.27E-03 0.02 
fimI fimbrin-like protein FimI -1.64 -0.72 1.54E-03 0.01 
fis DNA-binding protein Fis -1.84 -0.88 5.94E-06 9.38E-05 
fliR flagellar biosynthesis protein FliR -3.59 -1.84 0 0 





-2.15 -1.1 3.33E-05 4.54E-04 
ftsE cell division ATPase FtsE -1.81 -0.86 2.80E-05 3.91E-04 
ftsX cell division protein FtsX -1.6 -0.68 1.68E-04 1.88E-03 





uridylyltransferase subunit GalF 





-1.72 -0.78 2.83E-05 3.94E-04 
glnK nitrogen regulatory protein P-II 2 -1.98 -0.98 7.77E-03 0.04 
glnU 
 
-1.98 -0.98 1.43E-05 2.15E-04 
glnW 
 
-2.06 -1.04 4.38E-06 7.25E-05 
glnX 
 
-1.58 -0.66 8.70E-03 0.05 
glrK sensor kinase GlrK -1.53 -0.61 1.08E-03 8.97E-03 
gltU 
 
-2.07 -1.05 1.26E-03 0.01 
gltV 
 
-1.79 -0.84 8.96E-03 0.05 
glyT 
 
-2.8 -1.48 2.81E-11 1.01E-09 
gmd GDP-D-mannose dehydratase -13.46 -3.75 0 0 
gpt xanthine phosphoribosyltransferase -2.24 -1.16 5.44E-09 1.52E-07 
greA transcription elongation factor GreA -1.64 -0.71 2.41E-03 0.02 
guaB inosine 5'-monophosphate dehydrogenase -2.15 -1.1 7.00E-11 2.40E-09 
hha hemolysin expression-modulating protein -1.83 -0.87 1.72E-05 2.55E-04 
hisR 
 
-2.62 -1.39 2.28E-08 5.94E-07 
holB DNA polymerase III subunit delta' -1.63 -0.71 5.89E-05 7.57E-04 
holD DNA polymerase III subunit psi -1.66 -0.73 7.39E-04 6.67E-03 
holE DNA polymerase III subunit theta -1.53 -0.61 8.79E-03 0.05 
hopD leader peptidase HopD -1.68 -0.75 2.51E-05 3.59E-04 
hrpB ATP-dependent helicase -1.68 -0.75 9.06E-05 1.09E-03 
hslJ heat-inducible protein HslJ -3.27 -1.71 0 0 
htpX protease HtpX -1.95 -0.96 2.75E-06 4.83E-05 
htrA serine endoprotease -2.01 -1.01 4.30E-03 0.03 
iap 
alkaline phosphatase isozyme conversion 
aminopeptidase 
-1.62 -0.7 2.37E-03 0.02 
iciA 
chromosome replication initiation inhibitor 
protein 
-2.16 -1.11 2.55E-11 9.30E-10 
ileT 
 
-2.03 -1.02 4.77E-05 6.22E-04 
ileU 
 
-2.03 -1.02 6.63E-05 8.44E-04 
ileV 
 
-2.44 -1.29 8.01E-06 1.24E-04 
ilvG acetolactate synthase 2 catalytic subunit -1.53 -0.61 9.59E-04 8.20E-03 
iroB glycosyl transferase -1.5 -0.59 3.13E-03 0.02 
kdpB potassium-transporting ATPase subunit B -1.66 -0.73 5.68E-03 0.03 
kdpC potassium-transporting ATPase subunit C -1.62 -0.7 1.33E-03 0.01 
leuA 2-isopropylmalate synthase -2.19 -1.13 2.77E-06 4.85E-05 
leuB 3-isopropylmalate dehydrogenase -1.72 -0.78 1.60E-03 0.01 
leuC 
3-isopropylmalate dehydratase large 
subunit 
-1.76 -0.81 3.45E-03 0.02 
leuO HTH-type transcriptional regulator LeuO -1.8 -0.85 2.59E-03 0.02 
leuQ 
 





-2.59 -1.37 9.00E-10 2.69E-08 
leuU 
 
-1.87 -0.9 7.39E-05 9.21E-04 
leuW 
 
-2.21 -1.15 2.70E-08 6.99E-07 
leuZ 
 
-1.61 -0.69 4.27E-03 0.03 
lexA LexA repressor -1.75 -0.81 1.37E-03 0.01 
ligT 2'-5' RNA ligase -1.88 -0.91 3.07E-06 5.25E-05 
lolA outer-membrane lipoprotein carrier protein -1.82 -0.86 1.70E-03 0.01 
lppB major outer membrane lipoprotein -1.62 -0.7 6.66E-03 0.04 
lysV 
 
-2.35 -1.23 8.46E-05 1.04E-03 
maa maltose O-acetyltransferase -1.7 -0.76 4.25E-05 5.63E-04 
malE 
maltose ABC transporter substrate-binding 
protein MalE 
-2.17 -1.12 9.12E-03 0.05 
manA mannose-6-phosphate isomerase -1.84 -0.88 1.36E-05 2.05E-04 
manC mannose-1-phosphate guanylyltransferase -5.07 -2.34 0 0 
mdoD glucan biosynthesis protein D -2.65 -1.4 3.31E-06 5.59E-05 
metW 
 
-1.67 -0.74 0.01 0.05 
metZ 
 
-1.69 -0.76 4.37E-03 0.03 
mgtA magnesium-transporting ATPase -16.17 -4.02 0 0 
mgtB magnesium-transporting ATPase -8.04 -3.01 3.12E-11 1.11E-09 
mgtC protein MgtC -16.64 -4.06 0 0 
mliC lysozyme inhibitor -3.11 -1.64 5.21E-10 1.63E-08 
mltD 
membrane-bound lytic murein 
transglycosylase D 
-1.51 -0.6 6.91E-03 0.04 
mnmA tRNA-specific 2-thiouridylase MnmA -1.57 -0.65 3.30E-04 3.32E-03 
mntH divalent metal cation transporter MntH -2.29 -1.2 1.28E-12 5.63E-11 
mrcB transpeptidase/transglycosylase -2.53 -1.34 1.03E-07 2.43E-06 




-1.57 -0.65 3.10E-03 0.02 
mutT 8-dihydro-8-oxoguanine-triphosphatase -1.63 -0.7 3.29E-04 3.31E-03 
mutY A/G-specific adenine glycosylase -2.36 -1.24 1.41E-08 3.77E-07 
nadA quinolinate synthetase -3.3 -1.72 2.07E-12 8.73E-11 
nadB L-aspartate oxidase -1.52 -0.6 1.17E-03 9.53E-03 
ndh respiratory NADH dehydrogenase 2 -2.37 -1.24 2.35E-11 8.63E-10 
obgE GTPase ObgE -2.12 -1.08 3.52E-05 4.75E-04 
ompX outer membrane protease -4.53 -2.18 2.97E-06 5.14E-05 
osmB osmotically inducible lipoprotein B -20.71 -4.37 0 0 
osmY 
hyperosmotically inducible periplasmic 
protein 
-3.72 -1.89 3.68E-13 1.75E-11 




-1.77 -0.82 6.70E-06 1.05E-04 
panC pantoate synthetase -1.5 -0.59 2.47E-03 0.02 
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pdhR pyruvate dehydrogenase complex repressor -1.84 -0.88 6.19E-06 9.75E-05 
pdxH pyridoxamine 5'-phosphate oxidase -1.77 -0.82 9.27E-04 8.01E-03 
pdxK pyridoxal kinase -1.65 -0.72 9.69E-04 8.24E-03 
pfkA 6-phosphofructokinase -1.73 -0.79 5.08E-06 8.17E-05 
phnS 
2-aminoethylphosphonate ABC transporter 
substrate-binding protein PhnS 
-6.36 -2.67 1.67E-15 9.41E-14 
phnT 
2-aminoethylphosphonate ABC transporter 
ATP-binding protein PhnT 
-2.65 -1.41 1.44E-05 2.16E-04 
phnU 
2-aminoethylphosphonate ABC transporter 
permease PhnU 
-2.43 -1.28 6.32E-09 1.75E-07 
phoB response regulato PhoB -7.31 -2.87 0 0 
phoE outer membrane phosphoporin protein E -3.3 -1.72 1.83E-10 6.01E-09 
phoR sensory kinase PhoR -6.67 -2.74 0 0 
phoU transcriptional regulator PhoU -6.88 -2.78 1.15E-09 3.40E-08 
pliC lysozyme inhibitor -2.61 -1.38 5.71E-04 5.35E-03 
potA 
putrescine/spermidine ABC transporter 
ATP-binding protein PotA 
-2.03 -1.02 2.59E-09 7.45E-08 
pphA serine/threonine-protein phosphatase 1 -1.71 -0.77 1.02E-05 1.55E-04 
prfH peptide chain release factor -2.01 -1.01 1.19E-07 2.80E-06 
priB primosomal replication protein N -2.67 -1.42 6.63E-04 6.09E-03 
proM 
 
-2.39 -1.26 6.44E-05 8.21E-04 
pspA phage shock protein PspA -3.43 -1.78 5.01E-11 1.75E-09 
pspB phage shock protein PspB -3.07 -1.62 6.25E-13 2.86E-11 
pspC 
DNA-binding transcriptional activator 
PspC 
-2.8 -1.48 3.11E-13 1.52E-11 
pspD inner membrane phage-shock protein -2.61 -1.38 1.11E-16 6.77E-15 
pspG phage shock protein G -2.2 -1.14 8.59E-10 2.60E-08 
pstA 
phosphate ABC transporter permease 
subunit PtsA 
-17.91 -4.16 0 0 
pstB 
phosphate ABC transporter ATP-binding 
protein PstB 
-11.49 -3.52 7.11E-15 3.92E-13 
pstC phosphate ABC transporter permease PstC -26.42 -4.72 0 0 
pstS 
phosphate ABC transporter substrate-
binding protein PstS 
-57.1 -5.84 0 0 
ptrB protease 2 -1.83 -0.87 9.88E-04 8.38E-03 




-1.55 -0.64 2.01E-03 0.01 
pyrF 
OMP decarboxylase; OMPDCase; 
OMPdecase 
-3.45 -1.79 0 0 




-1.88 -0.91 1.70E-05 2.52E-04 
rapA RNA polymerase-associated protein RapA -1.94 -0.95 2.39E-04 2.53E-03 
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rcsA transcriptional regulator RcsA -7.99 -3 0 0 
rcsB transcriptional regulator RcsB -1.78 -0.84 6.54E-03 0.04 
recA recombinase A -5.21 -2.38 8.76E-10 2.63E-08 
recN DNA repair protein RecN -6.94 -2.8 0 0 
recX recombination regulator RecX -2.96 -1.57 1.11E-16 6.77E-15 
rfbD dTDP-4-dehydrorhamnose reductase -1.6 -0.68 9.76E-03 0.05 
rhaA L-rhamnose isomerase -1.72 -0.78 2.03E-04 2.22E-03 
rhlE ATP-dependent RNA helicase RhlE -2.13 -1.09 5.51E-04 5.21E-03 
rimO 
ribosomal protein S12 
methylthiotransferase RimO 
-2.02 -1.01 1.99E-06 3.66E-05 
rimP ribosome maturation factor RimP -2.13 -1.09 1.08E-06 2.11E-05 
rlmL 
bifunctional rRNA large subunit 
methyltransferase 
-1.84 -0.88 2.02E-03 0.01 
rluC 
rRNA lager subunit pseudouridylate 
synthase C 
-1.89 -0.92 1.86E-06 3.44E-05 
rnc ribonuclease III -1.66 -0.73 8.12E-05 9.97E-04 
rnpA ribonuclease P protein -1.6 -0.68 4.62E-03 0.03 
rph ribonuclease PH -2.5 -1.32 2.45E-12 1.01E-10 
rplA 50S ribosomal protein L1 -3.57 -1.83 4.54E-05 5.97E-04 
rplB 50S ribosomal protein L2 -2.78 -1.48 1.97E-03 0.01 
rplC 50S ribosomal protein L3 -3.31 -1.73 2.04E-04 2.23E-03 
rplD 50S ribosomal protein L4 -3.09 -1.63 4.39E-04 4.30E-03 
rplI 50S ribosomal protein L9 -2.74 -1.45 1.49E-03 0.01 
rplK 50S ribosomal protein L11 -3.98 -1.99 4.76E-08 1.18E-06 
rplP 50S ribosomal protein L16 -2.19 -1.13 0.01 0.05 
rplS 50S ribosomal protein L19 -2.16 -1.11 2.71E-03 0.02 
rplV 50S ribosomal protein L22 -2.46 -1.3 4.31E-03 0.03 
rplW 50S ribosomal protein L23 -3.05 -1.61 3.32E-04 3.34E-03 
rplY 50S ribosomal protein L25 -2.39 -1.26 1.54E-04 1.74E-03 
rpmB 50S ribosomal protein L28 -1.85 -0.89 4.84E-03 0.03 
rpmC 50S ribosomal protein L29 -2.07 -1.05 8.55E-03 0.05 
rpmE 50S ribosomal protein L31 -2.22 -1.15 1.50E-03 0.01 
rpmH 50S ribosomal protein L34 -1.82 -0.87 2.62E-05 3.71E-04 
rpsC 30S ribosomal protein S3 -2.38 -1.25 7.88E-03 0.04 
rpsF 30S ribosomal protein S6 -2.87 -1.52 5.90E-04 5.49E-03 
rpsJ 30S ribosomal protein S10 -2.84 -1.51 3.89E-04 3.89E-03 
rpsP 30S ribosomal protein S16 -1.94 -0.95 2.55E-03 0.02 
rpsR 30S ribosomal protein S18 -2.92 -1.55 1.44E-04 1.64E-03 
rpsS 30S ribosomal protein S19 -2.68 -1.42 1.30E-03 0.01 
rrsA 
 
-3.16 -1.66 1.13E-03 9.31E-03 
rrsB 
 
-3.38 -1.76 6.29E-04 5.84E-03 
rrsC 
 
-3.26 -1.7 9.70E-04 8.24E-03 
rsmC 16S rRNA methyltransferase -1.84 -0.88 1.18E-06 2.28E-05 
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rsuA 16S rRNA pseudouridine(516) synthase -1.91 -0.94 3.00E-06 5.15E-05 
rtcA RNA 3'-terminal-phosphate cyclase -15.51 -3.96 0 0 




-2.53 -1.34 1.04E-12 4.67E-11 
ruvA 
Holliday junction ATP-dependent DNA 
helicase RuvA 
-2.12 -1.08 1.95E-08 5.13E-07 
ruvB 
Holliday junction ATP-dependent DNA 
helicase RuvB 
-1.5 -0.58 5.41E-03 0.03 
sbmC DNA gyrase inhibitor -5.38 -2.43 4.44E-16 2.60E-14 
scsA copper sensitive suppression protein A -2.76 -1.46 4.59E-08 1.15E-06 
scsB copper sensitive suppression protein -2.2 -1.14 4.48E-06 7.38E-05 
secG preprotein translocase IISp family protein -1.74 -0.8 2.90E-04 3.01E-03 
serB 3-phosphoserine phosphatase -1.59 -0.67 9.65E-04 8.23E-03 
serW 
 
-2 -1 6.89E-03 0.04 
setB sugar efflux transporter B -1.79 -0.84 7.33E-05 9.15E-04 
sinH intimin-like protein SinH -1.63 -0.7 1.70E-03 0.01 
slrB 
PTS system glucitol/sorbitol-specific 
transporter subunit IIA 
-1.6 -0.68 5.29E-04 5.03E-03 
smvA methyl viologen resistance protein SmvA -4.49 -2.17 0 0 
spy stress response protein -2.59 -1.37 4.67E-12 1.88E-10 
ssb single-stranded DNA-binding protein -1.72 -0.78 5.39E-04 5.11E-03 
STM0016 hypothetical protein -3 -1.58 2.58E-05 3.66E-04 
STM0080 outer membrane lipoprotein -17.56 -4.13 0 0 
STM0100 cytoplasmic protein -3.74 -1.9 1.63E-07 3.73E-06 
STM0257 drug efflux protein -2.2 -1.13 4.96E-07 1.06E-05 
STM0289 cytoplasmic protein -1.97 -0.98 3.29E-03 0.02 
STM0314 
 
-5.23 -2.39 0 0 
STM0341 inner membrane protein -1.97 -0.98 7.97E-05 9.82E-04 
STM0342 periplasmic protein -2.28 -1.19 7.57E-06 1.18E-04 




-1.53 -0.61 4.04E-03 0.03 
STM04610 hypothetical protein -3.47 -1.79 1.06E-04 1.27E-03 




-1.59 -0.67 1.96E-03 0.01 




-2.29 -1.2 8.65E-04 7.57E-03 
STM0554 integrase -2.6 -1.38 1.12E-04 1.34E-03 
STM0555 
 
-1.7 -0.76 1.07E-03 8.92E-03 
STM0564 oxidoreductase -1.96 -0.97 2.39E-07 5.35E-06 
STM0587 cytoplasmic protein -3.31 -1.73 9.61E-11 3.27E-09 
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STM0610 anaerobic dehydrogenase component -1.9 -0.93 4.30E-03 0.03 




-1.88 -0.91 1.35E-04 1.57E-03 
STM0801 hypothetical protein -1.5 -0.59 8.60E-04 7.54E-03 
STM0869 TetR/Acr family regulator -2.06 -1.04 1.79E-07 4.06E-06 
STM0950 SlsA protein -1.83 -0.87 2.15E-04 2.33E-03 
STM0951 cytoplasmic protein -6.01 -2.59 0 0 
STM0952 LysR family transcriptional regulator -2.69 -1.43 3.33E-15 1.86E-13 
STM1024 hypothetical protein -3.11 -1.64 9.18E-04 7.94E-03 
STM1025 hypothetical protein -3.26 -1.7 2.75E-11 9.94E-10 
STM1060 iron-sulfur protein -1.51 -0.6 3.22E-03 0.02 
STM1241.1 
 
-7.82 -2.97 0 0 
STM1243 cold shock-like protein CspH -2.3 -1.2 6.32E-08 1.56E-06 
STM1247 
 
-3.44 -1.78 2.82E-10 8.95E-09 
STM1254 outer membrane lipoprotein -2.05 -1.03 7.10E-07 1.45E-05 
STM1273 nitric oxide reductase -2.93 -1.55 3.12E-12 1.28E-10 
STM1309 excinuclease -3.65 -1.87 0 0 
STM1311 DNA-binding transcriptional activator -1.99 -0.99 1.03E-04 1.23E-03 
STM1472 periplasmic protein -1.8 -0.85 8.49E-05 1.04E-03 
STM1492 ABC transporter permease -1.91 -0.94 2.26E-06 4.08E-05 
STM1493 ABC transporter substrate-binding protein -2.58 -1.37 7.38E-12 2.87E-10 
STM1494 ABC transporter permease -2.73 -1.45 1.99E-12 8.47E-11 
STM1561 lipoprotein -2 -1 3.27E-07 7.21E-06 
STM1573.S hypothetical protein -2.44 -1.29 5.29E-12 2.11E-10 
STM1585 outer membrane lipoprotein -2.34 -1.23 7.08E-07 1.45E-05 
STM1586 hypothetical protein -1.5 -0.58 6.06E-04 5.63E-03 
STM1621 periplasmic protein -1.88 -0.91 7.60E-05 9.41E-04 
STM1627 alcohol dehydrogenase class III -1.63 -0.71 8.67E-05 1.05E-03 
STM1628 cytoplasmic protein -2.01 -1 5.04E-06 8.13E-05 
STM1633 extracellular solute-binding protein -1.77 -0.82 2.34E-03 0.02 
STM1634 ABC transporter permease -1.61 -0.68 3.16E-03 0.02 
STM1649 cytoplasmic protein -1.88 -0.91 3.10E-05 4.26E-04 
STM1650 hypothetical protein -3.61 -1.85 6.73E-12 2.66E-10 
STM1665 cytoplasmic protein -1.61 -0.69 4.35E-03 0.03 
STM1670 lipoprotein -1.79 -0.84 8.60E-03 0.05 
STM1841 hypothetical protein -2.08 -1.05 3.11E-06 5.30E-05 
STM1869A hypothetical protein -1.98 -0.98 6.62E-03 0.04 
STM1870 hypothetical protein -1.86 -0.89 0.01 0.05 
STM1881 hypothetical protein -6.84 -2.77 0 0 
STM2003 
 
-2.27 -1.18 9.50E-05 1.14E-03 
STM2126 multidrug resistance protein MdtA -1.74 -0.8 2.45E-05 3.52E-04 
STM2148 periplasmic protein -1.59 -0.67 8.32E-03 0.05 
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STM2198 regulatory protein -1.64 -0.71 9.39E-04 8.08E-03 
STM2209.1 hypothetical protein -2.43 -1.28 5.05E-03 0.03 
STM2797 ArsR family regulatory protein -1.82 -0.87 1.00E-04 1.20E-03 
STM2800 L-alanine exporter AlaE -1.83 -0.87 4.46E-07 9.57E-06 
STM2803 GntR family regulatory protein -1.73 -0.79 4.87E-06 7.89E-05 
STM2821 
 
-2 -1 3.55E-04 3.55E-03 
STM2822 
 
-2.24 -1.16 1.90E-04 2.11E-03 
STM2823 
 
-2.14 -1.1 2.33E-04 2.49E-03 
STM2824 
 
-2.17 -1.12 4.20E-04 4.15E-03 
STM2825 
 




-1.59 -0.67 2.78E-04 2.89E-03 
STM2986.S integral membrane protein -1.5 -0.58 8.45E-03 0.05 
STM3022 transporter -1.95 -0.96 3.02E-05 4.16E-04 
STM3025.1 hypothetical protein -1.88 -0.91 2.10E-05 3.07E-04 
STM3026 outer membrane protein -2.01 -1.01 1.55E-03 0.01 
STM3085 outer membrane lipoprotein -4.3 -2.1 0 0 
STM3168 hypothetical protein -1.74 -0.8 3.04E-03 0.02 
STM3270 hypothetical protein -1.94 -0.95 1.68E-06 3.15E-05 
STM3397 
 
-2.3 -1.2 1.88E-04 2.10E-03 
STM3516 cytoplasmic protein -2.17 -1.11 1.37E-07 3.18E-06 
STM3517 DNA-damage-inducibile protein -4.82 -2.27 0 0 
STM3520 
 
-120.67 -6.91 0 0 
STM3521 ribonucleoprotein related-protein -93.74 -6.55 0 0 
STM3580 inner membrane lipoprotein -1.86 -0.9 5.90E-03 0.03 
STM3595 phosphatase -1.56 -0.64 1.51E-03 0.01 
STM3624A cystathionine gamma-synthase -2.01 -1.01 3.09E-04 3.14E-03 
STM3632 hypothetical protein -1.85 -0.89 1.50E-04 1.70E-03 
STM3633 regulatory protein -2.65 -1.41 1.03E-10 3.45E-09 
STM3650 hypothetical protein -1.93 -0.95 5.50E-05 7.10E-04 
STM3657 lipoprotein -3 -1.58 1.11E-16 6.77E-15 
STM3663 hypothetical protein -2.9 -1.54 1.13E-12 5.03E-11 
STM3761 inner membrane protein -1.97 -0.98 1.02E-03 8.57E-03 
STM3796A. integral membrane protein -2.33 -1.22 2.53E-10 8.07E-09 
STM3898 hypothetical protein -2.1 -1.07 8.75E-05 1.06E-03 
STM3980 outer membrane protein -1.5 -0.59 6.77E-03 0.04 
STM4032 acetyl esterase -2.71 -1.44 1.11E-16 6.77E-15 
STM4032.2 hypothetical protein -1.79 -0.84 7.09E-05 8.93E-04 
STM4041 inner membrane protein -2.41 -1.27 2.94E-06 5.13E-05 
STM4042 branched-chain amino acid permease -2.47 -1.3 2.60E-06 4.60E-05 
STM4134 
 
-1.65 -0.73 1.11E-03 9.15E-03 
STM4239 cytoplasmic protein -1.74 -0.8 2.46E-04 2.59E-03 
STM4268 hypothetical protein -1.86 -0.89 2.60E-06 4.60E-05 
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STM4289 hypothetical protein -1.83 -0.87 3.19E-05 4.38E-04 
STM4309 hypothetical protein -1.74 -0.8 1.44E-04 1.64E-03 
STM4310 inner membrane protein -1.59 -0.67 2.33E-03 0.02 
STM4457 transposase -2.12 -1.08 1.61E-06 3.03E-05 
STM4509.S hypothetical protein -4.09 -2.03 1.99E-10 6.49E-09 
STM4510 aspartate racemase -2 -1 1.06E-06 2.08E-05 
STM4552 inner membrane protein -4.32 -2.11 1.33E-15 7.62E-14 
STM4562 hypothetical protein -2.55 -1.35 1.92E-11 7.30E-10 
suhB inositol monophosphatase -2.41 -1.27 1.37E-08 3.67E-07 
sulA cell division inhibitor SulA -6.5 -2.7 0 0 
tbpA 
thiamine ABC transporter substrate-
binding protein ThiP 
-3.16 -1.66 2.56E-14 1.37E-12 
tgt queuine tRNA-ribosyltransferase -1.9 -0.93 2.20E-06 3.99E-05 




-1.82 -0.86 3.62E-05 4.86E-04 
thiE thiamine-phosphate synthase -1.58 -0.66 5.03E-03 0.03 
thiM hydroxyethylthiazole kinase -1.82 -0.86 2.36E-04 2.51E-03 
thiP thiamine ABC transporter permease ThiP -2.08 -1.06 7.37E-08 1.79E-06 
thiQ 
thiamine ABC transporter ATP-binding 
protein 
-1.64 -0.72 7.59E-05 9.41E-04 
thrT 
 
-2.95 -1.56 8.27E-12 3.19E-10 
tmk thymidylate kinase -1.73 -0.79 4.74E-06 7.73E-05 
tnpA_3 
insertion sequence element IS200 
transposase 
-2.98 -1.58 4.43E-03 0.03 
tnpA_6 
insertion sequence element IS200 
transposase 
-2.56 -1.35 3.39E-03 0.02 
tolA 
cell envelope integrity inner membrane 
protein TolA 
-1.69 -0.75 6.65E-04 6.10E-03 
tolQ colicin uptake protein TolQ -1.82 -0.86 2.66E-04 2.80E-03 
tolR colicin uptake protein TolR -1.64 -0.72 3.68E-03 0.02 
tonB transport protein TonB -1.54 -0.63 1.62E-03 0.01 
topA DNA topoisomerase I -1.57 -0.65 6.31E-03 0.04 
treR HTH-type transcriptional regulator TreR -2.62 -1.39 4.58E-13 2.14E-11 
trpE anthranilate synthase component I -1.56 -0.64 5.70E-04 5.35E-03 
trxC thioredoxin 2 -1.59 -0.67 2.71E-04 2.84E-03 
tyrU 
 
-2 -1 1.78E-04 1.99E-03 
tyrV 
 
-1.56 -0.65 8.34E-03 0.05 
udp uridine phosphorylase -1.64 -0.72 5.41E-03 0.03 
ugpA 
glycerol-3-phosphate ABC transporter 
permease UdpA 
-11.14 -3.48 0 0 
ugpB 
glycerol-3-phosphate ABC transporter 
substrate-binding protein UdpB 




glycerol-3-phosphate ABC transporter 
ATP-binding protein UgpC 
-8.11 -3.02 0 0 
ugpE 
glycerol-3-phosphate ABC transporter 
permease UdpE 
-13.51 -3.76 0 0 
ugpQ glycerophosphodiester phosphodiesterase -1.98 -0.98 2.68E-04 2.81E-03 
upp uracil phosphoribosyltransferase -2.79 -1.48 2.09E-06 3.82E-05 
uraA uracil transporter -1.58 -0.66 2.77E-03 0.02 
uup ABC transporter ATPase -1.66 -0.73 7.40E-04 6.67E-03 
uvrA excinuclease ABC subunit A -1.9 -0.93 6.83E-04 6.24E-03 
uvrB excinuclease ABC subunit B -2 -1 2.27E-06 4.08E-05 
valU 
 
-1.82 -0.86 1.00E-03 8.50E-03 
valX 
 
-1.63 -0.71 7.93E-03 0.04 
valY 
 
-1.68 -0.75 8.70E-03 0.05 
wcaA glycosyl transferase -7.66 -2.94 0 0 
wcaB 
colanic acid biosynthesis acetyltransferase 
WcaB 
-4.41 -2.14 4.57E-14 2.38E-12 
wcaC glycosyl transferase -5.53 -2.47 8.60E-12 3.29E-10 
wcaD colanic acid polymerase -8.69 -3.12 0 0 
wcaE glycosyl transferase family protein -25.76 -4.69 0 0 
wcaF 
colanic acid biosynthesis acetyltransferase 
WcaF 
-26.86 -4.75 0 0 
wcaG GDP-fucose synthetase -12.91 -3.69 0 0 
wcaH GDP-mannose mannosyl hydrolase -10.3 -3.36 0 0 
wcaI glycosyl transferase -7.82 -2.97 0 0 
wcaJ UDP-glucose lipid carrier transferase -2.14 -1.1 2.36E-06 4.22E-05 
wza polysaccharide export protein -28.28 -4.82 0 0 
wzb protein-tyrosine-phosphatase -31.78 -4.99 0 0 
wzc tyrosine-protein kinase -14.72 -3.88 0 0 
wzxC colanic acid exporter -1.75 -0.81 9.51E-04 8.15E-03 
xylA xylose isomerase -1.68 -0.75 4.05E-05 5.38E-04 
yabI DedA family membrane protein -1.85 -0.89 3.32E-05 4.53E-04 
yadI PTS system transporter subunit IIA -1.7 -0.77 2.64E-03 0.02 
yaeJ hydrolase domain-containing protein -1.58 -0.66 6.97E-04 6.35E-03 
yaiW outer membrane lipoprotein -1.86 -0.9 5.95E-07 1.24E-05 
yaiY inner membrane protein -4.94 -2.31 0 0 
yajG lipoprotein -1.65 -0.72 1.16E-04 1.37E-03 
yajI outer membrane lipoprotein -11.29 -3.5 0 0 




-1.84 -0.88 2.76E-04 2.88E-03 
ybdA enterobactin exporter EntS -2.26 -1.18 2.21E-11 8.18E-10 
ybdB proofreading thioesterase EntH -3.64 -1.87 3.59E-13 1.73E-11 
ybdR dehydrogenase -1.59 -0.67 1.31E-04 1.53E-03 
ybgC acyl-CoA thioester hydrolase -1.85 -0.89 9.11E-04 7.90E-03 
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ybgR zinc transporter ZitB -2.06 -1.04 4.06E-08 1.03E-06 
ybhO cardiolipin synthase -1.81 -0.85 2.18E-06 3.98E-05 
ybhP cytoplasmic protein -1.85 -0.88 3.00E-06 5.15E-05 
ybiJ periplasmic protein -1.54 -0.63 9.24E-03 0.05 
ybiS periplasmic protein -2.42 -1.27 7.69E-09 2.11E-07 
ybjO inner membrane protein -1.79 -0.84 1.54E-06 2.91E-05 
ycaD MFS family transporter protein -2.96 -1.57 2.22E-16 1.32E-14 
ycaO cytoplasmic protein -1.75 -0.81 2.79E-04 2.90E-03 
ycaP inner membrane protein -1.6 -0.68 2.45E-03 0.02 
yceG septation protein -2.05 -1.03 1.04E-06 2.06E-05 
ycfJ outer membrane lipoprotein -11.22 -3.49 0 0 
ycfR outer membrane protein -2.68 -1.42 6.87E-05 8.67E-04 
ycfS periplasmic protein -2.71 -1.44 5.44E-13 2.52E-11 
yciA acyl-CoA thioesterase -1.94 -0.95 3.28E-07 7.21E-06 
yciH translation initiation factor Sui1 -8.92 -3.16 0 0 
yciK oxoacyl-ACP reductase -3.34 -1.74 1.58E-14 8.59E-13 
yciL 23S rRNA pseudouridylate synthase B -2.91 -1.54 3.97E-13 1.88E-11 
ydaO 
tRNA 2-thiocytidine biosynthesis protein 
TtcA 
-1.7 -0.77 1.30E-03 0.01 
yddX biofilm-dependent modulation protein -3.16 -1.66 1.01E-10 3.43E-09 
ydeA sugar efflux transporter -1.65 -0.72 3.02E-04 3.09E-03 
ydeI periplasmic protein -1.77 -0.82 8.41E-06 1.30E-04 
ydeJ competence damage-inducible protein A -2.18 -1.12 3.66E-09 1.03E-07 
ydgC inner membrane protein -1.83 -0.87 1.24E-04 1.46E-03 
ydgF spermidine export protein MdtJ -1.92 -0.94 2.18E-04 2.36E-03 
ydgI amino acid transporter -2.52 -1.33 6.99E-12 2.74E-10 
ydhB LysR family transcriptional regulator -1.62 -0.69 6.80E-05 8.60E-04 
ydhC MFS family transport protein -2.07 -1.05 2.00E-10 6.49E-09 
ydiL cytoplasmic protein -1.96 -0.97 3.61E-03 0.02 
ydiN MFS family transport protein -1.88 -0.91 0.01 0.05 
ydjM LexA-regulated protein -1.8 -0.85 5.73E-04 5.36E-03 
ydjN kinase-like protein -1.77 -0.82 1.97E-04 2.16E-03 
yebE inner membrane protein -4.04 -2.01 1.13E-09 3.35E-08 
yebG DNA damage-inducible protein -10.6 -3.41 0 0 
yeeA inner membrane protein -3.45 -1.79 1.02E-10 3.43E-09 
yeeF amino acid transport protein -3.34 -1.74 3.80E-06 6.33E-05 
yegD chaperone -2.42 -1.28 4.70E-06 7.69E-05 
yegQ protease -1.93 -0.95 9.17E-08 2.20E-06 
yegS lipid kinase -2.51 -1.33 1.84E-09 5.34E-08 
yehE outer membrane protein -3.79 -1.92 2.22E-16 1.32E-14 
yfaZ inner membrane protein -1.93 -0.95 4.32E-07 9.30E-06 
yfcB 
50S ribosomal protein L3 glutamine 
methyltransferase 
-1.85 -0.88 8.71E-05 1.06E-03 
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yfdC inner membrane protein -1.55 -0.64 8.99E-04 7.84E-03 
yfgB 
dual-specificity RNA methyltransferase 
RlmN 
-1.8 -0.85 1.57E-03 0.01 
yfiF tRNA/rRNA methyltransferase -1.98 -0.99 2.35E-05 3.39E-04 
ygaC cytoplasmic protein -5.28 -2.4 0 0 
ygaM inner membrane protein -1.88 -0.91 1.24E-08 3.35E-07 
ygdR POT family peptide transport protein -2.6 -1.38 2.06E-08 5.40E-07 
yggE oxidative stress defense protein -4.97 -2.31 2.10E-13 1.04E-11 
yggG Zn-dependent protease -1.82 -0.86 1.04E-05 1.58E-04 
yggX Fe(2+)-trafficking protein -1.88 -0.91 3.54E-06 5.91E-05 
ygjT inner membrane protein -2.03 -1.02 2.24E-07 5.03E-06 
yhbE 
 
-3.04 -1.6 0 0 
yhbO intracellular proteinase -2.44 -1.29 6.39E-13 2.90E-11 
yhdG tRNA-dihydrouridine synthase B -2.41 -1.27 2.36E-10 7.59E-09 
yhdV outer membrane lipoprotein -5.83 -2.54 1.85E-12 7.95E-11 
yhfC transporter -2.14 -1.1 1.38E-07 3.19E-06 
yhgF RNase R -1.88 -0.91 2.25E-03 0.02 
yhjB transcriptional regulator -1.64 -0.71 1.69E-03 0.01 
yhjK diguanylate cyclase/phosphodiesterase -1.83 -0.87 6.42E-07 1.32E-05 
yiaD outer membrane lipoprotein -9.03 -3.18 1.11E-16 6.77E-15 
yiaE glyoxylate/hydroxypyruvate reductase B -1.74 -0.8 2.84E-05 3.96E-04 
yiaJ IclR family transcriptional repressor -1.52 -0.6 3.27E-03 0.02 
yibD glycosyl transferase -2.15 -1.1 4.24E-08 1.07E-06 




-2.32 -1.21 5.55E-08 1.37E-06 
yigM membrane protein -1.67 -0.74 1.18E-04 1.39E-03 
yiiU cell division protein ZapB -1.61 -0.69 8.86E-03 0.05 
yjaB N-acetyltransferase -1.59 -0.67 1.93E-04 2.14E-03 
yjbE outer membrane protein -10.27 -3.36 0 0 
yjbF outer membrane lipoprotein -25.86 -4.69 0 0 
yjbG periplasmic protein -19.47 -4.28 0 0 
yjbH outer membrane lipoprotein -2.63 -1.39 1.86E-05 2.74E-04 
yjbJ stress-response protein -2.67 -1.42 6.43E-08 1.58E-06 
yjcB inner membrane protein -3.21 -1.68 1.55E-12 6.79E-11 
yjeA elongation factor P--(R)-beta-lysine ligase -1.63 -0.71 3.55E-03 0.02 
yjeM inner membrane transporter -1.73 -0.79 1.04E-03 8.73E-03 
yjiO multidrug resistance protein MdtM -1.7 -0.77 7.90E-04 7.02E-03 
yjjQ 
LuxR/UhpA family transcriptional 
regulator 
-1.78 -0.83 7.45E-03 0.04 
yjjU phosphoesterase -1.78 -0.83 1.44E-06 2.75E-05 
yncB NADP-dependent oxidoreductase -1.5 -0.59 8.60E-04 7.54E-03 
yneH glutaminase -1.51 -0.59 8.50E-04 7.49E-03 
yohL transcriptional repressor RcnR -3.59 -1.85 4.10E-14 2.16E-12 
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-1.56 -0.64 7.51E-04 6.75E-03 
ypeC periplasmic protein -6.49 -2.7 3.18E-12 1.29E-10 
ypfG periplasmic protein -9.47 -3.24 0 0 
yqcC cytoplasmic protein -1.57 -0.65 5.87E-03 0.03 
yqjH transporter -1.69 -0.75 3.39E-05 4.61E-04 
yrbA BolA family transcriptional regulator -1.69 -0.76 1.99E-05 2.91E-04 
yrbB STAS domain-containing protein -2.13 -1.09 5.22E-07 1.11E-05 
yrbC ABC transporter substrate-binding protein -2.33 -1.22 3.61E-05 4.86E-04 
yrbE ABC transporter permease -1.64 -0.71 1.64E-03 0.01 
yrbF ABC transporter ATP-binding protein -1.62 -0.69 5.07E-04 4.86E-03 
yrfH 
ribosome-associated heat shock protein 
Hsp15 
-1.55 -0.63 8.20E-04 7.24E-03 
ysdA 
 
-5.05 -2.34 0 0 
ysdB 
 




-8.91 -3.16 0 0 
zntB zinc transport protein ZntB -1.93 -0.95 2.47E-06 4.41E-05 
zur zinc uptake transcriptional repressor -2.15 -1.1 5.62E-10 1.74E-08 
a Functional annotations are from NCBI for Salmonella Typhimurium strain LT2 (accession number 















Table 5. Differentially expressed genes of interest associated with transport, metabolism, 
regulatory, and pathogenesis functions. 






FDR             
p-value 
      
Transport and localization 




1.58 0.66 7.43E-03 0.04 
cysW 
sulfate/thiosulfate ABC transporter 
permease CysW 
1.62 0.69 5.28E-03 0.03 
dppC dipeptide ABC transporter permease DppC 1.66 0.73 3.23E-04 3.27E-03 
dppD 
dipeptide ABC transporter ATP-binding 
subunit DppD 
1.8 0.85 7.28E-04 6.60E-03 
dppF 
dipeptide ABC transporter ATP-binding 
subunit DppF 
1.68 0.75 8.38E-03 0.05 
hisM histidine ABC transporter permease HisM 2 1 2.26E-06 4.08E-05 
hisP 
histidine ABC transporter ATP-binding 
protein HisP 
1.81 0.86 1.80E-04 2.01E-03 
hisQ histidine ABC transporter permease HisQ 1.84 0.88 1.73E-03 0.01 
kdpB potassium-transporting ATPase subunit B -1.66 -0.73 5.68E-03 0.03 
kdpC potassium-transporting ATPase subunit C -1.62 -0.7 1.33E-03 0.01 
mgtA magnesium-transporting ATPase -16.17 -4.02 0 0 
mgtB magnesium-transporting ATPase -8.04 -3.01 3.12E-11 1.11E-09 
mgtC protein MgtC -16.64 -4.06 0 0 
osmB osmotically inducible lipoprotein B -20.71 -4.37 0 0 
phnS 2-aminoethylphosphonate ABC transporter 
substrate-binding protein PhnS 
-6.36 -2.67 1.67E-15 9.41E-14 
phnT 2-aminoethylphosphonate ABC transporter 
ATP-binding protein PhnT 
-2.65 -1.41 1.44E-05 2.16E-04 
phnU 2-aminoethylphosphonate ABC transporter 
permease PhnU 
-2.43 -1.28 6.32E-09 1.75E-07 
phoB response regulato PhoB -7.31 -2.87 0 0 
phoE outer membrane phosphoporin protein E -3.3 -1.72 1.83E-10 6.01E-09 
phoR sensory kinase PhoR -6.67 -2.74 0 0 
phoU transcriptional regulator PhoU -6.88 -2.78 1.15E-09 3.40E-08 
ppk polyphosphate kinase 1.6 0.68 5.55E-04 5.24E-03 
pstA 
phosphate ABC transporter permease 
subunit PtsA 
-17.91 -4.16 0 0 
pstB 
phosphate ABC transporter ATP-binding 
protein PstB 
-11.49 -3.52 7.11E-15 3.92E-13 
pstC phosphate ABC transporter permease PstC -26.42 -4.72 0 0 
pstS 
phosphate ABC transporter substrate-
binding protein PstS 
-57.1 -5.84 0 0 





peptide ABC transporter ATP-binding 
protein SapF 
1.55 0.63 2.74E-03 0.02 
ugpA 
glycerol-3-phosphate ABC transporter 
permease UdpA 
-11.14 -3.48 0 0 
ugpB glycerol-3-phosphate ABC transporter 
substrate-binding protein UdpB 
-11.45 -3.52 1.11E-16 6.77E-15 
ugpC glycerol-3-phosphate ABC transporter 
ATP-binding protein UgpC 
-8.11 -3.02 0 0 
ugpE 
glycerol-3-phosphate ABC transporter 
permease UdpE 
-13.51 -3.76 0 0 




-8.91 -3.16 0 0 
zntB zinc transport protein ZntB -1.93 -0.95 2.47E-06 4.41E-05 
zur zinc uptake transcriptional repressor -2.15 -1.1 5.62E-10 1.74E-08 
      Metabolism 








-6.35 -2.67 0 0 
entC isochorismate synthase -9.79 -3.29 0 0 
entD 4'-phosphopantetheinyl transferase -3.87 -1.95 0 0 
entE 3-dihydroxybenzoate-AMP ligase -8.61 -3.11 0 0 
entF enterobactin synthase subunit F -2.31 -1.21 8.57E-07 1.72E-05 
eutD phosphotransacetylase EutD 1.89 0.92 3.32E-03 0.02 
eutN microcompartment shell protein EutN 1.82 0.86 3.18E-03 0.02 
eutP ethanolamine utilization protein EutP 2.34 1.23 1.43E-07 3.29E-06 
eutQ ethanolamine utilization protein EutQ 2.03 1.02 4.91E-04 4.74E-03 
eutS carboxysome structural protein EutS 2.5 1.32 1.20E-08 3.26E-07 
eutT cobalamin adenosyltransferase EutT 2.11 1.08 1.20E-03 9.82E-03 
fepA outer membrane porin -5.33 -2.41 0 0 
fepE ferric enterobactin transport protein 1.56 0.64 1.32E-04 1.53E-03 
fes enterochelin esterase -2.84 -1.5 1.73E-09 5.03E-08 
prpR 
propionate catabolism operon regulatory 
protein 
1.93 0.95 5.90E-05 7.57E-04 
rcsA transcriptional regulator RcsA -7.99 -3 0 0 
rcsB transcriptional regulator RcsB -1.78 -0.84 6.54E-03 0.04 
tonB transport protein TonB -1.54 -0.63 1.62E-03 0.01 
wcaA glycosyl transferase -7.66 -2.94 0 0 
wcaB 
colanic acid biosynthesis acetyltransferase 
WcaB 
-4.41 -2.14 4.57E-14 2.38E-12 
wcaC glycosyl transferase -5.53 -2.47 8.60E-12 3.29E-10 
wcaD colanic acid polymerase -8.69 -3.12 0 0 




colanic acid biosynthesis acetyltransferase 
WcaF 
-26.86 -4.75 0 0 
wcaG GDP-fucose synthetase -12.91 -3.69 0 0 
wcaH GDP-mannose mannosyl hydrolase -10.3 -3.36 0 0 
wcaI glycosyl transferase -7.82 -2.97 0 0 
wcaJ UDP-glucose lipid carrier transferase -2.14 -1.1 2.36E-06 4.22E-05 
wza polysaccharide export protein -28.28 -4.82 0 0 
wzb protein-tyrosine-phosphatase -31.78 -4.99 0 0 
wzc tyrosine-protein kinase -14.72 -3.88 0 0 
wzxC colanic acid exporter -1.75 -0.81 9.51E-04 8.15E-03 
      Regulatory 
    
csgD 
DNA-binding transcriptional regulator 
CsgD 
2.59 1.37 6.64E-11 2.29E-09 
csgE 
curli production assembly/transport protein 
CsgE 
2.85 1.51 1.75E-12 7.58E-11 
csgF 
curli production assembly/transport protein 
CsgF 
1.97 0.98 7.86E-07 1.60E-05 
flhC transcriptional regulator FlhC 2.05 1.04 2.35E-05 3.39E-04 
flhD transcriptional regulator FlhD 2.04 1.03 5.44E-06 8.66E-05 
hybB hydrogenase 2 b cytochrome subunit 1.63 0.71 1.08E-03 8.97E-03 
hybD hydrogenase 2 maturation endopeptidase 1.89 0.92 5.09E-05 6.60E-04 
hybE hydrogenase 2-specific chaperone 2.01 1.01 2.82E-08 7.26E-07 
hybF 
hydrogenase nickel incorporation protein 
HybF 
2.04 1.03 9.53E-08 2.27E-06 
hybG hydrogenase 2 accessory protein HypG 2.12 1.08 5.17E-10 1.63E-08 
hypA hydrogenase nickel incorporation protein 2.05 1.03 1.13E-03 9.27E-03 
lexA LexA repressor -1.75 -0.81 1.37E-03 0.01 
nuoE NADH-quinone oxidoreductase subunit E 1.6 0.68 7.72E-03 0.04 
nuoK NADH-quinone oxidoreductase subunit K 1.5 0.59 1.71E-03 0.01 
pspA phage shock protein PspA -3.43 -1.78 5.01E-11 1.75E-09 
pspB phage shock protein PspB -3.07 -1.62 6.25E-13 2.86E-11 
pspC 
DNA-binding transcriptional activator 
PspC 
-2.8 -1.48 3.11E-13 1.52E-11 
pspD inner membrane phage-shock protein -2.61 -1.38 1.11E-16 6.77E-15 
pspG phage shock protein G -2.2 -1.14 8.59E-10 2.60E-08 
recA recombinase A -5.21 -2.38 8.76E-10 2.63E-08 
rplA 50S ribosomal protein L1 -3.57 -1.83 4.54E-05 5.97E-04 
rplB 50S ribosomal protein L2 -2.78 -1.48 1.97E-03 0.01 
rplC 50S ribosomal protein L3 -3.31 -1.73 2.04E-04 2.23E-03 
rplD 50S ribosomal protein L4 -3.09 -1.63 4.39E-04 4.30E-03 
rplI 50S ribosomal protein L9 -2.74 -1.45 1.49E-03 0.01 
rplK 50S ribosomal protein L11 -3.98 -1.99 4.76E-08 1.18E-06 
rplP 50S ribosomal protein L16 -2.19 -1.13 0.01 0.05 
rplS 50S ribosomal protein L19 -2.16 -1.11 2.71E-03 0.02 
rplV 50S ribosomal protein L22 -2.46 -1.3 4.31E-03 0.03 
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rplW 50S ribosomal protein L23 -3.05 -1.61 3.32E-04 3.34E-03 
rplY 50S ribosomal protein L25 -2.39 -1.26 1.54E-04 1.74E-03 
rpmB 50S ribosomal protein L28 -1.85 -0.89 4.84E-03 0.03 
rpmC 50S ribosomal protein L29 -2.07 -1.05 8.55E-03 0.05 
rpmE 50S ribosomal protein L31 -2.22 -1.15 1.50E-03 0.01 
rpmH 50S ribosomal protein L34 -1.82 -0.87 2.62E-05 3.71E-04 
rpsC 30S ribosomal protein S3 -2.38 -1.25 7.88E-03 0.04 
rpsF 30S ribosomal protein S6 -2.87 -1.52 5.90E-04 5.49E-03 
rpsJ 30S ribosomal protein S10 -2.84 -1.51 3.89E-04 3.89E-03 
rpsP 30S ribosomal protein S16 -1.94 -0.95 2.55E-03 0.02 
rpsR 30S ribosomal protein S18 -2.92 -1.55 1.44E-04 1.64E-03 
rpsS 30S ribosomal protein S19 -2.68 -1.42 1.30E-03 0.01 
ruvA 
Holliday junction ATP-dependent DNA 
helicase RuvA 
-2.12 -1.08 1.95E-08 5.13E-07 
ruvB 
Holliday junction ATP-dependent DNA 
helicase RuvB 
-1.5 -0.58 5.41E-03 0.03 
sulA cell division inhibitor SulA -6.5 -2.7 0 0 
ttrR tetrathionate response regulator TtrR 1.52 0.6 7.69E-04 6.89E-03 
ttrS tetrathionate sensor histidine kinase TtrS 1.76 0.81 2.95E-04 3.03E-03 
uvrA excinuclease ABC subunit A -1.9 -0.93 6.83E-04 6.24E-03 
uvrB excinuclease ABC subunit B -2 -1 2.27E-06 4.08E-05 
      Pathogenesis 
    hilD transcriptional regulator HilD 1.5 0.59 3.16E-03 0.02 
invA invasion protein InvA 1.66 0.74 1.08E-04 1.29E-03 
invB 
surface presentation of antigens protein 
SpaK 
1.86 0.9 4.80E-05 6.24E-04 
invE invasion protein InvE 1.7 0.77 3.99E-05 5.31E-04 
invI 
surface presentation of antigens protein 
SpaM 
1.75 0.81 1.36E-04 1.57E-03 
prgH secretion system protein PrgH 1.59 0.67 1.15E-03 9.39E-03 
prgJ secretion system protein PrgJ 1.61 0.69 1.03E-03 8.65E-03 
prgK secretion system lipoprotein PrgK 1.79 0.84 2.99E-04 3.06E-03 
sopD secreted effector protein SopD 1.59 0.67 4.59E-03 0.03 
spaP 
surface presentation of antigens protein 
SpaP 
2.12 1.08 6.98E-10 2.13E-08 
spaQ 
surface presentation of antigens protein 
SpaQ 
1.64 0.72 4.55E-04 4.45E-03 
spaR 
surface presentation of antigens protein 
SpaR 
1.89 0.92 1.60E-04 1.80E-03 
spaS 
surface presentation of antigens protein 
SpaS 
2.28 1.19 7.91E-07 1.60E-05 
ssaB secretion system apparatus protein SsaB 2.58 1.37 5.79E-07 1.21E-05 
ssaC 
secretion system apparatus outer 
membrane protein SsaC 
1.82 0.86 2.91E-05 4.03E-04 
ssaD secretion system apparatus protein SsaD 2.24 1.16 1.62E-08 4.29E-07 
ssaE secretion system effector SsaE 2.32 1.21 5.41E-07 1.14E-05 
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ssaG secretion system apparatus protein SsaG 2.69 1.43 1.95E-11 7.35E-10 
ssaH secretion system apparatus protein SsaH 2.43 1.28 2.24E-12 9.35E-11 
ssaI secretion system apparatus protein SsaI 1.77 0.82 2.35E-04 2.51E-03 
ssaJ 
secretion system apparatus lipoprotein 
SsaJ 
1.93 0.95 2.27E-04 2.43E-03 
ssaK secretion system apparatus protein SsaK 2.36 1.24 1.54E-10 5.09E-09 
ssaL secretion system apparatus protein SsaL 1.93 0.95 1.94E-04 2.14E-03 
ssaM secretion system apparatus protein SsaM 2.09 1.07 2.27E-04 2.43E-03 
ssaN 
secretion system apparatus ATP synthase 
SsaN 
1.9 0.93 1.29E-03 0.01 
ssaO secretion system apparatus protein SsaO 3.23 1.69 0 0 
ssaP secretion system apparatus protein SsaP 3.16 1.66 1.62E-13 8.08E-12 
ssaQ secretion system apparatus protein SsaQ 2.24 1.16 5.53E-06 8.77E-05 
ssaR secretion system apparatus protein SsaR 1.93 0.95 1.08E-05 1.65E-04 
ssaS secretion system apparatus protein SsaS 3.08 1.62 6.87E-14 3.54E-12 
ssaT secretion system apparatus protein SsaT 2.01 1.01 2.80E-03 0.02 
ssaV secretion system apparatus protein SsaV 2.08 1.06 7.87E-04 7.01E-03 
sscB secretion system chaperone SscB 1.73 0.79 1.98E-03 0.01 
sseD translocation machinery protein SseD 1.5 0.58 8.16E-03 0.04 
sseE secretion system effector SseE 1.54 0.63 3.20E-03 0.02 
sseF secretion system effector SseF 2.51 1.33 1.36E-09 3.99E-08 
sseG secretion system effector SseG 2.44 1.29 1.29E-08 3.48E-07 
sseI 
required for maintaining a long-term 
systemic infection 
1.87 0.9 2.65E-05 3.73E-04 
sseL deubiquitinase SseL 1.76 0.81 4.64E-05 6.08E-04 
ssrA secretion system sensor kinase SsrA 1.78 0.83 8.20E-07 1.65E-05 
ssrB 
secretion system transcriptonal activator 
SsrB 
1.61 0.69 5.98E-05 7.65E-04 




























Figure 2. Number of differentially expressed genes with known molecular function and biological processes, as reported by 




Figure 3. Hierarchical clustering of major downregulated genes involved in phosphate and 
cation transport and ethanolamine biosynthesis, showing correlation between treated and 
control samples replicates. Treated sample replicates are designated T-1-T-3 and 




Figure 4. Hierarchical clustering of upregulated genes by pathogenicity island, showing 
uncorrelated clustering due to inconsistent expression between replicates. Treated sample 
replicates are designated T-1-T-3 and untreated control sample replicates are designated 
C-1-C-3. SPI2 was upregulated in treated replicates T-2 and T-3 while SPI1 was 




Figure 5. TEM of Salmonella Typhimurium treated with SDBD cold plasma for 2, 4, and 





Figure 6. Comparison of average relative gene expression fold changes identified by 












































EVALUATION OF THE POTENTIAL DEVELOPMENT OF RESISTANCE TO COLD 




 Cold atmospheric plasma treatment is emerging as a surface sterilization or food 
decontamination alternative that inactivates bacterial pathogens through a multi-modal 
mechanism of physical damage to cellular macromolecules by charged particles and 
reactive oxygen and nitrogen species (RONS). Due to the indiscriminate, physical 
damage caused by RONS on bacterial cells, one of the major potential benefits of cold 
plasma treatments is a potentially limited ability for bacteria to develop resistance to the 
treatment. To preliminarily evaluate this potential, the purpose of this study was to 
compare the transcriptomic response of dried Salmonella cells before and after 5 
successive rounds of plasma treatment with surface dielectric barrier discharge (SDBD) 
actuators. Bacterial inactivation was not significantly different (P ≤ 0.01) for all 5 
treatments. Among 1,136 differentially expressed genes having fold changes greater than 
1.50 (P ≤ 0.01, FDR ≤ 0.05), 492 were up-regulated (1.50 to 6.06-fold) and 644 were 
downregulated (-1.50 top -241.14-fold) after plasma treatment with 533 genes 
differentially expressed in common before and after 5 rounds of plasma treatment.
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Downregulated genes were associated with nutrient uptake, osmoregulation, alternative 
carbon and nitrogen source utilization, transcription, translation, and DNA damage repair. 
The major upregulated genes included those encoding pathogenicity associated proteins, 
especially those from Salmonella pathogenicity island 2 (SPI2). A reduction in overall 
cellular stress, observed before and after 5 rounds of plasma treatment, is thought to be 
caused by cytosol leakage and cell lysis via lipid peroxidation, alleviating nutrient, 
osmotic, and desiccation stress. Differentially gene expression unique to treatment after 
the 5 rounds was associated with the same or similar pathways as prior to the 5 rounds, 
except that more genes within the pathways were differentially expressed. No significant 
differences in bacterial inactivation rates or differential gene expression that could 
potentially lead to resistance development were identified. To our knowledge, this is the 
first known study evaluating the potential of bacterial pathogens to develop resistance to 
cold plasma treatment and further confirms the role of cellular structural damage 
contributing to inactivation of Gram-negative bacteria. Following further optimization 
and delineation of plasma generation apparatuses and treatment parameters, cold plasma 
may be a viable alternative to help alleviate the global burden of continued antibiotic 
resistance development among bacterial pathogens. 
 
INTRODUCTION 
 Cold atmospheric plasma is a versatile emerging technology that has multiple 
potential applications ranging from surface sterilization to food decontamination (Kong et 
al., 2009; Misra et al., 2011). Consisting of ionized air generated at ambient temperature 
and atmospheric pressure, cold plasma is composed of UV light, charged particles, and 
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reactive oxygen and nitrogen species (RONS) that can have damaging effects on 
prokaryotic and eukaryotic cells in a dose-dependent manner (Mai-Prochnow et al., 2014; 
Pai et al., 2015). RONS are emerging as the primary plasma-produced products that 
damage living cells through oxidative stress. More specifically, lipid peroxidation, DNA 
damage, and protein damage can accumulate rapidly in plasma treated cells resulting in 
cell lysis, necrosis, and/or apoptosis (Han et al., 2016). Bacteria are among the organisms 
most sensitive to cold plasma-induced damage and are rapidly inactivated via lipid 
peroxidation and DNA damage (Joshi et al., 2011; Han et al., 2016; Kvam et al., 2016). 
Gram-negative bacteria in particular are rapidly inactivated with cold plasma through 
membrane damage resulting in cytosol leakage and cell lysis (Kvam et al., 2016; Lunov 
et al., 2016). Since Gram-negative bacteria are among the most important foodborne and 
hospital acquired pathogens, with increasing reports of multiple-drug resistance 
development (Chang et al., 2015), cold plasma has gained intense recent interest as a 
surface sterilization or decontamination method (Kong et al., 2009; Mai-Prochnow et al., 
2014). 
 One of the most promising features of cold plasma treatment is that the multi-
modal effects of RONS and charged particles on lipids, nucleic acids, and peptides may 
result in limited potential for bacteria to develop resistance to this method (Alkawareek et 
al., 2014). With an ever increasing number of multiple drug resistant bacterial strains 
(Chang et al., 2015) and growing worldwide concern about widespread antibiotic use 
(Littmann et al., 2015), there is a great need for antibiotic treatments having minimal 
risks for additional antibiotic resistance development (Spellberg and Shlaes, 2014). 
Although limited to surface sterilization or decontamination applications, cold plasma 
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treatments have great potential applications in this area due to the unique combination 
and interplay between biological and physical scenarios of bacterial inactivation (Lunov 
et al., 2016). However, no known studies have been published investigating the potential 
for resistance development by treating a surviving population of plasma-exposed cells 
multiple times and comparing the genotypic and phenotypic characteristics. Additionally, 
although most practical applications of cold plasma treatment are for surface 
decontamination applications, almost all studies investigating the mechanistic effects of 
cold plasma treatment on bacteria have been evaluated using bacterial suspensions and 
bacteria growing on agar or growth-supporting membrane filters rather than dried cells on 
a given substrate, as would be more representative of real-world applications. 
 Therefore, the goal of this study was to evaluate the transcriptomic responses of 
dried Salmonella cells to surface dielectric barrier discharge (SDBD) cold plasma 
treatment using RNA sequencing (RNA-seq) after five rounds of successive cold plasma 
treatment of plasma-injured cells. RNA-seq is ideally suited for this purpose due to its 
high resolution with limited background noise and high dynamic range, allowing 
identification of even relatively subtle differential gene expression changes resulting from 
the treatment (Wang et al., 2009). Salmonella, a robust and common bacterial foodborne 
pathogen that has a high tolerance to desiccation stress, was used in this study (Li et al., 
2012). Compared with a previous study evaluating the morphological and transcriptomic 
response of Salmonella to SDBD cold plasma treatment (Chapter 4), this study allowed 
for a preliminary evaluation of the potential for bacterial development of resistance to 




MATERIALS AND METHODS 
 Bacterial strain and culture conditions. Salmonella enterica subspecies 
enterica serovar Enteritidis strain H4639 was used in this study. For all experiments the 
strains were grown aerobically for 18-20 hours with shaking (250 rpm) at 37°C in 5 mL 
tryptic soy broth (TSB, Difco, Sparks, MD). The bacterial concentration of each liquid 
culture was determined by serially diluting the culture in 0.1% (w/v) sterile peptone 
(Difco, Sparks, MD) and plating in duplicate on tryptic soy agar (TSA, Difco, Sparks, 
MD), incubated overnight at 37°C.  
 Plasma actuator construction. Surface dielectric barrier discharge (SDBD) 
actuators were constructed using 3.6 cm x 0.5 cm x 0.5 mm (l x w x h) copper electrodes 
(McMaster-Carr Supply Company, GA, USA) placed on both sides of  5 cm2 x 0.127 mm 
Teflon dielectric barrier sheets (McMaster-Carr Supply Company, GA). Electrodes were 
staggered in relation to the dielectric material and grounded electrodes were insulated to 
prevent plasma ignition (Figure 1). SDBD actuators were operated with an input power of 
13.5 V with a 50% duty cycle using a high voltage transformer (Information Unlimited, 
NH) and pulse width modulation (PWM) with an Arduino Uno microcontroller setup 
(Arduino LLC, Italy) was used to allow actuators to be on for 800 ms and off for 300 ms.  
 Selection of plasma-injured cells for successive plasma treatments and 
potential resistance development analysis. To help determine if Salmonella has the 
potential of developing resistance to cold plasma treatments, Salmonella cells that were 
injured but not inactivated by cold plasma were needed for successive treatments. 
However, it is difficult to determine if surviving cells were actually exposed to the 
plasma species because of a suspected shadowing effect in which some cells within a 
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population are shielded from the reactive species by other cells. To overcome this 
difficulty and to select potentially injured cells, treated coverslip wash fluids were plated 
onto xylose lysine deoxycholate (XLD, Difco, Sparks, MD) agar with a TSA overlay 
(Kang and Fung, 2000). XLD agar, a selective medium for Salmonella, can inhibit 
injured cells from growing (particularly heat-injured cells), whereas TSA, a non-selective 
medium, is nutrient rich and supports the growth of injured Salmonella cells. Therefore, 
by plating on XLD with a TSA overlay, injured Salmonella cells can resuscitate on the 
TSA overlay while the selective agents of the XLD agar diffuse into the TSA overlay 
(Kang and Fung, 2000). This process allows the injured and resuscitated Salmonella cells 
to produce a typical black colony color reaction to XLD while not inhibiting colony 
growth completely. 
 In this study, since not all of the Salmonella cells plated onto the XLD with TSA 
overlay medium were injured, after 24 hours of incubation at 37 °C the colony numbers 
were counted and noticeably smaller colonies were marked. Smaller colonies were 
suspected to have arisen from injured cells that were resuscitated on the TSA but prolific 
growth was inhibited by the selective XLD agents. In contrast, larger colonies were 
assumed to be uninjured cells that may not have been exposed to the plasma generated 
reactive species. In contrast, colony sizes from untreated control samples plated onto 
XLD with TSA overlay were uniform in size. After 48 hours of incubation at 37 °C, the 
marked small colonies or colonies newly emerged within the second 24 hours of 
incubation were selected for successive cold plasma treatments. These colonies were then 
grown aerobically for 18-20 hours with shaking (250 rpm) at 37°C in 5 mL TSB and spot 
inoculated onto sterile glass coverslips and treated with cold plasma as described below. 
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After the fifth successive SDBD cold plasma treatment of Salmonella Enteritidis, each 
for 4 minutes at 1 cm, 3 replicates of 10 coverslips each were inoculated with plasma-
injured Salmonella cells and treated for 2 minutes at 1 cm for subsequent RNA isolation 
and RNA-seq analysis.  
 Plasma treatment conditions for RNA-seq analysis. Salmonella Enteritidis 
culture suspensions were spot inoculated onto sterile glass coverslips and air dried, 
uncovered, for 60 minutes in a biosafety cabinet prior to cold plasma treatment. To 
prepare the inocula, 1 mL of liquid culture was centrifuged at 9,000 x g for 3 minutes and 
re-suspended in 1 mL of 0.1% (w/v) sterile peptone. One hundred µL of the bacterial 
suspensions were used as inocula, spotted in 20-25 evenly spaced spots onto sterile 22 x 
22 mm glass coverslips (approximately 108 CFU/coverslip, between 106 and 107 
CFU/spot). Three replicates, each consisting of 10 inoculated coverslips placed in sterile 
35 mm petri dishes, were treated with SDBD cold plasma for 2 minutes at a distance of 1 
cm from the actuators at room temperature (~25°C) and atmospheric pressure (Figure 1). 
The sub-optimal treatment time of 2 minutes, correlating to an approximately 1 log 
reduction (Figure 2), and 10 coverslips per replicate were used so that a sufficient 
bacterial concentration (approximately 108 CFU) could be recovered for RNA isolation. 
 Plasma-treated and untreated control cell-inoculated coverslips were washed by 
vortexing for 30 s in 10 mL 0.1% (w/v) sterile peptone in 50 mL conical tubes. The 10 
coverslips of each replicate were washed individually in the same wash fluid in 
immediate succession following treatment of all coverslips for each replicate. The 10 
untreated control coverslips for each of 3 replicates were washed in the same way after 
drying for 60 minutes. Wash fluids were 10-fold serially diluted in 0.1% peptone for 
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enumeration, for which 100 µL of each dilution was plated in duplicate on TSA and 
incubated overnight at 37 °C. Bacterial inactivation due to cold plasma treatment was 
assessed by comparing the bacterial recovery from plasma-treated samples to that from 
untreated controls. 
 Isolation of bacterial RNA. Bacterial RNA was isolated from the 10 mL of 0.1% 
peptone used to wash the 10 coverslips of each of 3 replicates of plasma-treated and 
untreated control samples (12 total samples, 6 prior to successive treatments, 6 after 
successive treatments). Wash fluids for each replicate were centrifuged at 9,000 x g for 3 
minutes and the pellet was re-suspended in 400 µL of 0.1% peptone and then added to 
800 µL of Qiagen RNA Protect Bacteria Reagent according to the manufacturer’s 
protocol. RNA was then isolated using the Qiagen RNeasy minikit with an on-column 
RNase-free DNase treatment according to the manufacturer’s protocol. The quantity and 
quality of isolated RNA was assessed using a NanoDrop ND-2000 spectrophotometer 
(Thermo Fisher Scientific) and an Agilent 2100 Bioanalyzer (Agilent Technologies). 
Since fragmented 23S rRNA is characteristically high in Enterobacteriaceae (Bhagwat et 
al., 2013) and since the plasma treatment itself was suspected to contribute further to 
RNA degradation (Joshi et al., 2011), DV200 values were used as a measure of RNA 
quality rather than the traditional RNA integrity number (RIN). The DV200 value, a 
metric developed by Illumina that correlates to the percentage of RNA transcripts of at 
least 200 nucleotides in length, was found to be more reliable than RIN for high quality 
RNA-sequencing (Illumina, 2014). Only samples with a DV200 value of 40 or higher were 
used for cDNA library preparation and sequencing.  
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 Library preparation and sequencing. Enrichment of mRNA by rRNA 
depletion, fragmentation of mRNA, cDNA synthesis, and cDNA library preparation were 
done using the ScriptSeq Complete Kit (Bacteria) (Illumina). This kit is specifically 
designed for low input and partially degraded RNA samples. Some RNA degradation was 
expected as a result of the plasma treatment and was confirmed by the relatively low RIN 
numbers. Library quality was assessed using an Agilent 2100 Bioanalyzer and 
subsequently normalized and diluted according to Illumina protocols. All sample libraries 
were sequenced in a multiplexed manner on an Illumina HiSeq flow cell. Library 
preparation and sequencing was performed by Cofactor Genomics (St. Louis, MO). 
 Read mapping and differential gene expression analysis. Mapping and 
analysis of FastQ-files were performed using the CLC Genomics Workbench version 9 
(Qiagen) using default mapping parameters. Although Salmonella Enteritidis strain 
H4639 was used in this study, sequence reads were mapped against Salmonella enterica 
subspecies enterica serovar Typhimurium strain LT2 (accession number NC_003197) 
rather than Salmonella enterica subspecies enterica serovar Enteritidis strain P125109 
(accession number NC_011294) since strain LT2 is more fully annotated than strain 
P125109. When comparing read mapping against LTS and P125109, mapping was 
almost identical for the annotations in common (data not shown). The average percentage 
of reads mapped to the reference sequence was 84.49% (Table 1). Reproducibility of the 
read mapping was confirmed by comparing 3 replicates of each treatment and untreated 
control. Average gene fold changes were calculated from the combined replicates of each 
condition and genes were considered to be differentially expressed if the average fold 
change was greater than 1.5 or less than -1.5 with a false discovery rate (FDR) ≤ 0.05 and 
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P value ≤ 0.01. Functional annotation clustering based on known or predicted gene 
ontology was performed using PANTHER 10.0 (Mi et al., 2016). Co-regulated genes and 
gene pathways were identified by the KEGG Pathway database and STRING 10.0 
(Szklarczyk et al., 2015). 
 qRT-PCR analysis. Six differentially expressed (P  <  0.01) genes (pstA, phoR, 
phnU, fimA, eutD, invA) by RNA-seq were selected for analysis by quantitative real-time 
reverse transcriptase-PCR (qRT-PCR). Primer3 software (Untergasser et al., 2012) was 
used to design PCR primers, producing amplicon sizes between 100 and 200 bp (Table 
2). The gene encoding GyrB was used as a reference for relative expression 
normalization using PCR primers previously described (Goudeau et al., 2013). Total 
RNA was isolated as described above using a DNase I treatment (Qiagen) to eliminate 
genomic DNA contamination. cDNA was synthesized from total RNA with GoScript 
Reverse Transcriptase (Promega, Madison, WI) using gene-specific primers. SYBR 
Green qPCR was performed using 20 μL reaction mixtures containing 10 μL (1X) of 
Platinum SYBR Green real-time PCR SuperMix-UDG (Life Technologies, Foster City, 
CA), 1 μL (5 μM) of each primer, 1 μL of template cDNA, and 7μL of nuclease free 
water. A negative control (nuclease free water) and an RNA sample without reverse 
transcriptase were included to detect potential genomic DNA contamination for each 
reaction. qRT-PCR was performed in a Rotor-Gene 6000 thermocycler (Corbett 
Research, Sydney, Australia) with an initial hold for 10 min at 95°C, followed by 40 
cycles at 95°C for 15 sec, 60°C for 15 sec, and 72°C for 60 sec. The relative expression 
fold change for each gene was calculated using a method described previously (Pfaffl, 
2001) using the equation R = Etarget
ΔCp target/Eref
ΔCp ref, where R is the relative expression 
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ratio, E is the qPCR efficiency for each gene, “ref” refers the gyrB reference, “target” 
refers to target genes, and ΔCp equals control threshold crossing point (Cp) minus 
treatment Cp.   
 Statistical analysis. Three biological replicates of each treatment were 
conducted. The plate counts of recovered cells from wash fluids for each replicate were 
transformed to log CFU/mL. Log reductions due to plasma treatment were calculated by 
comparing the numbers of recovered cells from treated samples to untreated controls. 
Analysis of variance (ANOVA) was used to calculate statistical differences between 
samples from plate counts using SAS (Statistical Analysis System. Inst. Inc., Cary, NC, 
USA). Significant difference was defined at P ≤ 0.01. 
 
RESULTS 
Inactivation of Salmonella Enteritidis by SDBD.  
 Rates of inactivation of Salmonella Enteritidis by SDBD treatments of 2 and 4 
min at 1 cm were similar to those of a 5-strain mixture of Salmonella serovars in a 
previous study (Chapter 3). An approximately 1 log CFU/mL reduction was observed 
after 2 min treatments and an approximately 2.5 log CFU/mL reduction was observed 
after 4 min treatments (Figures 2 and 3). Average log CFU/mL reductions of treated 
samples used for RNA-seq analysis after 1 treatment (1x) and 5 successive treatments 
(5x) were not significantly different (P ≤ 0.01) at 1.14 and 1.44 CFU/mL, respectively 
(Figure 2). Five successive plasma treatments for 4 min also were not significantly 
different (P ≤ 0.01) from each other with average log CFU/mL reductions ranging from 




Global transcriptional changes resulting from SDBD treatment.  
 The SDBD plasma treatment of dried Salmonella Enteritidis cells on sterile glass 
coverslips after 5 successive treatments resulted in significant transcriptional changes 
within surviving cells. Among 4,631 annotated genes of Salmonella Typhimurium LT2, 
1,136 (24.5%) were expressed differentially by at least 1.5-fold (P-value ≤ 0.01 and FDR 
P-value ≤ 0.05) when compared to the untreated controls. A total of 644 genes were 
downregulated from -1.5-fold to -241.14-fold and 492 genes were upregulated from 1.5-
fold to 6.06-fold. More genes were downregulated than upregulated (644 vs. 492) the 
former had a significantly higher range of fold change (-241.14 vs. 6.06). Compared to a 
previous study evaluating the transcriptomic response of Salmonella to SDBD plasma 
prior to successive treatments of injured cells (Chapter 4), similar general patterns of 
differential expression were observed (Figure 4). The same three major KEGG pathways 
of “bacterial secretion system” (upregulated), “ribosome” (downregulated), and 
“biosynthesis of siderophore group nonribosomal proteins” (downregulated) were 
differentially expressed (Chapter 4). Heat map comparisons of differentially expressed 
genes after the 5 successive plasma treatments revealed high correlation between treated 
and control replicates, with treated samples clustering together and control samples 
clustering separately (Figure 5). The high reproducibility observed between replicates in 
this study was in contrast to the results of the previous study, in which one control 
replicate (C1) and one treated replicate (T1) were more similar to each other than to the 
other two control or treated replicates (Figure 5). When all 6 samples from both studies 
were compared in a single heat map of 1,340 differentially expressed genes (Figure 5), all 
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treated replicates clustered together, separate from control replicates. However, the 3 
treated and 3 control replicates after 5 successive plasma treatments clustered together 
while only 2 of the treated and 2 of the control replicates from the previous study 
clustered together (Figure 5).  
 A total of 533 genes were expressed differentially in both studies by ≤ -1.5-fold or 
≥ 1.5-fold with a FDR P value ≤ 0.05, both prior to and after 5 successive plasma 
treatments (Figure 4B). Two hundred and nine genes were differentially expressed only 
in the first study while 598 genes were differentially expressed in the second study 
(Figure 4B). The 533 genes expressed differentially in common included downregulation 
of genes associated with phosphate uptake, cation uptake, osmoregulation, tetrathionate 
utilization, phage-shock proteins, ribosomal subunit proteins, and DNA damage repair. 
The major upregulated genes included those encoding pathogenicity associated proteins, 
especially those from Salmonella pathogenicity island 2 (SPI2). Differentially expressed 
metabolic pathways common to both studies included upregulation of ethanolamine 
utilization and downregulation of colonic acid and enterobactin biosynthesis, associated 
with nutrient limitation, desiccation stress, and oxidative stress, respectively. Among the 
209 genes differentially expressed only prior to the 5 successive treatments, 149 were 
downregulated and 60 were upregulated. No significant functional enrichments were 
observed using STRING 10 for either downregulated or upregulated genes. Among the 
598 genes differentially expressed only after 5 successive plasma treatments, 287 were 
downregulated and 311 were upregulated. The major functional groups to which genes 
clustered were transport, metabolism, regulatory functions, and pathogenesis. 
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 Transport and localization. Genes expressed differentially after plasma 
treatment having transmembrane transport functions were associated with ribose 
transport and diffusion of small molecules, all of which were downregulated. The 
rbsABCD operon encodes an ATP-binding cassette (ABC) transport system that actively 
transports ribose, which is passively transported across the outer membrane, across the 
cytoplasmic membrane into the cell (Barroga et al., 1996). rbsA, B, C, and D were 
downregulated between -2.34 and -3.49-fold. Outer membrane porin proteins OmpA, 
OmpC, and OmpF, each associated with passive diffusion of small molecules and solutes 
across the outer membrane (Wang, 2002; Martínez-Flores et al., 1999), also were 
downregulated. Expression of OmpC and OmpF in Salmonella is regulated in response to 
changes in osmolarity by OmpR (Martínez-Flores et al., 1999), which was also 
downregulated. Decreased expression of the ribose transport system and small molecule 
diffusion porins may indicate increased availability of ribose and vital small molecules 
with a decrease in osmotic stress.  
 Metabolism. Multiple metabolic pathways were significantly differentially 
expressed after 5 successive plasma treatments but were not after only a single treatment. 
As reported by STRING 10, as many as 69 downregulated genes were associated with 
known metabolic processes. At least 21 downregulated genes were associated with amino 
acid biosynthesis and 16 with purine and pyrimidine metabolism (Table 3). While 
biosynthesis of glycine, serine, threonine, histidine, valine, leucine, and isoleucine were 
downregulated, cysteine biosynthesis genes within the cysCDHIJ regulon (Tei et al., 
1990) were upregulated (Table 3). Other downregulated genes with metabolic processes 
included those with riboflavin, carboxcylic acid, and propanediol metabolism functions 
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(Table 3). Propanediol metabolic proteins, encoded within the extensive pdu operon, are 
often expressed in conjunction with ethanolamine utilization proteins, encoded within the 
equally extensive eut operon (Goudeau et al., 2013). While 4 propanediol utilization 
genes (pduC, E, N, P) were downregulated, 6 ethanolamine utilization genes (eutA, E, G, 
H, J, R) were upregulated. These 6 upregulated genes are in addition to another 6 eut 
genes (eutD, N, P, Q, S, T) upregulated in common to this study and the previous study 
prior to 5 successive plasma treatments. These results confirm the increased role of 
ethanolamine utilization but not propanediol utilization after plasma treatment, possibly 
as a result of increased availability of ethanolamine, a major constituent of phospholipid 
membranes. Also upregulated were 4 genes within the citCDEFXGT operon (citD, G, F, 
and X), which allows E. coli to use citrate as a sole energy and carbon source in anaerobic 
conditions (Pos et al., 1998). Since anaerobic conditions were not expected on the plasma 
treated coverslips, increased expression of these genes may be due to increased 
availability of acetyl CoA, which is a byproduct of EutE within the ethenaolamine 
utilization process and is a precursor to citrate (Goudeau et al., 2013). Other upregulated 
metabolism related genes of interest included several lipid (lpxB, D, rfaJ, L, Y, rfbP, rfe, 
and wzxE) and cell wall component biosynthesis genes (mraY, murD, F) (Table 3). 
Additionally, a superoxide dismutatse gene, sodA, which would be expected to be 
upregulated in response to plasma treatment and potentially increased intracellular 
superoxide concentrations, was downregulated -1.80-fold. 
 Regulatory functions. Already mentioned for its role in osmoregulation, OmpR 
is also an important transcription factor that regulates expression of several key pathways 
(Cai and Inouye, 2002). Overexpression of OmpR represses flagellar filament expression 
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while promoting expression of curli synthesis genes (Shin and Park, 1995; Prigent-
Combaret et al., 2001). Thus, downregulation of OmpR, as observed in this study by -
1.72-fold, would result in increased expression of the flagellar gene regulators FlhC/D 
and downregulation of the curli synthesis regulator CsgD (Gutenplan and Kearns, 2013). 
However, the genes for all 3 of these proteins were upregulated after plasma treatment. 
Increased expression of the FlhC/D two component system would be expected to result in 
increased expression of flagellar genes, but no such increase was observed. In fact, 9 
genes within the flg operon, encoding flagellar basal body structural genes (Glutenplan 
and Kearns, 2013), were significantly downregulated from -1.53 to -2.74-fold. Similarly, 
increased expression of CsgD would be expected to result in increased expression of curli 
synthesis genes within the csgDEFG and csgBA operons (Barnhart and Chapman, 2006). 
However, only csgE and csgF were upregulated by 2.85 and 1.97-fold, respectively. 
Thus, the role of motility and chemotaxis is again unclear after plasma treatment with 
SDBD. 
 The importance of the maintenance of a transmembrane proton motive force in 
response to plasma treatment was confirmed after 5 successive plasma treatments. While 
only two genes (nuoE and nuoK) within the nuo locus, composed of 14 genes that encode 
structural proteins associated with a type I NADH dehydrogenase in the prokaryotic 
electron transport chain (Falk-Krzesinski et al., 1998), were upregulated in response to 
plasma treatment in the previous study, an additional 6 nuo genes (nuoH, I, J, L, M, N) 
were upregulated, in this study, from 1.53 to 1.76-fold. Additionally, proP and proV, 
genes encoding proteins that serve as proton symporters, sensing and responding to 
osmotic shift by importing osmolytes (Culham et al., 2003), were also upregulated by 
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2.16 and 1.7-fold. Since SDBD plasma produces a high local concentration of negative 
ions and potentially produces hydrogen ions through the interaction of reactive species 
with water molecules on cell surfaces (Pai et al., 2015), it is expected that ion 
accumulation at the cell surface may contribute to bacterial death (Lunov et al., 2016). 
Upregulation of such osmotic regulators may also be in response to the changing osmotic 
conditions experienced by surviving cells in response to cytosolic leakage and lysis of 
surrounding cells. 
 A more general global downregulation of gene expression observed previously in 
response to plasma treatment, as evidenced by downregulation of genes encoding 
ribosomal structural proteins, was confirmed in this study. While at least 21 ribosomal 
structural proteins were downregulated in the previous study, an additional 27 were 
downregulated after 5 successive plasma treatments (Table 3). Additionally, rpoA, rpoB, 
and rpoC, encoding the α-, β-, and β’-subunits of RNA polymerase (Zalenskaya et al., 
1990), were also significantly downregulated by -1.50 to -1.65-fold. Decreased 
expression of at least 38 ribosomal structural proteins and the 3 subunits of RNA 
polymerase underscore decreased transcription and translation as an important response 
of Salmonella to SDBD plasma treatment. Decreased translation via downregulation of 
ribosomal genes is a general response to cellular stress (Starosta et al., 2014), indicating a 
potential stress response by Salmonella resulting from plasma treatment. 
 Pathogenesis. In the previous study evaluating the transcriptomic response of 
Salmonella after a single plasma treatment, at least 39 genes associated with SPI1 and 
SPI2 were upregulated after plasma treatment, with as many as 26 of these contained 
within SPI2. Thirty five of those 39 genes were upregulated after 5 successive treatments 
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in addition to 7 more (ssaU, sseC, D, J, sifA, B, pipA, B, STM1638), 6 of which are 
secreted effector proteins located within SPI2 (ssaU is a T3SS structural apparatus 
protein). The 4 genes not upregulated after 5 successive plasma treatments (prgH, J, K, 
hilD) were all located within SPI1. In contrast to the previous study, differential 
expression of genes within SPI1 and SPI2 were expressed more consistently among the 3 
replicates (Figure 6). These results confirm the increased expression of genes located 
within SPI2 in contrast to SPI1 (Figure 6). In vivo, SPI1 is associated primarily with 
invasion into epithelial cells and SPI2 is primarily associated with macrophage infection 
and survival within macrophages (Marcus et al., 2000; Chakraborty et al., 2015).  As 
noted previously, acidification of the cellular cytoplasm by macrophage attack is a major 
contributor to induced expression of SPI2-encoded proteins (Chakraborty et al.,2015), 
with phosphate and magnesium ion limitation and hydrogen peroxide and nitric oxide 
stress also playing a role (Kroger et al., 2013). It is suspected that the changing osmotic 
conditions resulting from lysis of adjacent cells by the plasma treatment and an increased 
proton motive force may contribute to an acidification of the cytoplasm of surviving 
cells, thus inducing increased expression of SPI2-located genes. 
 
qRT-PCR validation of RNA-seq gene expression. 
 qRT-PCR analysis of 4 downregulated genes (pstA, phoR, phnU, fimA) and 2 
upregulated genes (eutD, invA) was used to validate differential gene expression 
identified by RNA-seq. The fold change differences for each gene were similar for the 
two methods despite their inherent differences in sensitivity (Figure 6). However, the 2 
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genes shown to be upregulated when analyzed by RNA-seq (eutD, invA) were shown to 
be downregulated when analyzed by qRT-PCR. 
 
DISCUSSION 
 One of the most attractive aspects of cold atmospheric plasma treatments for 
surface sterilization or decontamination applications is the limited potential for 
development of resistance in bacteria (Alkawareek et al., 2014). Multiple recent studies 
have highlighted the interplay between both physical and biological mechanisms leading 
to bacterial inactivation resulting from exposure to plasma-produced reactive species 
(Lunov et al., 2016; Han et al., 2016; Kvam et al., 2016). The multi-modal nature of 
plasma-induced bacterial inactivation is caused by RONS and charged particles that 
damage lipids, nucleic acids, and proteins in a non-discriminate manner (Kong et al., 
2009; Mai-Prochnow et al., 2014). Accordingly, unlike most antibiotic drugs, bacterial 
inactivation by cold plasma does not target a single cell product or process but damages 
cellular macromolecules to a point beyond which cells are not able to recover (Mai-
Prochnow et al., 2014).  
 When comparing the potential for development of resistance to cold plasma 
treatment with that to antibiotic drugs, there are 2 main features in common; 1) bacterial 
inactivation occurs through damage or inhibition of key cellular processes and 2) 
bacterial inactivation is dose-dependent on the length or intensity of cold plasma 
treatment and the amount or concentration of antibiotic applied (Levy and Marshall, 
2004; Mai-Prochnow et al., 2014). In general, the dosage used for each method must be 
high enough that cellular repair mechanisms or normal cellular processes are not able to 
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recover from the damage imposed (Hughes and Andersson, 2012; Alkawareek et al., 
2014). However, in the case of antibiotics, some bacterial cells within a population have 
been able to survive due to some phenotypic or genotypic variation that reduces their 
susceptibility to the antibiotic (Levy and Marshall, 2004; Hughes and Andersson, 2012). 
As a result, these cells are able to proliferate, affected very little or not at all by a single 
(or multiple) antibiotic(s). This process is more likely to occur when a single antibiotic 
drug is used to target a single protein or enzyme than when antibiotic cocktails are used 
(Allen et al., 2010). Bacterial resistance to the major classes of antibiotics has largely 
been a result of expression of only one or a few enzymes that negate the effects of the 
antibiotic (Hughes and Andersson, 2012). Specific identification of the mechanisms by 
which cold plasma inactivates cells is still not well understood and may be elusive due to 
the more general cellular damage that it causes, acting not on a single cellular process but 
on many, in addition to purely physical damage. Despite interest in the possibly limited 
potential for bacterial cells to develop resistance to plasma treatments, no known studies 
to evaluate this potential have been reported. 
 It was the goal of this study to evaluate the transcriptomic response of dried 
Salmonella cells to 5 successive SDBD cold plasma treatments and to compare the results 
to those of a previous study evaluating the transcriptomic response occurring prior to the 
5 treatments (Chapter 4). The objective of this work was to preliminarily evaluate the 
potential for resistance development to cold plasma by Gram-negative bacterial 
pathogens. Bacterial inactivation rates following SDBD plasma treatment were not 
statistically different prior to and after the treatments or throughout the 5 treatments 
(Figures 2 and 3). The transcriptomic response after the 5 successive treatments was also 
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strikingly similar to the transcriptomic response prior to the 5 treatments (Figure 5). 
Significantly downregulated genes included those associated with phosphate uptake, 
cation uptake, osmoregulation, tetrathionate utilization, phage-shock proteins, DNA 
damage repair, colonic acid biosynthesis, propanediol utilization, and enterobactin 
biosynthesis. Significantly upregulated genes coded for multiple ribosomal subunit 
proteins, pathogenicity associate proteins, and ethanolamine utilization proteins. While a 
general decreased stress response was observed, as evidenced by downregulation of 
nutrient and cation import, DNA damage repair, osmoregulation, and capsule compound 
forming genes, downregulation of ribosomal subunit and upregulation of pathogenicity 
associated genes indicated the accumulation of some cellular stress. Upregulation of 
pathogenicity associated genes in response to plasma treatment is a potential concern. 
However, a majority of the pathogenicity associated genes expressed were associated 
with macrophage attack and would not necessary increase the virulence of Salmonella 
when treated on an external surface.  Cellular invasion, facilitated by proteins encoded 
within a different pathogenicity island, would be required prior to functional use of those 
associated with survival within macrophages (Marcus et al., 2000; Chakraborty et al., 
2015). 
 Based on the results of this study, no significant differences in bacterial 
inactivation rates or differential gene expression were identified that could potentially 
lead to resistance development. However, it should be noted that the observed 
transcriptomic response was an indirect response since RNA was isolated only from 
intact, surviving cells that might not have been exposed to plasma produced species 
directly. Yet, the number and pattern of differentially expressed genes indicated a distinct 
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response to the treatment that is thought to be caused primarily by lysis of cells adjacent 
to those from which RNA was isolated, creating a nutrient rich, osmotically balanced 
microenvironment. Accordingly, the results of this study suggest cell membrane damage 
via lipid peroxidation to be the primary means of bacterial inactivation for Gram-negative 
bacteria, in accordance other studies (Lunov et al., 2016; Han et al., 2016; Kvam et al., 
2016; Joshi et al., 2011). Since lipid peroxidation by RONS is primarily a physical 
process depending upon the ability of RONS to interact with lipids, the potential for 
resistance development may be minimal (Alkawareek et al., 2014). Surface structure 
modifications such as capsule formation, biofilm formation, or thicker cell walls may 
provide an adaptive advantage to sub-lethally treated bacteria and should be investigated 
further. Indeed, Gram-positive bacteria having thicker cell walls than Gram-negative 
bacteria were more resistant to plasma treatments (Lunov et al., 2016), and oxidative 
DNA damage may have a more prominent role in inactivation than lipid peroxidation. 
For Gram-negative bacteria, this study confirms the importance of lipid peroxidation and 
cell membrane damage as major contributors to cellular inactivation and is the first 
known study evaluating the potential for resistance development by successively treating 
plasma-injured cells. No adaptive response was observed after successive treatments, 
suggesting that Salmonella has limited potential to develop resistance to cold plasma 
treatments. Furthermore, SDBD is confirmed as an effective plasma generation and 
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Table 1. Total number of cDNA sequence reads, number of mapped reads, and 
percentage of mapped reads for each treated and untreated control replicate. 
Sample 
(replicate) 






Control (5) 23,858,277 20,236,146 84.82 
Control (6) 24,839,493 20,927,265 84.25 
Control (7) 24,413,742 20,522,761 84.06 
    
Treated (5) 26,926,561 22,981,911 85.35 
Treated (6) 28,461,837 23,956,746 84.17 




Table 2. Target genes, gene function, and primer pair sequences used for qRT-PCR 
validation of differential gene expression observed by RNA-seq. 
Gene name Function Primer pair (5'-3') 
























   gyrB DNA gyrase subunit B F: CGCCGATAACTCCGTGTCCGTAAC 







Table 3. Differentially expressed genes of interest associated with transport, metabolism, 









FDR             
p-value 
Transport and localization 
    
cysU sulfate/thiosulfateABC transporter permease  1.9 0.92 0 0 
cysW sulfate/thiosulfate ABC transporter permease  2.23 1.16 0 0 
hisJ 
histidine ABC transporter substrate-binding 
protein  
1.5 0.59 0 0 
hisM histidine ABC transporter permease  2.49 1.32 0 0 
hisP histidine ABC transporter ATP-binding protein  1.86 0.9 0 0 
hisQ histidine ABC transporter permease  2.08 1.06 0 0 
kdpA potassium-transporting ATPase subunit A -1.57 -0.65 3.82E-03 7.13E-03 
kdpB potassium-transporting ATPase subunit B -1.56 -0.64 4.83E-05 1.16E-04 
kdpC potassium-transporting ATPase subunit C -1.56 -0.64 1.45E-06 4.06E-06 
mgtA magnesium-transporting ATPase -26.48 -4.73 0 0 
mgtB magnesium-transporting ATPase -15.07 -3.91 0 0 
mgtC protein MgtC -19.62 -4.29 0 0 
ompA outer membrane protein A -2.21 -1.14 0 0 
ompC outer membrane porin protein C -2.08 -1.06 0 0 
ompF outer membrane protein F -1.56 -0.64 0 0 
ompR osmolarity response regulator OmpR -1.72 -0.78 0 0 
ompX outer membrane protease -8.43 -3.08 0 0 
osmB osmotically inducible lipoprotein B -23.39 -4.55 0 0 
osmY hyperosmotically inducible periplasmic protein -3.11 -1.64 0 0 
phnS 
2-aminoethylphosphonate ABC transporter 
substrate-binding protein PhnS 
-6.34 -2.66 0 0 
phnT 
2-aminoethylphosphonate ABC transporter 
ATP-binding protein PhnT 
-2.57 -1.36 0 0 
phnU 
2-aminoethylphosphonate ABC transporter 
permease PhnU 




-1.72 -0.78 5.47E-08 1.73E-07 
phoB response regulato PhoB -8.52 -3.09 0 0 
phoE outer membrane phosphoporin protein E -2.95 -1.56 0 0 
phoN non-specific acid phosphatase -2.24 -1.16 0 0 
phoP virulence transcriptional regulator PhoP -1.55 -0.63 0 0 
phoR sensory kinase PhoR -5.63 -2.49 0 0 
phoU transcriptional regulator PhoU -17.24 -4.11 0 0 
ppk polyphosphate kinase 1.56 0.65 0 0 
pstA 
phosphate ABC transporter permease subunit 
PtsA 
-20.52 -4.36 0 0 
pstB 
phosphate ABC transporter ATP-binding 
protein PstB 
-22.95 -4.52 0 0 




phosphate ABC transporter substrate-binding 
protein PstS 
-136.53 -7.09 0 0 
rbsA 
D-ribose ABC transporter ATP-binding protein 
RbsA 
-2.34 -1.23 0 0 
rbsB 
D-ribose ABC transporter substrate-binding 
protein RbsB 
-3.49 -1.8 0 0 
rbsC ribose ABC transporter permease RbsC -2.76 -1.47 0 0 
rbsD D-ribose pyranase -2.34 -1.23 0 0 
rbsK ribokinase -2.31 -1.21 0 0 
rbsR transcriptional repressor RbsR -1.8 -0.85 0 0 
rcsA transcriptional regulator RcsA -2.96 -1.56 0 0 
rcsB transcriptional regulator RcsB -2.02 -1.02 0 0 
ugpA 
glycerol-3-phosphate ABC transporter permease 
UdpA 
-4.18 -2.06 0 0 
ugpB 
glycerol-3-phosphate ABC transporter 
substrate-binding protein UdpB 
-4.61 -2.2 0 0 
ugpC 
glycerol-3-phosphate ABC transporter ATP-
binding protein UgpC 
-3.84 -1.94 0 0 
ugpE 
glycerol-3-phosphate ABC transporter permease 
UdpE 
-3.54 -1.82 0 0 




-13.79 -3.79 0 0 
zntB zinc transport protein ZntB -1.58 -0.66 2.79E-10 1.10E-09 
zur zinc uptake transcriptional repressor -2.18 -1.12 0 0 
      
Metabolism 
    
argB acetylglutamate kinase -1.66 -0.73 1.91E-10 7.61E-10 
argH argininosuccinate lyase -1.73 -0.79 0 0 
argO arginine exporter protein ArgO -2.42 -1.27 0 0 
aroC chorismate synthase -1.64 -0.72 0 0 
asnA aspartate--ammonia ligase -1.71 -0.77 1.12E-14 5.74E-14 
cdd cytidine deaminase -2.67 -1.42 0 0 
citC [citrate (pro-3S)-lyase] ligase 1.96 0.97 1.11E-16 6.34E-16 
citD citrate lyase subunit gamma 1.68 0.75 2.35E-07 7.04E-07 
citF 
citrate lyase subunit alpha/citrate-ACP 
transferase 








1.92 0.94 3.62E-13 1.70E-12 
cysC adenylyl-sulfate kinase 2.01 1.01 5.52E-14 2.70E-13 
cysD sulfate adenylyltransferase subunit 2 1.81 0.85 0 0 
cysH phosphoadenosine phosphosulfate reductase 2.24 1.17 2.20E-13 1.05E-12 
cysI sulfite reductase hemoprotein subunit beta 1.74 0.8 4.46E-09 1.57E-08 
cysJ sulfite reductase flavoprotein subunit alpha 1.83 0.87 0 0 
cysN sulfate adenylyltransferase subunit 1 1.62 0.7 8.42E-09 2.89E-08 
deoA thymidine phosphorylase -2.62 -1.39 0 0 
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deoB phosphopentomutase -2.69 -1.43 0 0 
deoC 2-deoxyribose-5-phosphate aldolase -3.01 -1.59 0 0 




-3.71 -1.89 0 0 
entB 3-dihydro-2-3-dihydroxybenzoate synthetase -4.6 -2.2 0 0 
entC isochorismate synthase -3.67 -1.88 0 0 
entD 4'-phosphopantetheinyl transferase -2.27 -1.19 2.83E-14 1.41E-13 
entE 3-dihydroxybenzoate-AMP ligase -4.39 -2.13 0 0 
entF enterobactin synthase subunit F -2.91 -1.54 0 0 
eutA ethanolamine utilization protein EutA 1.87 0.91 0 0 
eutD phosphotransacetylase EutD 1.92 0.94 0 0 
eutE aldehyde oxidoreductase EutE 1.98 0.99 0 0 
eutG ethanol dehydrogenase EutG 2.09 1.07 0 0 
eutH ethanolamine transporter EutH 1.77 0.83 0 0 
eutJ ethanolamine utilization protein EutJ 2.21 1.14 0 0 
eutN microcompartment shell protein EutN 2.41 1.27 0 0 
eutP ethanolamine utilization protein EutP 2.53 1.34 0 0 
eutQ ethanolamine utilization protein EutQ 2.2 1.14 0 0 
eutR HTH-type transcriptional regulator EutR 2.12 1.08 0 0 
eutS carboxysome structural protein EutS 2.84 1.51 0 0 
eutT cobalamin adenosyltransferase EutT 2.11 1.08 0 0 
fepA outer membrane porin -4.55 -2.19 0 0 
fepB 
ferric-enterobactin ABC transporter substrate-
binding protein FepB 
-1.62 -0.7 2.03E-11 8.59E-11 




-1.51 -0.59 0 0 
hisB 
bifunctional imidazole glycerol-phosphate 
dehydratase/histidinol phosphatase 
-1.51 -0.6 0 0 
hisC histidinol-phosphate aminotransferase -2.12 -1.08 0 0 
hisD histidinol dehydrogenase -2.06 -1.04 0 0 
hisG ATP phosphoribosyltransferase -2.21 -1.14 0 0 
ilvE branched-chain amino acid aminotransferase -2.33 -1.22 0 0 
ilvG acetolactate synthase 2 catalytic subunit -1.87 -0.9 0 0 
ilvM acetolactate synthase 2 regulatory subunit -2.09 -1.06 0 0 
ilvN acetolactate synthase 1 regulatory subunit -1.55 -0.63 5.55E-16 3.09E-15 




1.64 0.71 0 0 








1.55 0.63 0 0 




ndk nucleoside diphosphate kinase -2.84 -1.51 0 0 
nrdA 
ribonucleotide-diphosphate reductase subunit 
alpha 
-1.81 -0.85 0 0 
nrdB 
ribonucleotide-diphosphate reductase subunit 
beta 
-1.75 -0.81 0 0 
nrdE 
ribonucleotide-diphosphate reductase subunit 
alpha 
-2.25 -1.17 0 0 
nrdF 
ribonucleotide-diphosphate reductase subunit 
beta 
-1.84 -0.88 6.55E-15 3.39E-14 
nrdH glutaredoxin-like protein -3.09 -1.63 0 0 
nrdI ribonucleotide reductase stimulatory protein -2.73 -1.45 0 0 
pduC propanediol dehydratase large subunit -1.74 -0.8 1.02E-05 2.62E-05 
pduE propanediol dehydratase small subunit -1.77 -0.82 4.14E-03 7.68E-03 
pduN 
propanediol utilization polyhedral body protein 
PduN 








-2.44 -1.29 0 0 
purB adenylosuccinate lyase -1.7 -0.77 0 0 
purG phosphoribosylformylglycinamidine synthase -1.57 -0.65 0 0 
rcsA transcriptional regulator RcsA -2.96 -1.56 0 0 
rcsB transcriptional regulator RcsB -2.02 -1.02 0 0 
rfaJ 2-glucosyltransferase 2.05 1.03 0 0 
rfaL O-antigen ligase 2.53 1.34 0 0 
rfaY lipopolysaccharide core heptose(II) kinase RfaY 1.55 0.64 3.04E-08 9.88E-08 
rfbN 
O antigen biosynthesis rhamnosyltransferase 
RfbN 




1.5 0.59 3.25E-08 1.05E-07 
rfbU O-antigen biosynthesis protein RfbU 2.97 1.57 0 0 
rfbX O-antigen transferase 3.15 1.66 0.01 0.02 
rfc O-antigen polymerase 3.07 1.62 0 0 
rfe 
undecaprenyl-phosphate alpha-N-
acetylglucosaminyl 1-phosphate transferase 
1.57 0.65 0 0 
sdaA L-serine deaminase I/L-threonine deaminase I -1.67 -0.74 0 0 
sdaC HAAAP family serine transport protein -1.94 -0.96 0 0 
sodA superoxide dismutase -1.8 -0.85 0 0 
STM2341 transketolase -1.55 -0.63 1.84E-07 5.55E-07 
STM3334 cytosine deaminase -1.6 -0.68 0 0 
tktA transketolase -2.29 -1.2 0 0 
tonB transport protein TonB -1.81 -0.85 0 0 





-1.81 -0.86 0 0 
trxB thioredoxin reductase -1.62 -0.7 0 0 
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wcaA glycosyl transferase -4.49 -2.17 0 0 
wcaB 
colanic acid biosynthesis acetyltransferase 
WcaB 
-3.22 -1.69 0 0 
wcaC glycosyl transferase -2.59 -1.37 0 0 
wcaD colanic acid polymerase -2.98 -1.57 1.22E-15 6.62E-15 
wcaE glycosyl transferase family protein -12.22 -3.61 0 0 
wcaF 
colanic acid biosynthesis acetyltransferase 
WcaF 
-13.78 -3.78 0 0 
wcaG GDP-fucose synthetase -11.92 -3.58 0 0 
wcaH GDP-mannose mannosyl hydrolase -8.03 -3.01 0 0 
wcaI glycosyl transferase -5.88 -2.56 0 0 
wcaJ UDP-glucose lipid carrier transferase -1.6 -0.68 9.98E-05 2.31E-04 
wza polysaccharide export protein -11.79 -3.56 0 0 
wzb protein-tyrosine-phosphatase -15.55 -3.96 0 0 
wzc tyrosine-protein kinase -6.29 -2.65 0 0 
wzxC colanic acid exporter -1.76 -0.82 1.43E-04 3.25E-04 
wzxE O-antigen translocase 1.64 0.72 0 0 
      
Regulatory 
    
csgD DNA-binding transcriptional regulator CsgD 3.38 1.76 0 0 
csgE 
curli production assembly/transport protein 
CsgE 
2.58 1.37 0 0 
csgF 
curli production assembly/transport protein 
CsgF 
1.76 0.82 0 0 
flgA 
flagellar basal body P-ring formation protein 
FlgA 
-2.29 -1.19 0 0 
flgB flagellar basal body rod protein FlgB -2.72 -1.44 0 0 
flgC flagellar basal body rod protein FlgC -2.63 -1.4 0 0 
flgD 
flagellar basal body rod modification protein 
FlgD 
-2.33 -1.22 0 0 
flgE flagellar hook protein FlgE -2.74 -1.45 0 0 
flgF flagellar basal body rod protein FlgF -2.04 -1.03 0 0 
flgG flagellar basal body rod protein FlgG -2.1 -1.07 0 0 
flgM anti-sigma-28 factor FlgM -1.69 -0.75 3.48E-13 1.64E-12 
flgN FlgK/FlgL export chaperone -1.53 -0.61 0 0 
flhC transcriptional regulator FlhC 2.05 1.04 0 0 
flhD transcriptional regulator FlhD 2.01 1.01 0 0 
fliR flagellar biosynthesis protein FliR -5.57 -2.48 0 0 
hybD hydrogenase 2 maturation endopeptidase 1.53 0.61 0 0 
hybE hydrogenase 2-specific chaperone 1.74 0.8 0 0 
hybF hydrogenase nickel incorporation protein HybF 1.81 0.85 0 0 
hybG hydrogenase 2 accessory protein HypG 2.09 1.06 0 0 
hycB hydrogenase-3 iron-sulfur subunit 1.76 0.81 0.01 0.02 
hypA hydrogenase nickel incorporation protein 2.15 1.1 3.27E-06 8.82E-06 
lexA LexA repressor -3.06 -1.61 0 0 
nuoH NADH-quinone oxidoreductase subunit H 1.71 0.77 0 0 
182 
 
nuoI NADH-quinone oxidoreductase subunit I 1.67 0.74 0 0 
nuoJ NADH-quinone oxidoreductase subunit J 1.72 0.78 0 0 
nuoK NADH-quinone oxidoreductase subunit K 1.69 0.76 0 0 
nuoL NADH-quinone oxidoreductase subunit L 1.61 0.69 0 0 
nuoM NADH-quinone oxidoreductase subunit M 1.64 0.71 0 0 
nuoN NADH-quinone oxidoreductase subunit N 1.53 0.61 0 0 
proP proline/betaine transporter 2.16 1.11 0 0 
proV 
glycine betaine ABC transporter ATP-binding 
protein ProV 
1.7 0.76 2.09E-04 4.63E-04 
pspA phage shock protein PspA -3.69 -1.88 0 0 
pspB phage shock protein PspB -2.92 -1.54 0 0 
pspC DNA-binding transcriptional activator PspC -2.54 -1.34 0 0 
pspD inner membrane phage-shock protein -2.53 -1.34 0 0 
pspG phage shock protein G -2.18 -1.12 0 0 
recA recombinase A -8.96 -3.16 0 0 
rplA 50S ribosomal protein L1 -5.19 -2.38 0 0 
rplB 50S ribosomal protein L2 -5.88 -2.56 0 0 
rplC 50S ribosomal protein L3 -5.91 -2.56 0 0 
rplD 50S ribosomal protein L4 -5.83 -2.54 0 0 
rplE 50S ribosomal protein L5 -2.65 -1.41 0 0 
rplF 50S ribosomal protein L6 -2.61 -1.38 0 0 
rplI 50S ribosomal protein L9 -6.16 -2.62 0 0 
rplJ 50S ribosomal protein L10 -2.07 -1.05 0 0 
rplK 50S ribosomal protein L11 -5.87 -2.55 0 0 
rplL 50S ribosomal protein L7/L12 -2.17 -1.12 0 0 
rplM 50S ribosomal protein L13 -1.53 -0.61 0 0 
rplN 50S ribosomal protein L14 -2.28 -1.19 0 0 
rplO 50S ribosomal protein L15 -1.97 -0.98 0 0 
rplP 50S ribosomal protein L16 -5.4 -2.43 0 0 
rplQ 50S ribosomal protein L17 -1.78 -0.83 0 0 
rplR 50S ribosomal protein L18 -2.84 -1.5 0 0 
rplS 50S ribosomal protein L19 -4.29 -2.1 0 0 
rplU 50S ribosomal protein L21 -1.65 -0.72 0 0 
rplV 50S ribosomal protein L22 -5.6 -2.49 0 0 
rplW 50S ribosomal protein L23 -6 -2.59 0 0 
rplX 50S ribosomal protein L24 -2.33 -1.22 0 0 
rplY 50S ribosomal protein L25 -3.81 -1.93 0 0 
rpmA 50S ribosomal protein L27 -1.9 -0.92 0 0 
rpmB 50S ribosomal protein L28 -2.45 -1.3 0 0 
rpmC 50S ribosomal protein L29 -5.39 -2.43 0 0 
rpmD 50S ribosomal protein L30 -2.62 -1.39 0 0 
rpmE 50S ribosomal protein L31 -5.24 -2.39 0 0 
rpmF 50S ribosomal protein L32 -4.29 -2.1 0 0 
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rpmG 50S ribosomal protein L33 -2.13 -1.09 0 0 
rpmH 50S ribosomal protein L34 -1.79 -0.84 0 0 
rpoA DNA-directed RNA polymerase subunit alpha -1.61 -0.68 0 0 
rpoB DNA-directed RNA polymerase subunit beta -1.65 -0.73 3.44E-13 1.62E-12 
rpoC DNA-directed RNA polymerase subunit beta' -1.5 -0.59 0 0 
rpoZ DNA-directed RNA polymerase subunit omega -1.61 -0.69 0 0 
rpsB 30S ribosomal protein S2 -2.27 -1.18 0 0 
rpsC 30S ribosomal protein S3 -5.53 -2.47 0 0 
rpsD 30S ribosomal protein S4 -1.85 -0.89 0 0 
rpsE 30S ribosomal protein S5 -2.77 -1.47 0 0 
rpsF 30S ribosomal protein S6 -6.23 -2.64 0 0 
rpsG 30S ribosomal protein S7 -2.58 -1.37 0 0 
rpsH 30S ribosomal protein S8 -2.65 -1.41 0 0 
rpsI 30S ribosomal protein S9 -1.8 -0.85 0 0 
rpsJ 30S ribosomal protein S10 -4.48 -2.16 0 0 
rpsK 30S ribosomal protein S11 -1.81 -0.86 0 0 
rpsL 30S ribosomal protein S12 -2.21 -1.14 0 0 
rpsM 30S ribosomal protein S13 -1.72 -0.78 0 0 
rpsN 30S ribosomal protein S14 -2.85 -1.51 0 0 
rpsP 30S ribosomal protein S16 -3.45 -1.79 0 0 
rpsQ 30S ribosomal protein S17 -4.8 -2.26 0 0 
rpsR 30S ribosomal protein S18 -6.91 -2.79 0 0 
rpsS 30S ribosomal protein S19 -6.22 -2.64 0 0 
rpsV 30S ribosomal subunit S22 -1.89 -0.92 0 0 
ruvA 
Holliday junction ATP-dependent DNA helicase 
RuvA 
-2.79 -1.48 0 0 
ruvB 
Holliday junction ATP-dependent DNA helicase 
RuvB 
-2.1 -1.07 0 0 
sulA cell division inhibitor SulA -10.22 -3.35 0 0 
uvrA excinuclease ABC subunit A -3.01 -1.59 0 0 
uvrB excinuclease ABC subunit B -3.24 -1.69 0 0 
      
Pathogenesis 
    
invA invasion protein InvA 1.69 0.76 0 0 
invB surface presentation of antigens protein SpaK 1.8 0.85 8.90E-10 3.34E-09 
invE invasion protein InvE 1.64 0.71 0 0 
invI surface presentation of antigens protein SpaM 1.94 0.96 0 0 
pipA pathogenicity island-encoded protein A 1.55 0.63 0 0 
pipB pathogenicity island-encoded protein B 1.57 0.65 8.52E-10 3.20E-09 
sifA secreted effector protein SifA 1.71 0.77 1.09E-12 4.95E-12 
sifB secreted effector protein SifB 3.72 1.9 0 0 
sopD secreted effector protein SopD 1.92 0.94 1.23E-09 4.53E-09 
spaP surface presentation of antigens protein SpaP 2.52 1.34 0 0 
spaQ surface presentation of antigens protein SpaQ 2.86 1.51 0 0 
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spaR surface presentation of antigens protein SpaR 2.45 1.29 0 0 
spaS surface presentation of antigens protein SpaS 2.89 1.53 0 0 
ssaB secretion system apparatus protein SsaB 3.31 1.73 0 0 
ssaC 
secretion system apparatus outer membrane 
protein SsaC 
3.3 1.72 0 0 
ssaD secretion system apparatus protein SsaD 3.15 1.65 0 0 
ssaE secretion system effector SsaE 2.74 1.45 0 0 
ssaG secretion system apparatus protein SsaG 3.64 1.86 0 0 
ssaH secretion system apparatus protein SsaH 2.77 1.47 0 0 
ssaI secretion system apparatus protein SsaI 2.01 1.01 0 0 
ssaJ secretion system apparatus lipoprotein SsaJ 2.65 1.41 0 0 
ssaK secretion system apparatus protein SsaK 3.52 1.82 0 0 
ssaL secretion system apparatus protein SsaL 2.56 1.35 0 0 
ssaM secretion system apparatus protein SsaM 3.39 1.76 0 0 
ssaN secretion system apparatus ATP synthase SsaN 2.35 1.23 0 0 
ssaO secretion system apparatus protein SsaO 3.05 1.61 0 0 
ssaP secretion system apparatus protein SsaP 2.76 1.46 0 0 
ssaQ secretion system apparatus protein SsaQ 2.8 1.49 0 0 
ssaR secretion system apparatus protein SsaR 3.09 1.63 0 0 
ssaS secretion system apparatus protein SsaS 4.36 2.12 0 0 
ssaT secretion system apparatus protein SsaT 4.69 2.23 0 0 
ssaU secretion system apparatus protein SsaU 2.32 1.21 0 0 
ssaV secretion system apparatus protein SsaV 3.55 1.83 0 0 
sscB secretion system chaperone SscB 2.53 1.34 0 0 
sseC secreted effector protein SseC 1.8 0.85 0 0 
sseD translocation machinery protein SseD 1.98 0.99 0 0 
sseE secretion system effector SseE 2.03 1.02 0 0 
sseF secretion system effector SseF 2.8 1.49 0 0 
sseG secretion system effector SseG 2.52 1.33 0 0 
sseI 
required for maintaining a long-term systemic 
infection 
1.79 0.84 2.58E-14 1.28E-13 
sseJ deacylase activity 1.74 0.8 3.04E-06 8.24E-06 
sseL deubiquitinase SseL 2.31 1.21 0 0 
ssrA secretion system sensor kinase SsrA 1.81 0.85 0 0 
STM1698 secreted effector kinase SteC 2.55 1.35 0 0 





















Figure 2. Average log10 reductions in CFU/mL for 2 min SDBD plasma treatments of 
dried Salmonella cells on sterile glass coverslips before (1x) and after (5x) 5 rounds of 




Figure 3. Average log10 reductions in CFU/mL for 5 successive plasma treatments using 






































































Figure 4. (A) Percentage of differentially expressed genes (≥ 1.5-fold or ≤ -1.5-fold) belonging to metabolic process categories as 
reported by PANTHER 10 before (1X) and after (5X) 5 rounds of successive plasma treatments of Salmonella Enteritidis. (B) Venn 
diagram representing the number of differentially expressed (≥ 1.5-fold or ≤ -1.5-fold) genes in common, before (1X), and after (5X) 5 





Figure 5. Hierarchical clustering of 533 differentially expressed genes in common within 
Salmonella Typhimurium LT2 cells before (1X) and after (5X) 5 rounds of successive 
plasma treatments showing clustering of treatment and control replicates. Treated 
samples prior to 5 successive treatments are designated T1-T3 and corresponding 
controls are designated C1-C3. Treated samples after 5 successive treatments are 




Figure 6. Hierarchical clustering of differentially expressed pathogenicity associated 
genes after 5 rounds of successive plasma treatment showing high correlation between 
treated (T5-T7) and control (C5-C7) replicates and the predominance of SPI2 expression 






Figure 7. Comparison of average relative gene expression fold changes identified by 
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ABSTRACT 
 As an emerging sterilization technology, cold atmospheric plasma, offers a dry, 
non-thermal, rapid process that is minimally damaging to a majority of substrates. 
However, despite intensive research in recent years, the mechanisms by which plasma 
interacts with living cells are poorly understood and the plasma generation apparatuses 
are complex and resource-intensive. Surface dielectric barrier discharge (SDBD) is a cold 
plasma generation technology that is more flexible, portable, scalable, and requires less 
input power than current cold plasma generation methods. In this study, the roles of 
reactive oxygen species (ROS), nitric oxide (NO), and charged particles (ions) produced 
by SDBD plasma on prokaryotic (5 strain mixture of Listeria monocytogenes (Lm)) and 
eukaryotic (human umbilical vein endothelial cells (HUVEC)) cellular function were 
evaluated. Oxidative stress responses, the accumulation of nitrite in aqueous media, ion 
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density, and bacterial inactivation at various distances from SDBD actuators were 
evaluated. SDBD actuator designs were also varied in terms of electrode number and 
length to evaluate the cellular effects of plasma volume and power distribution. NO and 
ions were found to contribute minimally to the observed cellular effects, whereas ROS 
were found to cause rapid bacterial inactivation, induce eukaryotic oxidative stress, and 
result in rapid oxidation of bovine muscle tissue. The results of this study underscore the 
dominance of ROS as the major plasma generated species responsible for prokaryotic and 
eukaryotic cellular effects. Furthermore, SDBD actuator designs can be optimized to 
maximize treatment effectiveness for flexible, non-strain-specific antibacterial therapies 
with potentially minimal bacterial resistance development. 
 
SIGNIFICANCE STATEMENT 
 Despite the well documented bactericidal effects of atmospheric cold plasma, 
limited understanding of its effects on cellular function and complex plasma generation 
apparatuses have limited the practical applications of this technology. This study revealed 
that reactive oxygen species (ROS), rather than nitric oxide and ions, were the major 
contributors to bacterial inactivation, eukaryotic oxidative stress induction, and muscle 
tissue oxidation. Additionally, the effects of plasma volume and power distribution 
among surface dielectric barrier discharge (SBDB) actuators were found to impact ROS 
production efficiency. Since ROS cause physical damage to lipids, proteins, and nucleic 
acids, optimization of versatile and flexible SDBD actuators may provide a foundation 
for developing antibacterial therapies to which bacterial pathogens have a limited ability 




 The development of antibiotic resistance among pathogens, such as Methicillin-
resistant Staphylococcus aureus (MRSA) [1] and carbapenem-resistant 
Enterobacteriaceae (CRE) [2, 3], has become a major health concern in recent decades. 
In many cases of such infections, treatment options are limited to the use of relatively 
toxic drugs, such as colistin, which has become a last-resort choice [4].  Currently, high-
frequency monitoring and patient isolation, both of which have limited effectiveness, 
may be the only treatment options for some infections. Pathogen-specific drugs for multi-
drug resistant bacteria are continually under development but often have limited 
usefulness due to the rapid development of resistance of the pathogens to new drugs. As a 
result, new types of drug- and non-drug-based therapies and treatment options are being 
investigated that could allow an increased or indefinite usable lifespan before resistance 
develops. A key consideration when developing such novel therapies is that they must 
display selectivity between eukaryotic and prokaryotic cells. Some antibacterial 
antibiotic-enhancing alkaloids, for example, are highly toxic to eukaryotic cells and may 
have negative side effects, such as immunosuppression [5]. The development of novel 
approaches, either those that block or circumvent resistance mechanisms or those that 
attack new targets, is essential. Cold plasmas, or nonthermal plasmas, have been heavily 
investigated in recent years due to their many potential benefits in the field of healthcare, 
mainly for applications in disinfection and sterilization [6-10], wound healing [11-13], 
and cancer treatment [14-18]. Various cold plasma technologies have shown 
effectiveness against drug-resistant bacteria and are currently being reviewed for clinical 
applications [19-21]. However, the current designs rely on close proximity [21] and 
195 
 
require an external gas flow for distribution of plasma-generated species to treatment 
sites [17,18]. Surface dielectric barrier discharge (SDBD), a novel method of nonthermal 
plasma generation, as previously described [6, 22], overcomes these drawbacks by having 
low power requirements, more treatment flexibility, and an increased effective treatment 
range. Because SDBD plasma generation, a semi-direct method of exposure to plasma 
species, does not require the substrate to complete the electric circuit, potential negative 
effects such as burning and tissue desiccation can be mitigated. SDBD exposure has 
shown  a dose-based differential response in eukaryotic cells [22] and lethal effects on 
prokaryotic cells [6]. It was observed that prokaryotic cells have a lower tolerance to 
plasma-generated species than eukaryotic cells and therefore surface decontamination of 
eukaryotic tissues may be possible without adverse effects on the treated tissue. SDBD, 
being a surface treatment, may provide an alternative for precision surface treatments in 
hospitals, medical facilities, and dermatological applications. 
 Although investigated for many years, the specific mechanisms of cold plasma 
interaction with prokaryotic and eukaryotic cells are poorly understood. To gain a better 
understanding of the cellular mechanisms associated with SDBD-induced plasma species, 
the roles of ROS, RNS, and ions on prokaryotic and eukaryotic cells were investigated in 
this study. Listeria monocytogenes was used as a representative prokaryote and human 
umbilical and venous endothelial cells (HUVECs) were used to represent eukaryotic 
cells. Reactive oxygen species (ROS) were found to be the predominant component of 
the plasma species produced by SDBD that influenced prokaryotic and eukaryotic cells. 
Furthermore, it was shown that SDBD actuator design optimization can help lower the 




MATERIALS AND METHODS 
 Plasma Actuator Arrangement. Plasma actuators were constructed using 
0.0254-cm thick copper clad Teflon sheets (McMaster-Carr Supply Company, USA) as a 
dielectric medium, to which 0.2 cm wide copper tape (McMaster-Carr Supply Company, 
USA) was attached asymmetrically on either side to serve as electrodes (Figure 1). All 
experiments were carried out with identical actuators operating at 13.5 W and 50% duty 
cycle (effective power of 6.75 W). Different configurations of electrodes were used, as 
described below. 
 (i) To test the effects of power density on nitrite production, three different 
actuators were developed with electrodes of length 3.6 cm, 5.4 cm, and 11 cm. Power per 
unit length of the electrode was calculated for each configuration using the equation: 





𝑇𝑜𝑡𝑎𝑙 𝑙𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑝𝑙𝑎𝑠𝑚𝑎 (𝑚) 
 
where the total length of plasma is measured by multiplying the number of edges on 
which the plasma is generated by the length of the electrodes. Accordingly, power 
densities per unit length of 93.75 W/m, 62.5 W/m and 30.68 W/m were observed for 
electrode lengths of 3.6 cm, 5.4 cm, and 11 cm, respectively. 
 (ii) To understand the effect of number of electrodes, three actuators were 
prepared using 3.6 cm long electrodes on a dielectric of area 5 cm × 4 cm. The numbers 
of electrodes placed on the dielectric were 2, 4, and 7 with the same power input as 
above. Samples were exposed to plasma at 1 cm from the actuator. However, to test the 
effect of change in distance between the actuator and the sample, the 4-electrode 
configuration was used at distances of 1, 3, 5, and 7 cm from the sample.  
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 (iii) For mammalian cell culture experiments, the actuator size had to be adjusted 
to fit the culture plates, according to the description in a previous study [22]. In brief, 
parallel electrodes of 11 cm × 0.5 cm were placed on the Teflon sheets on the side 
exposed to the sample being treated, with a total actuator size of 12.5 cm × 3 cm. A 
common ground electrode in the form of a rectangle of 11 cm × 0.5 cm was used on the 
opposing side (Figure 1). The actuator was placed at ~1 cm from the surface of the cell 
monolayer formed on the bottom of the petri dish. In accordance with previous work 
[22], all cells were treated with plasma for 4 min.  
 
 Air Ion Production due to Plasma Exposure. The density of ions generated due 
to SDBD cold plasma exposure were measured with an air ion counter modle AIC 
(AlphaLab, Inc., Salt Lake City, UT), which measures separately the number of positive 
and negative ions per cm3 of air. This air ion meter is based on a Gerdien Tube (Gerdien 
Condenser) design and contains a fan that pulls air through the meter at a calibrated rate. 
The density of ions resulting from plasma exposure was measured at 1, 3, 5, and 7 cm 
from the actuator surface with and without turning on the fan.  The air ion density 
resulting from plasma generation was compared to the ambient air to determine the 
relative increase in ion density. All measurements were done in triplicate and with the fan 
off to prevent any bias due to induced convection. Ion density was measured once a 
steady state reading was observed by the air ion counter. 
 
 Microbial Inoculation and Sample Preparation. Five strains of Listeria 
monocytogenes (F6854, 12433, G3982, J0161 and, Scott A) were cultured for 24 hours at 
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37°C in tryptic soy broth (TSB, Difco). After incubation, 1 mL of each culture was 
centrifuged at 9,000 x g for 3 minutes. Pellets were re-suspended in 1 mL of 0.1% (w/v) 
sterile peptone water (Difco) and combined to obtain a 5-strain mixture (5 mL total). The 
mixture was then diluted 10-fold to produce the desired inoculum concentration of 106 
CFU/mL, and was uniformly distributed in 20-25 spots on sterile glass coverslips (22 mm 
x 22 mm). Inoculated coverslips were air dried in a biosafety cabinet for approximately 
60 min prior to plasma treatment. 
 
 Electrical Conductivity of Plasma Treated Water and Media. Ten mL of 
water or growth medium used for HUVEC culture were treated with plasma for 2 and 4 
minutes. The electrical conductivity of the treated water and growth medium was 
measured with a portable pH/EC/TDS meter model MW802 (Milwaukee Instruments, 
Inc., Rocky Mt, NC) at 30 min, 1 hr, 12 hr, and 24 hr after plasma treatment.  
 
 Endothelial Cell Culture. Human umbilical vein endothelial cells (HUVEC-2, 
derived from single donors, Life Technologies) cells were cultured in Medium 200 
phenol red free (PRF), supplemented with low serum growth supplement (LSGS, 
containing 2% v/v fetal bovine serum, 1 µg/mL hydrocortisone, 10 ng/mL human 
epidermal growth factor, 3 ng/mL basic fibroblast growth factor, and 10 µg/mL heparin) 
following the manufacturer’s instructions, as described previously [22]. HUVECs were 
maintained at 37°C, 5% CO2/95% air, in a humidified cell culture incubator and fed with 
fresh medium every 36 hours. When confluent, cells were dissociated with 0.025% 
trypsin and 0.01% EDTA in PBS and neutralized with trypsin neutralizer solution 
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(phosphate-buffered saline (PBS) containing calf serum as a trypsin inhibitor), 
centrifuged at 125×g for 5 minutes and resuspended in growth medium. Viable cells were 
counted using trypan blue and seeded into various culture plates, as required. Based on 
viability analysis [22], cells were exposed to plasma for 4 minutes at a distance of 
approximately 1 cm. 
 
 Extracellular Nitrite Detection. Cells were seeded into a 24 well plate at 12,000 
cells per well and incubated with 500 µL medium. After 24 hours, cells were pretreated 
with carboxy-PTIO (100 µM), which scavenges NO stoichiometrically, and incubated for 
45 minutes before they were exposed to plasma. Untreated samples with and without the 
NO scavenger were used as controls. Culture medium was retrieved at 30 min, 1 hour, 12 
hours, and 24 hours for nitrite analysis and mixed with an equal volume of Griess 
Reagent Kit (for nitrite detection) as specified by the vendor (Molecular Probes, Life 
Technologies, USA), then incubated at room temperature for 20 min. The absorbance 
was measured at 490 nm with an Emax precision microplate reader using the software 
SoftMax Pro 4.3 (Molecular Devices, Sunnyvale, CA), using a calibration curve with a 
range of 0–100 µM concentrations of NaNO2.   
 Fresh medium was used to measure nitrite production induced by plasma to 
establish a baseline nitrite concentration attributable to plasma exposure to discount nitric 
oxide synthase (NOS) activity. For measuring the effects of power density and number of 
electrodes, tests were conducted using 1 mL of medium in a 6-well plate and nitrite 




 Intracellular ROS Detection. Cells were seeded in a 96 well plate at a density of 
7,000 cells per well and incubated with 200 µL medium.  Caboxy-H2DCF-DA was added 
to all cultures at 50M following the vendor’s protocol. Four different conditions were 
created: (a) Control with NAC (5mM, based on ref [23]) but not exposed to plasma; (b) 
Plasma treated cells without NAC; (c) Plasma treated cells with NAC; (d) H2O2 (200µM) 
as a positive control. For conditions containing NAC, the scavenger was added 45 
minutes prior to plasma treatment. Intracellular ROS levels were assessed using the 
Image-IT LIVE Green Reactive Oxygen Species Detection Kit (Molecular Probes, Life 
Technologies, USA) according to the manufacturer’s protocol. Fluorescence intensity 
was measured in a microplate reader, SpectraMAX GEMINI XS, using the software 
SoftMax Pro 4.3 (Molecular Devices, Sunnyvale, CA) at 495/529 nm. Fluorescence 
intensity was recorded at 30 min, 1 hour, 12 hours, and 24 hours after plasma treatment  
using an inverted microscope (Nikon Eclipse TE 2000-U, Melville, NY).   
 
 Evaluation of ROS and Plasma Effects on Bovine Muscle Tissue. Two 
separate sets of experiments were designed to evaluate the role of plasma generated ROS 
on muscle tissue. First, the tissue was inoculated with pathogens (5 strain cocktail of 
Listeria monocytogenes) and exposed to plasma for 4 minutes with a 4 electrode 
configuration at 1 cm from the sample. In the second experiment, the muscle tissue was 
coated with 1 ml of 5 mM NAC prepared in PBS to observe if the effects of plasma were 
due predominately to ROS. Samples that did not have NAC were coated with PBS alone 




 Transmission electron microscopy. Transmission electron microscopy (TEM) 
was used to visualize untreated control and plasma-treated Escherichia coli K12 cells to 
evaluate the morphological effects of the plasma treatment. A suspension of 
approximately 107 CFU/mL of E. coli K12 cells, prepared as described above, were 
spotted onto carbon-backed gold TEM grids placed onto sterile glass coverslips, air-dried 
for 60 minutes, and treated with SDBD plasma actuators for 2 and 4 minutes at a distance 
of 1 cm, as described above. The cells were then negative stained with phosphotungstic 
acid and visualized with a JEOL JEM-2100 Scanning Transmission Electron Microscope 
System 
 
 Statistical Analysis. All the experiments were conducted in triplicate. Reported 
values were represented as mean ± SD. Significant difference between two groups was 
analyzed using a paired sample t-test with a 95% confidence interval. Differences in the 
results were considered statistically significant when p < 0.05. 
 
RESULTS AND DISCUSSION 
Correlation of Nitrite Production and Power Distribution 
 Nitric oxide (NO) is an important intracellular and intercellular signaling 
molecule involved in regulation of cardiovascular, nervous, and immunological function 
[24]. NO regulates vascular tone, endothelial permeability, smooth muscle cell 
proliferation, platelet aggregation, and other functions [24, 25]. It is synthesized 
intracellularly during the conversion of L-arginine into L-citrulline in the presence of 




generated readily in aqueous solutions by oxidation of NO [26] by O3 or O2
-. For this 
reason, the production of extracellular NO following exposure to cold plasma was 
determined by measuring the accumulation of NO2
-, the stable metabolite of NO secreted 
into the culture medium to provide evidence of reactive nitrogen species (RNS) produced 
by the plasma source [27, 28]. 
 To evaluate the correlation of nitrite formation with power consumption, a two-
electrode configuration was used, wherein the actuator consisted of two exposed 
electrodes with a single encapsulated electrode on the opposite side of the dielectric. The 
plasma was generated between the two exposed electrodes. HUVEC media (without 
cells) in a 6-well plate was exposed to plasma at approximately 1 cm from the actuator 
for a treatment time of 2 minutes. The power per unit length was varied by altering the 
length of the electrodes. Three different actuators with different power densities were 
tested. It was observed (Figure 2a) that the nitrite concentration increased with the 
increase in the power per unit length. This result suggested a direct correlation of power 
with nitrite generation, and hence suggests that higher NO concentrations can be 
generated with a higher power input. These results agree with the findings of Pavlovich et 
al., who suggested a transition to higher NOx phase with increased power density [29]. 
 
Correlation of Nitrite Production and Bacterial Inactivation 
 The correlation of nitrite generation and bacterial inactivation was evaluated using 
a five strain mixture of Listeria monocytogenes. Additionally, the effect of increased 
plasma volume was investigated by varying the number of electrodes between 2, 4, and 7. 
Since all tests were carried out after sufficient drying of bacterial suspensions on glass 
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coverslips, the observed results were on a dry surface. However, the presence of moisture 
and humidity on the cellular level cannot be ruled out completely and further analysis is 
required to quantify the effect of moisture on bacterial inactivation with plasma 
treatment. A higher concentration of OH radicals were observed through optical emission 
spectroscopy in moist environments in a previous study [22].  
 Listeria cells were exposed to plasma for a period of 2 minutes at 1 cm from the 
samples. Nitrite concentration decreased with increasing electrode numbers from two to 
four and remain relatively the same between 4 and 7 (Figure 2b). Since the same net 
power was applied to all configurations, by increasing the number of electrodes, the 
volume of plasma produced increased, while the power per unit length decreased. 
Therefore, an increased electrode number increased the plasma volume, albeit at lower 
power per unit length. The 2-electrode configuration had a power per unit length of 93.75 
W/cm, as compared to the 15.63 W/cm in the 7 electrode configuration.   
 Bacterial inactivation showed an opposite trend, increasing with an increase in 
electrode number at the same power input (decrease in power per unit length). A 
complete inactivation of the bacterial cells inoculated on glass coverslips (106 CFU/mL) 
was observed with the 4 and 7 electrode configurations after 2 minutes of treatment. The 
increased bacterial inactivation associated with increased plasma volume suggests no 
clear correlation between nitrite production and bacterial inactivation.  A lower power per 
unit length still produced a high reduction of L. monocytogenes, in contrast to what was 
observed by others [30] and suggests that device design may be a major contributing 
factor to bacterial inactivation [29, 31-33]. The increase in decontamination effects with 
increase in the number of electrodes may be a consequence of overall increase in the 
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relative densities of different plasma species as a result of increased plasma volume.  The 
results do suggest that the low power, large plasma volume regime may be a better 
approach for sterilization and decontamination, thus making possible development of low 
power plasma devices for decontamination applications.  
 
Correlation of Ion Density and Bacterial Inactivation 
 To investigate the role of ions in the plasma decontamination process, ion density 
was correlated with bacterial inactivation using a 4-electrode plasma actuator with 
treatment distances between 1 and 7 cm (Figure 1). The 4-electrode configuration was 
selected since a substantially higher bacterial reduction was observed as compared to that 
measured with the 2-electrode configuration. Ions  are produced by the plasma process 
from secondary electrons near the actuator [34]. Measurements from the air ion counter 
indicated that the ion densities at the treated surface were correlated with distances from 
the actuator, at approximately 2200 ions/cm3 and 400 ions/cm3 at 1 and 7 cm, 
respectively. The technique reported here prevented a biased extraction of ions from the 
surface of the plasma actuator and results revealed that ion density decreases with 
increased distance from the plasma generation source.  These ions and electrons transfer 
energy to radicals and metastables, which are responsible for microbial inactivation and 
other cellular effects. Ozone, one of the primary metastables produced, increased to more 
than 0.14 ppm within 10 seconds (data not shown). 
 Bacterial inactivation decreased with increased plasma treatment distance from 1-
7 cm, correlating with the decreased ion flux (Figure 3a). Alternatively, bacterial 
inactivation increased with increasing electrode numbers for the same power input. 
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Antibacterial activities were measured at 1 cm from the actuators, where the ion densities 
are at the highest. Complete inactivation was observed within 2 minutes of treatment with 
the 7-electrode arrangement (Figure 2b). However, the magnitude of ions produced (~ 
103 -104) was the same for the 2, 4 and 7 electrode configurations, demonstrating that 
increased net ion density does not correlate with the increased bacterial inactivation 
observed with increased electrode numbers. This finding may suggest that ions have a 
synergistic effect close to the actuators, but their effects decrease with distance from the 
actuators.   
 
Ion Accumulation in Aqueous Media 
 In addition to actuator distance, duration of exposure to ions is also a factor in 
plasma effects on cells, particularly in aqueous environments.  To understand this factor, 
the lifespan of ions was measured in deionized (DI) water and untreated medium by 
observing the change in conductivity over time after different durations of plasma 
exposure (Figure 3b). The conductivity in the untreated medium was significantly higher 
than that in DI water, probably due to the presence of electrolytes and proteins in the 
medium. Hence, conductivity changes in the medium could not be measured. The ionic 
perturbations observed in DI water after plasma treatments were negligible. Untreated DI 
water retained a conductivity of 0 mS/cm3, even after 24 hours. The absence of change in 
the perturbations introduced in the conductivity of DI water post treatment showed that 
the conductivity created is a consequence of oxygen and nitrogen species rather than ions, 
which have a life span on the order of nanoseconds to milliseconds [31, 37]. Therefore, 
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the effects of ions in aqueous environments may be discounted as playing an important 
role. 
 Another possible explanation for these results is the generation of acidic H3O
+ 
ions by reactions of the water molecules with H2O2 [36]. Other researchers have noted an 
increase in acidity and formation of nitrous (HNO2) and nitric (HNO3) acid, along with 
H2O2, in unbuffered water [33, 38]. A similar decrease in pH was observed in previous 
work [22] and was attributed to formation of HNO2 and HNO3, along with carbonic acid 
(H2CO3). Increased conductivity may be a result of dissociation of these acids since 
acidified aqueous nitrate and nitrite anions have been shown to form when water is 
exposed to atmospheric plasmas [33, 39].   
 No substantial increase in ionic perturbations (conductivity) with increased 
electrode numbers was observed, further suggesting that ions may not contribute to the 
cellular effects of plasma treatment but rather to the formation of nitrites and increase in 
the oxidative species, also contributing to increased acidity. The pH ranged from 7 to 3.6, 
3.6, and 3.4 and remained constant over a period of 24 hours when exposed to plasma 
with the 2, 4, and 7 electrode configurations, respectively, for 2 minute treatments at 1 
cm. These results corroborate the theory of Kono et al. that a synergystic antimicrobial 
effect occurs as a result of NO2
-, H2O2, and low pH [39, 40]. This is another example of 
how device design affects device performance, evident from the difference in trends of 
pH change observed here and that observed by Kojtari et al [41]. A time course analysis 
is required for each of the electrode arrangements to ascertain the full effect on change in 
pH.  Hence, in an aqueous medium the ions do not contribute to observed cellular effects 
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due to their short lifespans (on the order of nanoseconds) and to their inability to travel 
across the cell membrane due to the presence of charge (e.g., O2
-). 
 
Eukaryotic Cellular Responses to RNS 
 To evaluate the cellular effects of RNS, HUVEC cells were treated with SDBD 
cold plasma with and without the presence of a water-soluble NO scavenger, cPTIO. The 
resulting concentration of nitrites in the most stable configuration, the metabolite form of 
NO, in aqueous media, was then measured via the Griess assay  [28, 44, 45] (Figure 4). 
One hundred µM of c-PTIO was used since this concentration was effective at mitigating 
the effects of both extracellular and intracellular NO with no observable effects on the 
cells themselves [14, 23]. In plasma, NO2 produced from NO and ozone (O3) reacts with 
H2O to form NO2
- and NO3
- [43].  
NO + O3 → NO2 + O2  
2NO2 + H2O → HNO2(aq) + HNO3(aq) 
 Nitrite concentrations in plasma treated samples containing HUVEC cells without 
the c-PTIO scavenger were nearly 10 fold higher than in samples containing both 
HUVEC cells and the scavenger (Figure 5A), indicating that increased nitrite 
concentration is due to NO conversion to nitrite. Thirty minutes after plasma exposure of 
samples without the scavenger, nitrite concentrations were observed to be as high as 195 
µM, decreased to approximately 130 µM after one hour, and stabilized to approximately 
105 µM after 24 hours. HUVEC cell-containing control samples (no plasma exposure) 
with and without the scavenger had negligible nitrite concentrations at all time points. 
These results confirm that the increased nitrite concentration was not produced solely by 
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the enzyme NOS in HUVEC cells, but rather was a result of the plasma treatment. This 
finding corroborates those of another study in which high HUVEC cell viability was 
measured after a 4 min plasma treatment [22].  
 When evaluating nitrite concentrations in HUVEC medium devoid of cells, a 
similar trend was observed. Nitrite concentrations in HUVEC medium without the 
scavenger were highest 30 minutes after plasma exposure, with an average of 70 µM, and 
then decreased to18 µM over a period of 24 hours. This finding suggests that the 
increased concentration of nitrites was a result of oxidative stress caused by ROS rather 
than RNS. ROS can also interact with NO to produce other reactive species that may 
contribute to the reduced pH. Acids such as nitric acid may also be significant 
contributors to the increased NOS activity, as indicated by the decrease in pH [22, 32, 
46]. In acidic environments, NO2
- and O2
- can react to form peroxynitrous acid 
(ONOOH) and nitrous acid (HNO2) [46].  
 
Eukaryotic Cellular Responses to ROS 
 The cellular effects of ROS produced by SDBD plasma were also evaluated using 
HUVEC cells, but with the addition of a ROS scavenger (NAC) and a ROS indicator 
(carboxy-H2DCF-DA) (Figure 4). NAC readily binds with all ROS, including those that 
contain nitrogen [48], both intracellularly and extracellularly [49]. At the intracellular 
level, NAC is rapidly hydrolyzed to L-cysteine, allowing increased production of 
glutathione (GSH), a powerful antioxidant. In the presence of  glutathione peroxidase 
(GSH-Px), GSH and H2O2 react to form disulfide (GS-SG) and water [49, 50-52] (Figure 
4). At the extracellular level, NAC simply acts as a nucleophile, donating an electron to 
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ROS introduced by the plasma treatment [49]. Five mM of NAC was used in this study 
since this concentration was found to provide effective cyto-protective properties while 
also not having toxic effects on the cells [23, 53]. Carboxy-H2DCF-DA is an acetylated 
form of fluorescin that is deacytelated by ROS, causing it to fluoresce. Thus, relative 
fluorescence intensity can be correlated to the relative intracellular accumulation of ROS.   
 The extent of oxidative stress experienced by a cell depends on the concentration 
of ROS within a cell and the rate at which the ROS can be reduced. O2
- and H2O2 are 
produced during normal cellular respiration but are rapidly and efficiently reduced by 
several enzymes [47]. Oxidative stress occurs when these enzymes are not able to reduce 
ROS rapidly enough, causing an increase in ROS concentration and the potential for 
oxidative damage to DNA, lipids, and proteins. O2
- and H2O2, although having the 
potential to cause oxidative damage themselves, can serve as precursors to the more 
potent hydroxyl radical (OH*) through pathways such as the Fenton reaction [47]. OH* is 
the most reactive ROS and rapidly causes oxidative damage to cellular components. 
 The effect of ROS generated by plasma treatment on HUVEC cells was observed 
by using carboxy-H2DCF-DA, with and without the presence of NAC (Figure 5B). 
Positive control samples without NAC, containing 200 µM H2O2 (Figure 5C(c)), had a 
fluorescence intensity similar to that of the plasma treated samples without NAC (Figure 
5C(a)). Fluorescent micrographs showed the highest fluorescence intensity for the 
plasma treated samples without NAC (Figure 5C(a)) and the lowest for the untreated 
control samples with NAC (Figure 5C(d)). Plasma treated samples with NAC (Figure 
5C(b)) showed a lower intensity than those without, indicating that NAC was able to 
neutralize the plasma generated ROS and reduce the level of oxidative stress experienced 
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by the cells. Additionally, fluorescence intensity increased over time after plasma 
treatment and was highest after 24 hours, indicating the occurrence of oxidative stress 
within the cells. No significant ROS related stress was observed in any of the untreated 
control samples, with or without NAC.     
 Taken together, these results suggest three major conclusions. First, production of 
a relatively high concentration of ROS by SDBD plasma was confirmed, with the relative 
concentration (and therefore cellular effects) negatively correlated with increased 
distance from the actuators. Second, ROS produced by SDBD plasma was found to cause 
oxidative stress in HUVEC cells that continued to increase after plasma treatment was 
stopped. Third, compared with ROS, NO and ions play a minor role in the eukaryotic and 
prokaryotic cellular response to cold plasma treatment. 
 Extracellular ROS generation by SDBD plasma actuators was assessed using 
optical emission spectroscopy in a previous work, wherein the major oxidative species 
were found to be O3, OH*, NO, and O2
+ [22]. These ROS can serve as precursors to other 
ROS, such as H2O2 and HNO2, in an aqueous medium [54]. Several authors have 
attempted to validate the dominance of HNO3 and H2O2 in the plasma interaction with 
cells, especially in the generation of plasma activated water (PAW) [38].  However, the 
general conclusion was that these agents, alone [55] or in combination, did not give the 
same response as observed with plasma treatment [33, 41, 56], thus indicating a 
multicomponent chemical dynamic.  
 
ROS and Plasma Effects on Bovine Muscle Tissue 
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 The dominance of the role of ROS rather than RNS in the plasma treatment 
process was further confirmed by assessing the effects of plasm treatment on pathogen-
inoculated bovine muscle tissue. Interestingly, negligible bacterial inactivation was 
observed on muscle tissue samples surface inoculated with L. monocytogenes. This 
observation may be partly attributed to the surface roughness and porosity of the muscle 
tissue  [57], providing more shelter for the bacteria, or a shadowing effect, from the 
plasma generated species. Alternatively, this observation may be a result of the high 
concentration of myoglobin and other components having high affinities for oxidation by 
ROS. Pavlovich et al. observed similar results using pig skin, in which a slight reduction 
in E. coli concentration was observed after plasma treatment as compared to other 
substrates [29]. The presence of such compounds may reduce the concentration of ROS 
able to interact with and damage bacterial cells. 
 Although limited bacterial inactivation was observed, the texture and color of the 
muscle tissue noticeably changed from smooth to wrinkled and from bright red to a rustic 
brown. This texture and color change may be characteristic evidence of oxymyoglobin 
(OxyMb) oxidation to form methemoglobin (MetHb) by ROS [26]. The high 
concentration of iron in oxymyoglobin (or oxyhemoglobin) may contribute to the high 
affinity of ROS to oxymyoglobin [58]. Tang et al [59] reported  a similar observation in 
which the addition of glutathione to bovine muscle cytosol improved oxymyoglobin 
redox stability. Further investigation of this observation was carried out by treating the 
muscle tissue samples, with and without NAC, an ROS scavenger, prior to plasma 
treatment. Plasma treated samples with NAC showed no observable color or texture 
changes, whereas those without NAC exhibited the characteristic color change from 
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bright red to rustic brown (Figure 6). NAC produced no visibly detrimental effects on 
untreated muscle tissue control samples (Figure 6(a)). These results confirm that SDBD 
produces a relatively high concentration of ROS, even beyond the plasma region itself, 
and is a major contributing factor to the cellular effects of plasma treatment. Further 
histological analysis of the tissue samples is required to better characterize the observed 
effects of cells subjected to plasma treatment. 
 
Cell Surface Effects of SDBD Treatment.  
 TEM of SDBD plasma-treated E. coli cells compared to untreated controls 
revealed noticeable morphological differences with increasing treatment times ranging 
from 2 to 4 min (Figure 7). Untreated cells had distinct boundaries when clustered in 
groups, with multiple cells undergoing mitosis and clearly visible fimbriae under high 
magnification. After 2 min treatments cell surfaces were visually darker and cell 
boundaries appeared more ragged, less uniform, and less distinct between individual 
cells. Substantially more debris, also visible only in treated samples, may be a result of 
membrane damage and cytosol leakage. Membrane and cell surface damage became 
increasingly more evident after 4 min treatments, evidenced by darker staining, less 
distinct cellular margins, and greater amounts of extracellular debris (Figure 7). 
 
Summary and Conclusions 
 A differential response to plasma treatment between prokaryotic and eukaryotic 
cells has been observed by several resarchers [9, 66 ,22]. Compared to eukaryotes, 
prokaryotic cells are much more sensitive to oxidative stress [64]. A similar differential 
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response has been observed between normally functioning eukaryotic cells and cancer 
cells [67], attributed to the Warburg effect, by which cancer cells are damaged more 
readily by ROS due to their increased reliance on aerobic metabolism [68, 69].  Based on 
this characteristic, a selective treatment of cancer cells among healthy mammalian cells 
may be possible [67, 70]. The rate of cellular inactivation by plasma generated in air or 
oxygen was several times faster than when it is generated in noble gases, further 
corroborating the dominant role of ROS on cellular effects [65].  Identifying and 
quantifying the specific ROS produced will aid in further tuning of the system for higher 
precision and effective applications. Since nonthermal plasmas allow a surface treatment 
effect rather than a bulk effect, it will be beneficial to tune the system for etching-like 
capabilities, providing an exact treatment approach. Furthermore, an increased 
understanding of the utilization of the flow induction capabilities of SDBD for long range 
applications should be investigated further and be more fully characterized. 
 To summarize, these results provide evidence that ROS, rather than NO and ions, 
are the primary contributors to plasma-induced bacterial inactivation, eukaryotic 
oxidative stress, and muscle tissue oxidation. Maximal cellular effects were observed 
when samples were placed in close proximity to plasma actuators, possibly the result of a 
synergistic effect of ROS, NO, and ions that decreased with increasing distance from the 
actuators, as was also observed by Kono et al. [40]. The observed ion density was highest 
immediately adjacent to the plasma region and decreased rapidly with increased distance 
from the actuators. In aqueous medium, ROS, NO, and ions contributed to a decrease in 
pH, adding to the synergistic effects. At increased distances from plasma actuators, ROS 
were the major plasma generated species interacting with treated cells. 
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 Nitrites may be beneficial in higher concentrations for wound care applications 
such as in acidified nitrite creams for topical NO donating wound healing agents [71] and 
surface disinfection of robust, difficult to inactivate bacterial strains [72]. Direct plasma 
exposure methods such as volumetric DBD, although sometimes more efficient at 
bacterial inactivation, have been observed to cause tissue damage and often provides a 
non-uniform treatment [29].  Hence, the semidirect method of plasma exposure used in 
this work (SDBD) is a good alternative with capabilities of flow control to push the 
generated plasma species to the surface being treated. SDBD actuator designs also allow 
manipulation of the species being generated by changing the plasma parameters and 
electrode configurations, thus providing a specific desired effect (i.e. sterilization vs. 
wound healing). The selectivity and tuning capabilities offered by this technology can 
help in our efforts to resolve major global public health issues such as the development of 
bacterial antimicrobial resistance, chronic wound infections, and sterilization of a variety 
of both organis and inorganic surfaces. Optimized SDBD actuators are viable candidate 
for numerous applications in the healthcare industry, especially for sterilization and 
wound healing. 
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Figure 2. (a) Correlation of power density per unit length of electrode to nitrite production using a two electrode configuration by 
changing the electrode length; (b) Correlation of reduction in Listeria monocytogenes (5 strain mixture) with increase in number of 




Figure 3. (a) Correlation of change in ion density and reduction in concentration of Listeria monocytogenes (5 strain mixture), with 
distance from plasma actuators using a four electrode configuration; (b) Change in conductivity of deionized water over 24 hours after 






Figure 4. Schematic showing the cytoprotective interactions of ROS scavenger NAC (5mM) with different ROS species (both 




Figure 5. (A) Analysis of plasma induced nitrite concentration as a indicator for NO generation, with and without NO scavenger 
cPTIO; (B)Analysis of plasma induced intracellular ROS (Oxidative stress response) as a indicator for ROS generation, with and 
without ROS scavenger NAC (5mM); (C) Fluorescent micrographs of HUVECs representing oxidative stress response to plasma with 
and without ROS scavenger NAC (5mM). (a) Plasma treated HUVECs; (b) Plasma treated HUVECs with NAC (5mM); (c) Positive 






Figure 6. Effects of plasma exposure on bovine muscle tissue; (a) control (no NAC); (b) 
plasma treated (no NAC); (c) control (with 5mM NAC); (d) plasma treated sample (with 






Figure 7. TEM of Escherichia coli K12 treated with SDBD cold plasma for 2 and 4 min, 
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